<div class="mw-parser-output"><div class="shortdescription nomobile noexcerpt noprint searchaux" style="display:none">Hormone therapy used to treat symptoms of menopause</div>
<style data-mw-deduplicate="TemplateStyles:r1033289096">.mw-parser-output .hatnote{font-style:italic}.mw-parser-output div.hatnote{padding-left:1.6em;margin-bottom:0.5em}.mw-parser-output .hatnote i{font-style:normal}.mw-parser-output .hatnote+link+.hatnote{margin-top:-0.5em}</style><div role="note" class="hatnote navigation-not-searchable">This article is about hormone replacement therapy in menopause. For other forms, see <a href="/wiki/Hormone_therapy" title="Hormone therapy">Hormone therapy</a>.</div>
<p><b>Hormone replacement therapy</b> (<b>HRT</b>), also known as <b>menopausal hormone therapy</b> or <b>postmenopausal hormone therapy</b>, is a form of <a href="/wiki/Hormone_therapy" title="Hormone therapy">hormone therapy</a> used to treat <a href="/wiki/Menopausal_symptoms" class="mw-redirect" title="Menopausal symptoms">symptoms</a> associated with female <a href="/wiki/Menopause" title="Menopause">menopause</a>.<sup id="cite_ref-pmid26444994_1-0" class="reference"><a href="#cite_note-pmid26444994-1">&#91;1&#93;</a></sup><sup id="cite_ref-pmid20566620_2-0" class="reference"><a href="#cite_note-pmid20566620-2">&#91;2&#93;</a></sup> These symptoms can include <a href="/wiki/Hot_flash" title="Hot flash">hot flashes</a>, <a href="/wiki/Vaginal_atrophy" class="mw-redirect" title="Vaginal atrophy">vaginal atrophy</a>, accelerated <a href="/wiki/Skin" title="Skin">skin</a> aging, <a href="/wiki/Vaginal_dryness" class="mw-redirect" title="Vaginal dryness">vaginal dryness</a>, decreased <a href="/wiki/Muscle_mass" class="mw-redirect" title="Muscle mass">muscle mass</a>, <a href="/wiki/Sexual_dysfunction" title="Sexual dysfunction">sexual dysfunction</a>, and <a href="/wiki/Osteoporosis" title="Osteoporosis">bone loss</a>. They are in large part related to the diminished levels of <a href="/wiki/Sex_hormone" title="Sex hormone">sex hormones</a> that occur during menopause.<sup id="cite_ref-pmid26444994_1-1" class="reference"><a href="#cite_note-pmid26444994-1">&#91;1&#93;</a></sup><sup id="cite_ref-pmid20566620_2-1" class="reference"><a href="#cite_note-pmid20566620-2">&#91;2&#93;</a></sup>
</p><p>The main <a href="/wiki/Sex-hormonal_agent" title="Sex-hormonal agent">hormonal medications</a> used in HRT for menopausal symptoms are <a href="/wiki/Estrogen_(medication)" title="Estrogen (medication)">estrogens</a> and <a href="/wiki/Progestogen" title="Progestogen">progestogens</a>, amongst which <a href="/wiki/Progesterone" title="Progesterone">progesterone</a> is the major naturally-occurring female sex hormone and also a <a href="/wiki/Chemical_synthesis" title="Chemical synthesis">manufactured</a> <a href="/wiki/Progesterone_(medication)" title="Progesterone (medication)">medication</a> used in menopausal hormone therapy.<sup id="cite_ref-pmid26444994_1-2" class="reference"><a href="#cite_note-pmid26444994-1">&#91;1&#93;</a></sup> Though both classes of hormones can have symptomatic benefit, progestogen is specifically added to estrogen regimens when the <a href="/wiki/Uterus" title="Uterus">uterus</a> is present to avoid the increased risk of endometrial cancer. This is because unopposed estrogen therapy promotes <a href="/wiki/Endometrial_hyperplasia" title="Endometrial hyperplasia">endometrial thickening</a> and can increase the risk of <a href="/wiki/Endometrial_cancer" title="Endometrial cancer">cancer</a>, while progestogen reduces this risk.<sup id="cite_ref-Maturitas_3-0" class="reference"><a href="#cite_note-Maturitas-3">&#91;3&#93;</a></sup><sup id="cite_ref-eden_4-0" class="reference"><a href="#cite_note-eden-4">&#91;4&#93;</a></sup> <a href="/wiki/Androgen" title="Androgen">Androgens</a> like <a href="/wiki/Testosterone_(medication)" title="Testosterone (medication)">testosterone</a> are sometimes used as well.<sup id="cite_ref-ziaei_5-0" class="reference"><a href="#cite_note-ziaei-5">&#91;5&#93;</a></sup> HRT is available through a variety of different <a href="/wiki/Routes_of_administration" class="mw-redirect" title="Routes of administration">routes</a>.<sup id="cite_ref-pmid26444994_1-3" class="reference"><a href="#cite_note-pmid26444994-1">&#91;1&#93;</a></sup><sup id="cite_ref-pmid20566620_2-2" class="reference"><a href="#cite_note-pmid20566620-2">&#91;2&#93;</a></sup>
</p><p>The long-term effects of HRT on most organ systems vary by age and time since the last <a href="/wiki/Physiology" title="Physiology">physiological</a> exposure to hormones, and there can be large differences in individual regimens, factors which have made analyzing effects difficult.<sup id="cite_ref-WHI_18_year_follow_up_6-0" class="reference"><a href="#cite_note-WHI_18_year_follow_up-6">&#91;6&#93;</a></sup> The <a href="/wiki/Women%27s_Health_Initiative" title="Women&#39;s Health Initiative">Women's Health Initiative</a> (WHI) is an ongoing study of over 27,000 women that began in 1991, with the most recent analyses suggesting that, when initiated within 10 years of menopause, HRT reduces all-cause <a href="/wiki/Death" title="Death">mortality</a> and risks of coronary disease, osteoporosis, and dementia; after 10 years the beneficial effects on mortality and coronary heart disease are no longer apparent, though there are decreased risks of hip and vertebral fractures and an increased risk of venous thromboembolism when taken orally.<sup id="cite_ref-7" class="reference"><a href="#cite_note-7">&#91;7&#93;</a></sup><sup id="cite_ref-Lokkegard_2017_8-0" class="reference"><a href="#cite_note-Lokkegard_2017-8">&#91;8&#93;</a></sup>
</p><p>"Bioidentical" hormone replacement is a development in the <a href="/wiki/21st_century" title="21st century">21st century</a> and uses manufactured compounds with "exactly the same chemical and molecular structure as hormones that are produced in the human body."<sup id="cite_ref-Mayo_9-0" class="reference"><a href="#cite_note-Mayo-9">&#91;9&#93;</a></sup> These are mainly <a href="/wiki/Phytosteroid" title="Phytosteroid">steroids derived from plants</a><sup id="cite_ref-clev_10-0" class="reference"><a href="#cite_note-clev-10">&#91;10&#93;</a></sup> and can be a component of either registered <i>pharmaceutical</i> or custom-made <i>compounded</i> preparations, with the latter generally not recommended by regulatory bodies due to their lack of standardization and formal oversight.<sup id="cite_ref-pmid21464264_11-0" class="reference"><a href="#cite_note-pmid21464264-11">&#91;11&#93;</a></sup>  Bioidentical hormone replacement has inadequate <a href="/wiki/Clinical_research" title="Clinical research">clinical research</a> to determine its safety and efficacy as of 2017.<sup id="cite_ref-cobin_12-0" class="reference"><a href="#cite_note-cobin-12">&#91;12&#93;</a></sup>
</p><p>The current indications for use from the <a href="/wiki/United_States" title="United States">United States</a> <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA) include short-term treatment of <a href="/wiki/Menopausal_symptoms" class="mw-redirect" title="Menopausal symptoms">menopausal symptoms</a>, such as <a href="/wiki/Vasomotor" title="Vasomotor">vasomotor</a> <a href="/wiki/Hot_flash" title="Hot flash">hot flashes</a> or <a href="/wiki/Vaginal_atrophy" class="mw-redirect" title="Vaginal atrophy">vaginal atrophy</a>, and prevention of <a href="/wiki/Osteoporosis" title="Osteoporosis">osteoporosis</a>.<sup id="cite_ref-FDA_13-0" class="reference"><a href="#cite_note-FDA-13">&#91;13&#93;</a></sup> 
</p>
<style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none" /><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Medical_uses"><span class="tocnumber">1</span> <span class="toctext">Medical uses</span></a>
<ul>
<li class="toclevel-2 tocsection-2"><a href="#Menopausal_symptoms"><span class="tocnumber">1.1</span> <span class="toctext">Menopausal symptoms</span></a></li>
<li class="toclevel-2 tocsection-3"><a href="#Heart_disease"><span class="tocnumber">1.2</span> <span class="toctext">Heart disease</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Blood_clots"><span class="tocnumber">1.3</span> <span class="toctext">Blood clots</span></a></li>
<li class="toclevel-2 tocsection-5"><a href="#Stroke"><span class="tocnumber">1.4</span> <span class="toctext">Stroke</span></a></li>
<li class="toclevel-2 tocsection-6"><a href="#Endometrial_cancer"><span class="tocnumber">1.5</span> <span class="toctext">Endometrial cancer</span></a></li>
<li class="toclevel-2 tocsection-7"><a href="#Breast_cancer"><span class="tocnumber">1.6</span> <span class="toctext">Breast cancer</span></a></li>
<li class="toclevel-2 tocsection-8"><a href="#Ovarian_cancer"><span class="tocnumber">1.7</span> <span class="toctext">Ovarian cancer</span></a></li>
<li class="toclevel-2 tocsection-9"><a href="#Other_malignancies"><span class="tocnumber">1.8</span> <span class="toctext">Other malignancies</span></a>
<ul>
<li class="toclevel-3 tocsection-10"><a href="#Colorectal_cancer"><span class="tocnumber">1.8.1</span> <span class="toctext">Colorectal cancer</span></a></li>
<li class="toclevel-3 tocsection-11"><a href="#Cervical_cancer"><span class="tocnumber">1.8.2</span> <span class="toctext">Cervical cancer</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-12"><a href="#Sexual_function"><span class="tocnumber">1.9</span> <span class="toctext">Sexual function</span></a></li>
<li class="toclevel-2 tocsection-13"><a href="#Neurodegenerative_disorders"><span class="tocnumber">1.10</span> <span class="toctext">Neurodegenerative disorders</span></a></li>
<li class="toclevel-2 tocsection-14"><a href="#Muscle_and_bone"><span class="tocnumber">1.11</span> <span class="toctext">Muscle and bone</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-15"><a href="#Side_effects"><span class="tocnumber">2</span> <span class="toctext">Side effects</span></a>
<ul>
<li class="toclevel-2 tocsection-16"><a href="#Common"><span class="tocnumber">2.1</span> <span class="toctext">Common</span></a></li>
<li class="toclevel-2 tocsection-17"><a href="#Uncommon"><span class="tocnumber">2.2</span> <span class="toctext">Uncommon</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-18"><a href="#Contraindications"><span class="tocnumber">3</span> <span class="toctext">Contraindications</span></a>
<ul>
<li class="toclevel-2 tocsection-19"><a href="#Absolute_contraindications"><span class="tocnumber">3.1</span> <span class="toctext">Absolute contraindications</span></a></li>
<li class="toclevel-2 tocsection-20"><a href="#Relative_contraindications"><span class="tocnumber">3.2</span> <span class="toctext">Relative contraindications</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-21"><a href="#History_and_research"><span class="tocnumber">4</span> <span class="toctext">History and research</span></a>
<ul>
<li class="toclevel-2 tocsection-22"><a href="#Trials"><span class="tocnumber">4.1</span> <span class="toctext">Trials</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-23"><a href="#Available_forms"><span class="tocnumber">5</span> <span class="toctext">Available forms</span></a>
<ul>
<li class="toclevel-2 tocsection-24"><a href="#Continuous_versus_cyclic"><span class="tocnumber">5.1</span> <span class="toctext">Continuous versus cyclic</span></a></li>
<li class="toclevel-2 tocsection-25"><a href="#Route_of_administration"><span class="tocnumber">5.2</span> <span class="toctext">Route of administration</span></a></li>
<li class="toclevel-2 tocsection-26"><a href="#Bioidentical_hormone_therapy"><span class="tocnumber">5.3</span> <span class="toctext">Bioidentical hormone therapy</span></a>
<ul>
<li class="toclevel-3 tocsection-27"><a href="#Compounding"><span class="tocnumber">5.3.1</span> <span class="toctext">Compounding</span></a></li>
</ul>
</li>
</ul>
</li>
<li class="toclevel-1 tocsection-28"><a href="#Society_and_public_perception"><span class="tocnumber">6</span> <span class="toctext">Society and public perception</span></a>
<ul>
<li class="toclevel-2 tocsection-29"><a href="#Wyeth_controversy"><span class="tocnumber">6.1</span> <span class="toctext">Wyeth controversy</span></a></li>
<li class="toclevel-2 tocsection-30"><a href="#Popularity"><span class="tocnumber">6.2</span> <span class="toctext">Popularity</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-31"><a href="#See_also"><span class="tocnumber">7</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1 tocsection-32"><a href="#References"><span class="tocnumber">8</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-33"><a href="#External_links"><span class="tocnumber">9</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
</div>
<h2><span class="mw-headline" id="Medical_uses">Medical uses</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=1" title="Edit section: Medical uses">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Approved uses of HRT in the United States include short-term treatment of menopausal symptoms such as hot flashes and vaginal atrophy, and prevention of osteoporosis.<sup id="cite_ref-FDA_13-1" class="reference"><a href="#cite_note-FDA-13">&#91;13&#93;</a></sup> The <a href="/wiki/American_College_of_Obstetrics_and_Gynecology" class="mw-redirect" title="American College of Obstetrics and Gynecology">American College of Obstetrics and Gynecology</a> (ACOG) approves of HRT for symptomatic relief of menopausal symptoms,<sup id="cite_ref-14" class="reference"><a href="#cite_note-14">&#91;14&#93;</a></sup> and advocates its use beyond the age of 65 in appropriate scenarios.<sup id="cite_ref-15" class="reference"><a href="#cite_note-15">&#91;15&#93;</a></sup> The <a href="/wiki/North_American_Menopause_Society" title="North American Menopause Society">North American Menopause Society</a> (NAMS) 2016 annual meeting mentioned that HRT may have more benefits than risks in women before the age of 60.<sup id="cite_ref-16" class="reference"><a href="#cite_note-16">&#91;16&#93;</a></sup>
</p><p>A consensus expert opinion published by <a href="/wiki/The_Endocrine_Society" class="mw-redirect" title="The Endocrine Society">The Endocrine Society</a> stated that when taken during perimenopause or the initial years of menopause, HRT carries fewer risks than previously published, and reduces all cause mortality in most scenarios.<sup id="cite_ref-endocrine_17-0" class="reference"><a href="#cite_note-endocrine-17">&#91;17&#93;</a></sup> The <a href="/wiki/American_Association_of_Clinical_Endocrinologists" title="American Association of Clinical Endocrinologists">American Association of Clinical Endocrinologists</a> (AACE) has also released position statements approving of HRT when appropriate.<sup id="cite_ref-cobin_12-1" class="reference"><a href="#cite_note-cobin-12">&#91;12&#93;</a></sup>
</p><p>Women receiving this treatment are usually <a href="/wiki/Menopause" title="Menopause">post-</a>, <a href="/wiki/Perimenopause" class="mw-redirect" title="Perimenopause">peri-</a>, or <a href="/wiki/Oophorectomy" title="Oophorectomy">surgically menopausal</a>. Menopause is the permanent cessation of <a href="/wiki/Menstruation" title="Menstruation">menstruation</a> resulting from loss of ovarian follicular activity, defined as beginning twelve months after the final natural menstrual cycle. This twelve month time point divides menopause into early and late transition periods known as 'perimenopause' and 'postmenopause'.<sup id="cite_ref-eden_4-1" class="reference"><a href="#cite_note-eden-4">&#91;4&#93;</a></sup> Premature menopause can occur if the ovaries are <a href="/wiki/Oophorectomy" title="Oophorectomy">surgically removed</a>, as can be done to treat <a href="/wiki/Ovarian_cancer" title="Ovarian cancer">ovarian</a> or <a href="/wiki/Uterine_cancer" title="Uterine cancer">uterine cancer</a>.
</p><p>Demographically, the vast majority of data available is in postmenopausal American women with concurrent pre-existing conditions and an average age of over 60 years.<sup id="cite_ref-marjoribanks_18-0" class="reference"><a href="#cite_note-marjoribanks-18">&#91;18&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Menopausal_symptoms">Menopausal symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=2" title="Edit section: Menopausal symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:302px;"><a href="/wiki/File:Symptoms_of_menopause_(vector).svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/9f/Symptoms_of_menopause_%28vector%29.svg/300px-Symptoms_of_menopause_%28vector%29.svg.png" decoding="async" width="300" height="303" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/9f/Symptoms_of_menopause_%28vector%29.svg/450px-Symptoms_of_menopause_%28vector%29.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/9f/Symptoms_of_menopause_%28vector%29.svg/600px-Symptoms_of_menopause_%28vector%29.svg.png 2x" data-file-width="1363" data-file-height="1377" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Symptoms_of_menopause_(vector).svg" class="internal" title="Enlarge"></a></div>Symptoms of menopause</div></div></div>
<p>HRT is often given as a short-term relief from menopausal symptoms during <a href="/wiki/Perimenopause" class="mw-redirect" title="Perimenopause">perimenopause</a>.<sup id="cite_ref-nhs_19-0" class="reference"><a href="#cite_note-nhs-19">&#91;19&#93;</a></sup> Potential menopausal symptoms include:<sup id="cite_ref-pmid26444994_1-4" class="reference"><a href="#cite_note-pmid26444994-1">&#91;1&#93;</a></sup><sup id="cite_ref-pmid20566620_2-3" class="reference"><a href="#cite_note-pmid20566620-2">&#91;2&#93;</a></sup>
</p>
<ul><li><a href="/wiki/Hot_flash" title="Hot flash">Hot flashes</a> - vasomotor symptoms</li>
<li><a href="/wiki/Vulvovaginal_atrophy" class="mw-redirect" title="Vulvovaginal atrophy">Vulvovaginal atrophy</a> - atrophic vaginitis and <a href="/wiki/Vaginal_dryness" class="mw-redirect" title="Vaginal dryness">dryness</a></li>
<li><a href="/wiki/Dyspareunia" title="Dyspareunia">Dyspareunia</a> - painful sexual intercourse due to vaginal atrophy and lack of <a href="/wiki/Vaginal_lubrication" title="Vaginal lubrication">lubrication</a></li>
<li><a href="/wiki/Osteoporosis" title="Osteoporosis">Bone loss</a> - decreased <a href="/wiki/Bone_mineral_density" class="mw-redirect" title="Bone mineral density">bone mineral density</a>, which can eventually lead to <a href="/wiki/Osteopenia" title="Osteopenia">osteopenia</a>, <a href="/wiki/Osteoporosis" title="Osteoporosis">osteoporosis</a>, and associated <a href="/wiki/Bone_fracture" title="Bone fracture">fractures</a></li>
<li><a href="/wiki/Decreased_sexual_desire" class="mw-redirect" title="Decreased sexual desire">Decreased sexual desire</a></li>
<li><a href="/wiki/Defeminization" title="Defeminization">Defeminization</a> - diminished <a href="/wiki/Gynoid_fat_distribution" title="Gynoid fat distribution">feminine fat distribution</a> and accelerated <a href="/wiki/Skin_aging" class="mw-redirect" title="Skin aging">skin aging</a><sup id="cite_ref-pmid12762829_20-0" class="reference"><a href="#cite_note-pmid12762829-20">&#91;20&#93;</a></sup><sup id="cite_ref-pmid22533363_21-0" class="reference"><a href="#cite_note-pmid22533363-21">&#91;21&#93;</a></sup></li>
<li><a href="/wiki/Sleep_disturbance" class="mw-redirect" title="Sleep disturbance">Sleep disturbances</a> and <a href="/wiki/Arthralgia" title="Arthralgia">joint pain</a></li></ul>
<p>The most common of these are <a href="/wiki/Sexual_dysfunction" title="Sexual dysfunction">loss of sexual drive</a> and <a href="/wiki/Vaginal_dryness" class="mw-redirect" title="Vaginal dryness">vaginal dryness</a>.<sup id="cite_ref-eden_4-2" class="reference"><a href="#cite_note-eden-4">&#91;4&#93;</a></sup><sup id="cite_ref-sarrel_22-0" class="reference"><a href="#cite_note-sarrel-22">&#91;22&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Heart_disease">Heart disease</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=3" title="Edit section: Heart disease">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Blausen_0257_CoronaryArtery_Plaque.png" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/d/d1/Blausen_0257_CoronaryArtery_Plaque.png/220px-Blausen_0257_CoronaryArtery_Plaque.png" decoding="async" width="220" height="155" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/d/d1/Blausen_0257_CoronaryArtery_Plaque.png/330px-Blausen_0257_CoronaryArtery_Plaque.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/d1/Blausen_0257_CoronaryArtery_Plaque.png/440px-Blausen_0257_CoronaryArtery_Plaque.png 2x" data-file-width="940" data-file-height="661" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Blausen_0257_CoronaryArtery_Plaque.png" class="internal" title="Enlarge"></a></div>The risks of <a href="/wiki/Coronary_disease" class="mw-redirect" title="Coronary disease">coronary heart disease</a> with HRT vary depending on age and time since menopause.</div></div></div>
<p>The effect of HRT in menopause appears to be divergent, with lower risk of heart disease when started within five years, but no impact after ten.<sup id="cite_ref-BoardmanHartley2015_23-0" class="reference"><a href="#cite_note-BoardmanHartley2015-23">&#91;23&#93;</a></sup><sup id="cite_ref-24" class="reference"><a href="#cite_note-24">&#91;24&#93;</a></sup><sup id="cite_ref-25" class="reference"><a href="#cite_note-25">&#91;25&#93;</a></sup> There may be an increase in heart disease if HRT is given twenty years post-menopause.<sup id="cite_ref-Manson_WHI_2013_26-0" class="reference"><a href="#cite_note-Manson_WHI_2013-26">&#91;26&#93;</a></sup> This variability has led some reviews to suggest an absence of significant effect on <a href="/wiki/Morbidity" class="mw-redirect" title="Morbidity">morbidity</a>.<sup id="cite_ref-Hormone_replacement_therapy_after_s_27-0" class="reference"><a href="#cite_note-Hormone_replacement_therapy_after_s-27">&#91;27&#93;</a></sup> Importantly, there is no difference in long-term mortality from HRT, regardless of age.<sup id="cite_ref-WHI_18_year_follow_up_6-1" class="reference"><a href="#cite_note-WHI_18_year_follow_up-6">&#91;6&#93;</a></sup>
</p><p>A <a href="/wiki/Cochrane_review" class="mw-redirect" title="Cochrane review">Cochrane review</a> suggested that women starting HRT less than 10 years after menopause had lower mortality and <a href="/wiki/Coronary_heart_disease" class="mw-redirect" title="Coronary heart disease">coronary heart disease</a>, without any strong effect on the risk of stroke and <a href="/wiki/Pulmonary_embolism" title="Pulmonary embolism">pulmonary embolism</a>.<sup id="cite_ref-BoardmanHartley2015_23-1" class="reference"><a href="#cite_note-BoardmanHartley2015-23">&#91;23&#93;</a></sup> Those starting therapy more than 10 years after menopause showed little effect on mortality and coronary heart disease, but an increased risk of stroke. Both therapies had an association with <a href="/wiki/Deep_vein_thrombosis" title="Deep vein thrombosis">venous clots</a> and pulmonary embolism.<sup id="cite_ref-BoardmanHartley2015_23-2" class="reference"><a href="#cite_note-BoardmanHartley2015-23">&#91;23&#93;</a></sup>
</p><p>HRT with estrogen and progesterone also improves <a href="/wiki/Lipid_profile" title="Lipid profile">cholesterol levels</a>. With menopause, <a href="/wiki/High_density_lipoprotein" class="mw-redirect" title="High density lipoprotein">HDL</a> decreases, while <a href="/wiki/Low_density_lipoprotein" class="mw-redirect" title="Low density lipoprotein">LDL</a>, <a href="/wiki/Triglyceride" title="Triglyceride">triglycerides</a> and <a href="/wiki/Lipoprotein_a" class="mw-redirect" title="Lipoprotein a">lipoprotein a</a> increase, patterns that reverse with estrogen. Beyond this, HRT improves <a href="/wiki/Ejection_fraction" title="Ejection fraction">heart contraction</a>, <a href="/wiki/Coronary_arteries" title="Coronary arteries">coronary</a> blood flow, <a href="/wiki/Carbohydrate" title="Carbohydrate">sugar</a> <a href="/wiki/Metabolism" title="Metabolism">metabolism</a>, and decreases <a href="/wiki/Platelet" title="Platelet">platelet</a> aggregation and <a href="/wiki/Atherosclerosis" title="Atherosclerosis">plaque formation</a>. HRT may promote <a href="/wiki/Reverse_cholesterol_transport" title="Reverse cholesterol transport">reverse cholesterol transport</a> through induction of <a href="/wiki/Cholesterol" title="Cholesterol">cholesterol</a> <a href="/wiki/ABC_transporters" class="mw-redirect" title="ABC transporters">ABC transporters</a>.<sup id="cite_ref-pmid20807164_28-0" class="reference"><a href="#cite_note-pmid20807164-28">&#91;28&#93;</a></sup> HRT also results in a large reduction in the pro-thrombotic <a href="/wiki/Lipoprotein_a" class="mw-redirect" title="Lipoprotein a">lipoprotein a</a>.<sup id="cite_ref-29" class="reference"><a href="#cite_note-29">&#91;29&#93;</a></sup> Studies on cardiovascular disease with testosterone therapy have been mixed, with some suggesting no effect or a mild negative effect, though others have shown an improvement in surrogate markers such as cholesterol, triglycerides and weight.<sup id="cite_ref-30" class="reference"><a href="#cite_note-30">&#91;30&#93;</a></sup><sup id="cite_ref-Testosterone_Consensus_2019_31-0" class="reference"><a href="#cite_note-Testosterone_Consensus_2019-31">&#91;31&#93;</a></sup> Testosterone has a positive effect on vascular endothelial function and tone with observational studies suggesting that women with lower testosterone may be at greater risk for heart disease. Available studies are limited by small sample size and study design. Low sex hormone binding globulin, which occurs with menopause, is associate with increased body mass index and risk for type 2 diabetes.<sup id="cite_ref-Androgens_Review_2017_32-0" class="reference"><a href="#cite_note-Androgens_Review_2017-32">&#91;32&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Blood_clots">Blood clots</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=4" title="Edit section: Blood clots">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Great_saphenous_vein_thrombosis_05091312009.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/e6/Great_saphenous_vein_thrombosis_05091312009.jpg/220px-Great_saphenous_vein_thrombosis_05091312009.jpg" decoding="async" width="220" height="166" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/e6/Great_saphenous_vein_thrombosis_05091312009.jpg/330px-Great_saphenous_vein_thrombosis_05091312009.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/e6/Great_saphenous_vein_thrombosis_05091312009.jpg/440px-Great_saphenous_vein_thrombosis_05091312009.jpg 2x" data-file-width="518" data-file-height="392" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Great_saphenous_vein_thrombosis_05091312009.jpg" class="internal" title="Enlarge"></a></div>Clot in the greater <a href="/wiki/Great_saphenous_vein" title="Great saphenous vein">saphenous vein</a>; oral estrogen is associated with increased risk of venous blood clots due to increased liver formation of <a href="/wiki/Vitamin_K" title="Vitamin K">vitamin K</a>-dependent <a href="/wiki/Coagulation" title="Coagulation">clotting factors</a>.</div></div></div>
<p>Effects of hormone replacement therapy on <a href="/wiki/Deep_vein_thrombosis" title="Deep vein thrombosis">venous blood clot</a> formation and potential for <a href="/wiki/Pulmonary_embolism" title="Pulmonary embolism">pulmonary embolism</a> may vary with different estrogen and progestogen therapies, and with different doses or method of use.<sup id="cite_ref-marjoribanks_18-1" class="reference"><a href="#cite_note-marjoribanks-18">&#91;18&#93;</a></sup> Comparisons between routes of administration suggest that when estrogens are applied to the skin or vagina, there is a lower risk of blood clots,<sup id="cite_ref-marjoribanks_18-2" class="reference"><a href="#cite_note-marjoribanks-18">&#91;18&#93;</a></sup><sup id="cite_ref-Scarabin_341–345_33-0" class="reference"><a href="#cite_note-Scarabin_341–345-33">&#91;33&#93;</a></sup> whereas when used orally, the risk of blood clots and pulmonary embolism is increased.<sup id="cite_ref-BoardmanHartley2015_23-3" class="reference"><a href="#cite_note-BoardmanHartley2015-23">&#91;23&#93;</a></sup> Skin and vaginal routes of hormone therapy are not subject to <a href="/wiki/First_pass_metabolism" class="mw-redirect" title="First pass metabolism">first pass metabolism</a>, and so lack the <a href="/wiki/Anabolic" class="mw-redirect" title="Anabolic">anabolic</a> effects that oral therapy has on liver synthesis of <a href="/wiki/Vitamin_K" title="Vitamin K">vitamin K</a>-dependent <a href="/wiki/Clotting_factor" class="mw-redirect" title="Clotting factor">clotting factors</a>, possibly explaining why oral therapy may increase blood clot formation.<sup id="cite_ref-34" class="reference"><a href="#cite_note-34">&#91;34&#93;</a></sup>
</p><p>While a 2018 review found that taking progesterone and estrogen together can decrease this risk,<sup id="cite_ref-Scarabin_341–345_33-1" class="reference"><a href="#cite_note-Scarabin_341–345-33">&#91;33&#93;</a></sup> other reviews reported an increased risk of blood clots and pulmonary embolism when estrogen and progestogen were combined, particularly when treatment was started 10 years or more after menopause and when the women were older than 60 years.<sup id="cite_ref-marjoribanks_18-3" class="reference"><a href="#cite_note-marjoribanks-18">&#91;18&#93;</a></sup><sup id="cite_ref-BoardmanHartley2015_23-4" class="reference"><a href="#cite_note-BoardmanHartley2015-23">&#91;23&#93;</a></sup>
</p><p>The risk of venous thromboembolism may be reduced with bioidentical preparations, though research on this is only preliminary.<sup id="cite_ref-35" class="reference"><a href="#cite_note-35">&#91;35&#93;</a></sup>
</p>
<table class="wikitable sortable mw-collapsible mw-collapsed" style="margin: 1em auto;">
<caption class="nowrap"><style data-mw-deduplicate="TemplateStyles:r1063604349">.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:"[ "}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:" ]"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}</style><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Risk_of_venous_thromboembolism_with_hormone_therapy_and_birth_control_pills_(QResearch/CPRD)" title="Template:Risk of venous thromboembolism with hormone therapy and birth control pills (QResearch/CPRD)"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Risk_of_venous_thromboembolism_with_hormone_therapy_and_birth_control_pills_(QResearch/CPRD)" title="Template talk:Risk of venous thromboembolism with hormone therapy and birth control pills (QResearch/CPRD)"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Template:Risk_of_venous_thromboembolism_with_hormone_therapy_and_birth_control_pills_(QResearch/CPRD)&amp;action=edit"><abbr title="Edit this template">e</abbr></a></li></ul></div> Risk of venous thromboembolism (VTE) with hormone therapy and birth control (QResearch/CPRD)
</caption>
<tbody><tr>
<th class="unsortable">Type</th>
<th class="unsortable">Route</th>
<th class="unsortable">Medications</th>
<th><a href="/wiki/Odds_ratio" title="Odds ratio">Odds ratio</a> (95% <a href="/wiki/Confidence_interval" title="Confidence interval"><abbr title="confidence interval">CI</abbr></a>)
</th></tr>
<tr>
<td rowspan="14">Menopausal hormone therapy</td>
<td rowspan="10"><a href="/wiki/Oral_administration" title="Oral administration">Oral</a></td>
<td><a href="/wiki/Estradiol_(medication)" title="Estradiol (medication)">Estradiol</a> alone<br />&#160;&#160;&#160;&#160;≤1&#160;mg/day<br />&#160;&#160;&#160;&#160;&gt;1&#160;mg/day</td>
<td>1.27 (1.16–1.39)*<br />1.22 (1.09–1.37)*<br />1.35 (1.18–1.55)*
</td></tr>
<tr>
<td><a href="/wiki/Conjugated_estrogens" title="Conjugated estrogens">Conjugated estrogens</a> alone<br />&#160;&#160;&#160;&#160;≤0.625&#160;mg/day<br />&#160;&#160;&#160;&#160;&gt;0.625&#160;mg/day</td>
<td>1.49 (1.39–1.60)*<br />1.40 (1.28–1.53)*<br />1.71 (1.51–1.93)*
</td></tr>
<tr>
<td><a href="/wiki/Estradiol/medroxyprogesterone_acetate" title="Estradiol/medroxyprogesterone acetate">Estradiol/medroxyprogesterone acetate</a></td>
<td>1.44 (1.09–1.89)*
</td></tr>
<tr>
<td><a href="/wiki/Estradiol/dydrogesterone" title="Estradiol/dydrogesterone">Estradiol/dydrogesterone</a><br />&#160;&#160;&#160;&#160;≤1&#160;mg/day <abbr title="estradiol">E2</abbr><br />&#160;&#160;&#160;&#160;&gt;1&#160;mg/day <abbr title="estradiol">E2</abbr></td>
<td>1.18 (0.98–1.42)<br />1.12 (0.90–1.40)<br />1.34 (0.94–1.90)
</td></tr>
<tr>
<td><a href="/wiki/Estradiol/norethisterone" title="Estradiol/norethisterone">Estradiol/norethisterone</a><br />&#160;&#160;&#160;&#160;≤1&#160;mg/day <abbr title="estradiol">E2</abbr><br />&#160;&#160;&#160;&#160;&gt;1&#160;mg/day <abbr title="estradiol">E2</abbr></td>
<td>1.68 (1.57–1.80)*<br />1.38 (1.23–1.56)*<br />1.84 (1.69–2.00)*
</td></tr>
<tr>
<td><a href="/wiki/Estradiol/norgestrel" class="mw-redirect" title="Estradiol/norgestrel">Estradiol/norgestrel</a> or <a href="/wiki/Estradiol/drospirenone" title="Estradiol/drospirenone">estradiol/drospirenone</a></td>
<td>1.42 (1.00–2.03)
</td></tr>
<tr>
<td><a href="/wiki/Conjugated_estrogens/medroxyprogesterone_acetate" title="Conjugated estrogens/medroxyprogesterone acetate">Conjugated estrogens/medroxyprogesterone acetate</a></td>
<td>2.10 (1.92–2.31)*
</td></tr>
<tr>
<td><a href="/wiki/Conjugated_estrogens/norgestrel" title="Conjugated estrogens/norgestrel">Conjugated estrogens/norgestrel</a><br />&#160;&#160;&#160;&#160;≤0.625&#160;mg/day <abbr title="conjugated estrogens">CEEs</abbr><br />&#160;&#160;&#160;&#160;&gt;0.625&#160;mg/day <abbr title="conjugated estrogens">CEEs</abbr></td>
<td>1.73 (1.57–1.91)*<br />1.53 (1.36–1.72)*<br />2.38 (1.99–2.85)*
</td></tr>
<tr>
<td><a href="/wiki/Tibolone" title="Tibolone">Tibolone</a> alone</td>
<td>1.02 (0.90–1.15)
</td></tr>
<tr>
<td><a href="/wiki/Raloxifene" title="Raloxifene">Raloxifene</a> alone</td>
<td>1.49 (1.24–1.79)*
</td></tr>
<tr>
<td rowspan="2"><a href="/wiki/Transdermal_administration" class="mw-redirect" title="Transdermal administration">Transdermal</a></td>
<td><a href="/wiki/Estradiol_(medication)" title="Estradiol (medication)">Estradiol</a> alone<br />&#160;&#160;&#160;≤50&#160;μg/day<br />&#160;&#160;&#160;&gt;50&#160;μg/day</td>
<td>0.96 (0.88–1.04)<br />0.94 (0.85–1.03)<br />1.05 (0.88–1.24)
</td></tr>
<tr>
<td><a href="/wiki/Estradiol_(medication)" title="Estradiol (medication)">Estradiol</a>/<a href="/wiki/Progestogen_(medication)" title="Progestogen (medication)">progestogen</a></td>
<td>0.88 (0.73–1.01)
</td></tr>
<tr>
<td rowspan="2"><a href="/wiki/Vaginal_administration" class="mw-redirect" title="Vaginal administration">Vaginal</a></td>
<td><a href="/wiki/Estradiol_(medication)" title="Estradiol (medication)">Estradiol</a> alone</td>
<td>0.84 (0.73–0.97)
</td></tr>
<tr>
<td><a href="/wiki/Conjugated_estrogens" title="Conjugated estrogens">Conjugated estrogens</a> alone</td>
<td>1.04 (0.76–1.43)
</td></tr>
<tr>
<td rowspan="7"><a href="/wiki/Combined_birth_control" class="mw-redirect" title="Combined birth control">Combined birth control</a></td>
<td rowspan="7"><a href="/wiki/Oral_administration" title="Oral administration">Oral</a></td>
<td><a href="/wiki/Ethinylestradiol/norethisterone" title="Ethinylestradiol/norethisterone">Ethinylestradiol/norethisterone</a></td>
<td>2.56 (2.15–3.06)*
</td></tr>
<tr>
<td><a href="/wiki/Ethinylestradiol/levonorgestrel" title="Ethinylestradiol/levonorgestrel">Ethinylestradiol/levonorgestrel</a></td>
<td>2.38 (2.18–2.59)*
</td></tr>
<tr>
<td><a href="/wiki/Ethinylestradiol/norgestimate" class="mw-redirect" title="Ethinylestradiol/norgestimate">Ethinylestradiol/norgestimate</a></td>
<td>2.53 (2.17–2.96)*
</td></tr>
<tr>
<td><a href="/wiki/Ethinylestradiol/desogestrel" title="Ethinylestradiol/desogestrel">Ethinylestradiol/desogestrel</a></td>
<td>4.28 (3.66–5.01)*
</td></tr>
<tr>
<td><a href="/wiki/Ethinylestradiol/gestodene" title="Ethinylestradiol/gestodene">Ethinylestradiol/gestodene</a></td>
<td>3.64 (3.00–4.43)*
</td></tr>
<tr>
<td><a href="/wiki/Ethinylestradiol/drospirenone" title="Ethinylestradiol/drospirenone">Ethinylestradiol/drospirenone</a></td>
<td>4.12 (3.43–4.96)*
</td></tr>
<tr>
<td><a href="/wiki/Ethinylestradiol/cyproterone_acetate" title="Ethinylestradiol/cyproterone acetate">Ethinylestradiol/cyproterone acetate</a></td>
<td>4.27 (3.57–5.11)*
</td></tr>
<tr class="sortbottom">
<td colspan="4" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Notes:</b> (1) <a href="/wiki/Nested_case%E2%80%93control_study" title="Nested case–control study">Nested case–control studies</a> (2015, 2019) based on data from the <a href="/wiki/QResearch" title="QResearch">QResearch</a> and <a href="/wiki/Clinical_Practice_Research_Datalink" title="Clinical Practice Research Datalink">Clinical Practice Research Datalink</a> (CPRD) databases. (2) <a href="/wiki/Bioidentical_hormone_therapy" class="mw-redirect" title="Bioidentical hormone therapy">Bioidentical</a> <a href="/wiki/Progesterone_(medication)" title="Progesterone (medication)">progesterone</a> was not included, but is known to be associated with no additional risk relative to estrogen alone. <b>Footnotes:</b> * = <a href="/wiki/Statistical_significance" title="Statistical significance">Statistically significant</a> (<i>p</i> &lt; 0.01). <b>Sources</b>: See template.
</td></tr></tbody></table>
<h3><span class="mw-headline" id="Stroke">Stroke</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=5" title="Edit section: Stroke">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Multiple studies suggest that the possibility of HRT related stroke is absent if therapy is started within five years of menopause,<sup id="cite_ref-Carras_PLOIS_2017_36-0" class="reference"><a href="#cite_note-Carras_PLOIS_2017-36">&#91;36&#93;</a></sup> and that the association is absent or even preventive when given by non-oral routes.<sup id="cite_ref-Lokkegard_2017_8-1" class="reference"><a href="#cite_note-Lokkegard_2017-8">&#91;8&#93;</a></sup> <a href="/wiki/Ischemic_stroke" class="mw-redirect" title="Ischemic stroke">Ischemic stroke</a> risk was increased during the time of intervention in the WHI, with no significant effect after the cessation of therapy<sup id="cite_ref-Manson_WHI_2013_26-1" class="reference"><a href="#cite_note-Manson_WHI_2013-26">&#91;26&#93;</a></sup> and no difference in mortality at long term follow up.<sup id="cite_ref-WHI_18_year_follow_up_6-2" class="reference"><a href="#cite_note-WHI_18_year_follow_up-6">&#91;6&#93;</a></sup> When oral synthetic estrogen or combined estrogen-progestogen treatment is delayed until 5 years from menopause, <a href="/wiki/Cohort_analysis" title="Cohort analysis">cohort studies</a> in Swedish women have suggested an association with <a href="/wiki/Hemorrhagic_stroke" class="mw-redirect" title="Hemorrhagic stroke">hemorrhagic</a> and <a href="/wiki/Ischemic_stroke" class="mw-redirect" title="Ischemic stroke">ischemic stroke</a>.<sup id="cite_ref-Carras_PLOIS_2017_36-1" class="reference"><a href="#cite_note-Carras_PLOIS_2017-36">&#91;36&#93;</a></sup> Another large cohort of <a href="/wiki/Denmark" title="Denmark">Danish</a> women suggested that the specific route of administration was important, finding that although oral estrogen increased risk of stroke, absorption through the skin had no impact, and vaginal estrogen actually had a decreased risk.<sup id="cite_ref-Lokkegard_2017_8-2" class="reference"><a href="#cite_note-Lokkegard_2017-8">&#91;8&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Endometrial_cancer">Endometrial cancer</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=6" title="Edit section: Endometrial cancer">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Blausen_0348_EndometrialCancer.png" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/9b/Blausen_0348_EndometrialCancer.png/220px-Blausen_0348_EndometrialCancer.png" decoding="async" width="220" height="165" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/9b/Blausen_0348_EndometrialCancer.png/330px-Blausen_0348_EndometrialCancer.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/9b/Blausen_0348_EndometrialCancer.png/440px-Blausen_0348_EndometrialCancer.png 2x" data-file-width="1024" data-file-height="768" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Blausen_0348_EndometrialCancer.png" class="internal" title="Enlarge"></a></div>Endometrial cancer can be associated with HRT, particularly in those not taking a <a href="/wiki/Progestogen" title="Progestogen">progestogen</a>.</div></div></div>
<p>In postmenopausal women, continuous combined estrogen plus progestin decreases endometrial cancer incidence.<sup id="cite_ref-37" class="reference"><a href="#cite_note-37">&#91;37&#93;</a></sup>  The duration of progestogen therapy should be at least 14 days per cycle to prevent endometrial disease.<sup id="cite_ref-38" class="reference"><a href="#cite_note-38">&#91;38&#93;</a></sup>
</p><p>Endometrial cancer has been grouped into two forms in the context of hormone replacement. Type 1 is the most common, can be associated with estrogen therapy, and is usually low grade. Type 2 is not related to estrogen stimulation and usually higher grade and poorer in prognosis.<sup id="cite_ref-Progestogerone_39-0" class="reference"><a href="#cite_note-Progestogerone-39">&#91;39&#93;</a></sup> The <a href="/wiki/Endometrial_hyperplasia" title="Endometrial hyperplasia">endometrial hyperplasia</a> that leads to <a href="/wiki/Endometrial_cancer" title="Endometrial cancer">endometrial cancer</a> with estrogen therapy can be prevented by concomitant administration of <a href="/wiki/Progestogen" title="Progestogen">progestogen</a>.<sup id="cite_ref-Progestogerone_39-1" class="reference"><a href="#cite_note-Progestogerone-39">&#91;39&#93;</a></sup> The extensive use of high-dose estrogens for <a href="/wiki/Birth_control" title="Birth control">birth control</a> in the 1970s is thought to have resulted in a significant increase in the incidence of type 1 endometrial cancer.<sup id="cite_ref-40" class="reference"><a href="#cite_note-40">&#91;40&#93;</a></sup>
</p><p>Paradoxically, progestogens do promote the growth of <a href="/wiki/Uterine_fibroids" class="mw-redirect" title="Uterine fibroids">uterine fibroids</a>, and a <a href="/wiki/Pelvic_ultrasound" class="mw-redirect" title="Pelvic ultrasound">pelvic ultrasound</a> can be performed before beginning HRT to make sure there are no underlying uterine or endometrial lesions.<sup id="cite_ref-Progestogerone_39-2" class="reference"><a href="#cite_note-Progestogerone-39">&#91;39&#93;</a></sup>
</p><p>Androgens do not stimulate endometrial proliferation in post menopausal women, and appear to inhibit the proliferation induced by estrogen to a certain extent.<sup id="cite_ref-41" class="reference"><a href="#cite_note-41">&#91;41&#93;</a></sup>
</p><p>There is insufficient high‐quality evidence to inform women considering hormone replacement therapy after treatment for endometrial cancer.<sup id="cite_ref-42" class="reference"><a href="#cite_note-42">&#91;42&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Breast_cancer">Breast cancer</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=7" title="Edit section: Breast cancer">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Studies regarding the association of <a href="/wiki/Breast_cancer" title="Breast cancer">breast cancer</a> with hormone replacement are inconsistent and vary with type of replacement and time since menopause. While some evaluations suggest an increased risk, in others it is decreased.<sup id="cite_ref-Conjugated_equine_estrogen_and_medr_43-0" class="reference"><a href="#cite_note-Conjugated_equine_estrogen_and_medr-43">&#91;43&#93;</a></sup> This inconsistency of effect has been suggested to imply a lack of meaningful impact of HRT on breast cancer risk.<sup id="cite_ref-Hormone_replacement_therapy_after_s_27-1" class="reference"><a href="#cite_note-Hormone_replacement_therapy_after_s-27">&#91;27&#93;</a></sup>
</p><p>There is a <a href="/wiki/Statistical_significance" title="Statistical significance">non-statistically significant</a> increased rate of <a href="/wiki/Breast_cancer" title="Breast cancer">breast cancer</a> for hormone replacement therapy with synthetic progesterone.<sup id="cite_ref-WHI_18_year_follow_up_6-3" class="reference"><a href="#cite_note-WHI_18_year_follow_up-6">&#91;6&#93;</a></sup> The risk may be reduced with <a href="/wiki/Bioidentical" class="mw-redirect" title="Bioidentical">bioidentical</a> progesterone,<sup id="cite_ref-Breast_cancer_and_progesterone_44-0" class="reference"><a href="#cite_note-Breast_cancer_and_progesterone-44">&#91;44&#93;</a></sup> though the only prospective study that suggested this was <a href="/wiki/Power_(statistics)" class="mw-redirect" title="Power (statistics)">underpowered</a> due to the rarity of breast cancer in the <a href="/wiki/Cohort_study" title="Cohort study">control population</a>. There have been no <a href="/wiki/Randomized_controlled_trials" class="mw-redirect" title="Randomized controlled trials">randomized controlled trials</a> as of 2018.<sup id="cite_ref-Conjugated_equine_estrogen_and_medr_43-1" class="reference"><a href="#cite_note-Conjugated_equine_estrogen_and_medr-43">&#91;43&#93;</a></sup> The relative risk of breast cancer also varies depending on the interval between menopause and HRT and route of synthetic progestin administration.<sup id="cite_ref-45" class="reference"><a href="#cite_note-45">&#91;45&#93;</a></sup><sup id="cite_ref-46" class="reference"><a href="#cite_note-46">&#91;46&#93;</a></sup> 
</p><p>The most recent follow up of the Women's Health Inititiative participants demonstrated a lower incidence of breast cancer in post-hysterectomy participants taking equine estrogen alone, though the relative risk was increased if estrogen was taken with medroxy-progesterone.<sup id="cite_ref-47" class="reference"><a href="#cite_note-47">&#91;47&#93;</a></sup> Estrogen is usually only given alone in the setting of a hysterectomy due to the increased risk of vaginal bleeding and uterine cancer with unopposed estrogen.<sup id="cite_ref-Anderson04_48-0" class="reference"><a href="#cite_note-Anderson04-48">&#91;48&#93;</a></sup><sup id="cite_ref-49" class="reference"><a href="#cite_note-49">&#91;49&#93;</a></sup>
</p><p>HRT has been more strongly associated with risk of breast cancer in women with lower <a href="/wiki/Body_mass_index" title="Body mass index">body mass indices</a> (BMIs). No breast cancer association has been found with BMIs of over 25.<sup id="cite_ref-50" class="reference"><a href="#cite_note-50">&#91;50&#93;</a></sup> It has been suggested by some that the absence of significant effect in some of these studies could be due to selective prescription to overweight women who have higher baseline <a href="/wiki/Estrone" title="Estrone">estrone</a>, or to the very low progesterone serum levels after oral administration leading to a high tumor inactivation rate.<sup id="cite_ref-pmid23336704_51-0" class="reference"><a href="#cite_note-pmid23336704-51">&#91;51&#93;</a></sup>
</p><p>Evaluating the response of breast tissue density to HRT using mammography appears to help assessing the degree of breast cancer risk associated with therapy; women with dense or mixed-<a href="/wiki/Dense_breast_tissue" title="Dense breast tissue">dense breast tissue</a> have a higher risk of developing breast cancer than those with low density tissue.<sup id="cite_ref-52" class="reference"><a href="#cite_note-52">&#91;52&#93;</a></sup>
</p><p><a href="/wiki/Micronization" title="Micronization">Micronized</a> progesterone does not appear to be associated with breast cancer risk when used for less than 5 years with limited data suggesting an increased risk when used for longer duration.<sup id="cite_ref-53" class="reference"><a href="#cite_note-53">&#91;53&#93;</a></sup>
</p><p>A retrospective <a href="/wiki/Cox_proportional_hazards_model" class="mw-redirect" title="Cox proportional hazards model">Cox proportional hazards</a> analysis from <a href="/wiki/Richard_Neapolitan" title="Richard Neapolitan">Richard Neapolitan</a> endorsed the reduced risk breast cancer with conjugated equine estrogen usage alone, but also suggested that conjugated equine estrogen with medroxyprogesterone acetate was associated with a risk reduction in breast cancer and that bioidentical hormone therapy was not associated with a statistically significant effect.<sup id="cite_ref-Conjugated_equine_estrogen_and_medr_43-2" class="reference"><a href="#cite_note-Conjugated_equine_estrogen_and_medr-43">&#91;43&#93;</a></sup> There have been no prospective randomized clinical trials comparing the two routes of administration with regards to breast cancer.<sup id="cite_ref-BMS_54-0" class="reference"><a href="#cite_note-BMS-54">&#91;54&#93;</a></sup>
</p><p>For women who previously have had breast cancer, it is recommended to first consider other options for menopausal effects, such as <a href="/wiki/Bisphosphonate" title="Bisphosphonate">bisphosphonates</a> or <a href="/wiki/Selective_estrogen_receptor_modulator" title="Selective estrogen receptor modulator">selective estrogen receptor modulators</a> (SERMs) for osteoporosis, <a href="/wiki/Cholesterol-lowering_agent" class="mw-redirect" title="Cholesterol-lowering agent">cholesterol-lowering agents</a> and <a href="/wiki/Aspirin" title="Aspirin">aspirin</a> for cardiovascular disease, and <a href="/wiki/Vaginal_estrogen" title="Vaginal estrogen">vaginal estrogen</a> for local symptoms. Observational studies of systemic HRT after breast cancer are generally reassuring. If HRT is necessary after breast cancer, estrogen-only therapy or estrogen therapy with a progestogen may be safer options than combined systemic therapy.<sup id="cite_ref-55" class="reference"><a href="#cite_note-55">&#91;55&#93;</a></sup> In women who are <a href="/wiki/BRCA1" title="BRCA1">BRCA1</a> or <a href="/wiki/BRCA2" title="BRCA2">BRCA2</a> mutation carriers, HRT does not appear to impact breast cancer risk.<sup id="cite_ref-56" class="reference"><a href="#cite_note-56">&#91;56&#93;</a></sup> The relative number of women using HRT who also obtain regular screening mammograms is higher than that in women who do not use HRT, a factor which has been suggested as contributing to different breast cancer detection rates in the two groups.<sup id="cite_ref-57" class="reference"><a href="#cite_note-57">&#91;57&#93;</a></sup>
</p><p>With androgen therapy, pre-clinical studies have suggested an inhibitory effect on breast tissue though the majority of epidemiological studies suggest a positive association.<sup id="cite_ref-58" class="reference"><a href="#cite_note-58">&#91;58&#93;</a></sup>
</p>
<table class="wikitable sortable mw-collapsible mw-collapsed" style="font-size:small; margin: 1em auto;">
<caption class="nowrap"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1063604349"/><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Worldwide_epidemiological_evidence_on_breast_cancer_risk_with_menopausal_hormone_therapy" title="Template:Worldwide epidemiological evidence on breast cancer risk with menopausal hormone therapy"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Worldwide_epidemiological_evidence_on_breast_cancer_risk_with_menopausal_hormone_therapy" title="Template talk:Worldwide epidemiological evidence on breast cancer risk with menopausal hormone therapy"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Template:Worldwide_epidemiological_evidence_on_breast_cancer_risk_with_menopausal_hormone_therapy&amp;action=edit"><abbr title="Edit this template">e</abbr></a></li></ul></div> <span style="font-family:sans-serif;font-size:105%;color:black;background-color:transparent;;">Worldwide epidemiological evidence on breast cancer risk with menopausal hormone therapy (<abbr title="Collaborative Group on Hormonal Factors in Breast Cancer">CGHFBC</abbr>, 2019)</span>
</caption>
<tbody><tr>
<th rowspan="2" class="unsortable">Therapy
</th>
<th colspan="2" class="unsortable">&lt;5 years
</th>
<th colspan="2" class="unsortable">5–14 years
</th>
<th colspan="2" class="unsortable">15+ years
</th></tr>
<tr>
<th>Cases
</th>
<th><a href="/wiki/Adjusted_relative_risk" class="mw-redirect" title="Adjusted relative risk"><abbr title="Adjusted relative risk">RR</abbr></a> (95% <a href="/wiki/Confidence_interval" title="Confidence interval"><abbr title="confidence interval">CI</abbr></a>)
</th>
<th>Cases
</th>
<th><a href="/wiki/Adjusted_relative_risk" class="mw-redirect" title="Adjusted relative risk"><abbr title="Adjusted relative risk">RR</abbr></a> (95% <a href="/wiki/Confidence_interval" title="Confidence interval"><abbr title="confidence interval">CI</abbr></a>)
</th>
<th>Cases
</th>
<th><a href="/wiki/Adjusted_relative_risk" class="mw-redirect" title="Adjusted relative risk"><abbr title="Adjusted relative risk">RR</abbr></a> (95% <a href="/wiki/Confidence_interval" title="Confidence interval"><abbr title="confidence interval">CI</abbr></a>)
</th></tr>
<tr>
<td><b>Estrogen alone</b>
</td>
<td><b>1259</b>
</td>
<td><b>1.18 (1.10–1.26)</b>
</td>
<td><b>4869</b>
</td>
<td><b>1.33 (1.28–1.37)</b>
</td>
<td><b>2183</b>
</td>
<td><b>1.58 (1.51–1.67)</b>
</td></tr>
<tr>
<td>&#160;&#160;&#160;&#160;<i>By <a href="/wiki/Estrogen_(medication)" title="Estrogen (medication)">estrogen</a></i>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td></tr>
<tr>
<td>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<a href="/wiki/Conjugated_estrogens" title="Conjugated estrogens">Conjugated estrogens</a>
</td>
<td>481
</td>
<td>1.22 (1.09–1.35)
</td>
<td>1910
</td>
<td>1.32 (1.25–1.39)
</td>
<td>1179
</td>
<td>1.68 (1.57–1.80)
</td></tr>
<tr>
<td>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<a href="/wiki/Estradiol_(medication)" title="Estradiol (medication)">Estradiol</a>
</td>
<td>346
</td>
<td>1.20 (1.05–1.36)
</td>
<td>1580
</td>
<td>1.38 (1.30–1.46)
</td>
<td>435
</td>
<td>1.78 (1.58–1.99)
</td></tr>
<tr>
<td>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<a href="/wiki/Estropipate" title="Estropipate">Estropipate (estrone sulfate)</a>
</td>
<td>9
</td>
<td>1.45 (0.67–3.15)
</td>
<td>50
</td>
<td>1.09 (0.79–1.51)
</td>
<td>28
</td>
<td>1.53 (1.01–2.33)
</td></tr>
<tr>
<td>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<a href="/wiki/Estriol_(medication)" title="Estriol (medication)">Estriol</a>
</td>
<td>15
</td>
<td>1.21 (0.68–2.14)
</td>
<td>44
</td>
<td>1.24 (0.89–1.73)
</td>
<td>9
</td>
<td>1.41 (0.67–2.93)
</td></tr>
<tr>
<td>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other estrogens
</td>
<td>15
</td>
<td>0.98 (0.46–2.09)
</td>
<td>21
</td>
<td>0.98 (0.58–1.66)
</td>
<td>5
</td>
<td>0.77 (0.27–2.21)
</td></tr>
<tr>
<td>&#160;&#160;&#160;&#160;<i>By route</i>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td></tr>
<tr>
<td>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<a href="/wiki/Oral_administration" title="Oral administration">Oral</a> estrogens
</td>
<td>–
</td>
<td>–
</td>
<td>3633
</td>
<td>1.33 (1.27–1.38)
</td>
<td>–
</td>
<td>–
</td></tr>
<tr>
<td>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<a href="/wiki/Transdermal_administration" class="mw-redirect" title="Transdermal administration">Transdermal</a> estrogens
</td>
<td>–
</td>
<td>–
</td>
<td>919
</td>
<td>1.35 (1.25–1.46)
</td>
<td>–
</td>
<td>–
</td></tr>
<tr>
<td>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<a href="/wiki/Vaginal_administration" class="mw-redirect" title="Vaginal administration">Vaginal</a> estrogens
</td>
<td>–
</td>
<td>–
</td>
<td>437
</td>
<td>1.09 (0.97–1.23)
</td>
<td>–
</td>
<td>–
</td></tr>
<tr>
<td><b>Estrogen and progestogen</b>
</td>
<td><b>2419</b>
</td>
<td><b>1.58 (1.51–1.67)</b>
</td>
<td><b>8319</b>
</td>
<td><b>2.08 (2.02–2.15)</b>
</td>
<td><b>1424</b>
</td>
<td><b>2.51 (2.34–2.68)</b>
</td></tr>
<tr>
<td>&#160;&#160;&#160;&#160;<i>By <a href="/wiki/Progestogen_(medication)" title="Progestogen (medication)">progestogen</a></i>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td></tr>
<tr>
<td>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<a href="/wiki/Levonorgestrel" title="Levonorgestrel">(Levo)norgestrel</a>
</td>
<td>343
</td>
<td>1.70 (1.49–1.94)
</td>
<td>1735
</td>
<td>2.12 (1.99–2.25)
</td>
<td>219
</td>
<td>2.69 (2.27–3.18)
</td></tr>
<tr>
<td>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<a href="/wiki/Norethisterone_acetate" title="Norethisterone acetate">Norethisterone acetate</a>
</td>
<td>650
</td>
<td>1.61 (1.46–1.77)
</td>
<td>2642
</td>
<td>2.20 (2.09–2.32)
</td>
<td>420
</td>
<td>2.97 (2.60–3.39)
</td></tr>
<tr>
<td>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<a href="/wiki/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">Medroxyprogesterone acetate</a>
</td>
<td>714
</td>
<td>1.64 (1.50–1.79)
</td>
<td>2012
</td>
<td>2.07 (1.96–2.19)
</td>
<td>411
</td>
<td>2.71 (2.39–3.07)
</td></tr>
<tr>
<td>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<a href="/wiki/Dydrogesterone" title="Dydrogesterone">Dydrogesterone</a>
</td>
<td>65
</td>
<td>1.21 (0.90–1.61)
</td>
<td>162
</td>
<td>1.41 (1.17–1.71)
</td>
<td>26
</td>
<td>2.23 (1.32–3.76)
</td></tr>
<tr>
<td>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<a href="/wiki/Progesterone_(medication)" title="Progesterone (medication)">Progesterone</a>
</td>
<td>11
</td>
<td>0.91 (0.47–1.78)
</td>
<td>38
</td>
<td>2.05 (1.38–3.06)
</td>
<td>1
</td>
<td>–
</td></tr>
<tr>
<td>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<a href="/wiki/Promegestone" title="Promegestone">Promegestone</a>
</td>
<td>12
</td>
<td>1.68 (0.85–3.31)
</td>
<td>19
</td>
<td>2.06 (1.19–3.56)
</td>
<td>0
</td>
<td>–
</td></tr>
<tr>
<td>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<a href="/wiki/Nomegestrol_acetate" title="Nomegestrol acetate">Nomegestrol acetate</a>
</td>
<td>8
</td>
<td>1.60 (0.70–3.64)
</td>
<td>14
</td>
<td>1.38 (0.75–2.53)
</td>
<td>0
</td>
<td>–
</td></tr>
<tr>
<td>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other progestogens
</td>
<td>12
</td>
<td>1.70 (0.86–3.38)
</td>
<td>19
</td>
<td>1.79 (1.05–3.05)
</td>
<td>0
</td>
<td>–
</td></tr>
<tr>
<td>&#160;&#160;&#160;&#160;<i>By progestogen frequency</i>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td></tr>
<tr>
<td>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<a href="/wiki/Continuous_therapy" class="mw-redirect" title="Continuous therapy">Continuous</a>
</td>
<td>–
</td>
<td>–
</td>
<td>3948
</td>
<td>2.30 (2.21–2.40)
</td>
<td>–
</td>
<td>–
</td></tr>
<tr>
<td>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<a href="/wiki/Cyclic_therapy" class="mw-redirect" title="Cyclic therapy">Intermittent</a>
</td>
<td>–
</td>
<td>–
</td>
<td>3467
</td>
<td>1.93 (1.84–2.01)
</td>
<td>–
</td>
<td>–
</td></tr>
<tr>
<td><b>Progestogen alone</b>
</td>
<td><b>98</b>
</td>
<td><b>1.37 (1.08–1.74)</b>
</td>
<td><b>107</b>
</td>
<td><b>1.39 (1.11–1.75)</b>
</td>
<td><b>30</b>
</td>
<td><b>2.10 (1.35–3.27)</b>
</td></tr>
<tr>
<td>&#160;&#160;&#160;&#160;<i>By progestogen</i>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td></tr>
<tr>
<td>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<a href="/wiki/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">Medroxyprogesterone acetate</a>
</td>
<td>28
</td>
<td>1.68 (1.06–2.66)
</td>
<td>18
</td>
<td>1.16 (0.68–1.98)
</td>
<td>7
</td>
<td>3.42 (1.26–9.30)
</td></tr>
<tr>
<td>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<a href="/wiki/Norethisterone_acetate" title="Norethisterone acetate">Norethisterone acetate</a>
</td>
<td>13
</td>
<td>1.58 (0.77–3.24)
</td>
<td>24
</td>
<td>1.55 (0.88–2.74)
</td>
<td>6
</td>
<td>3.33 (0.81–13.8)
</td></tr>
<tr>
<td>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<a href="/wiki/Dydrogesterone" title="Dydrogesterone">Dydrogesterone</a>
</td>
<td>3
</td>
<td>2.30 (0.49–10.9)
</td>
<td>11
</td>
<td>3.31 (1.39–7.84)
</td>
<td>0
</td>
<td>–
</td></tr>
<tr>
<td>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other progestogens
</td>
<td>8
</td>
<td>2.83 (1.04–7.68)
</td>
<td>5
</td>
<td>1.47 (0.47–4.56)
</td>
<td>1
</td>
<td>–
</td></tr>
<tr>
<td><b>Miscellaneous</b>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td></tr>
<tr>
<td>&#160;&#160;&#160;&#160;<a href="/wiki/Tibolone" title="Tibolone">Tibolone</a>
</td>
<td>–
</td>
<td>–
</td>
<td>680
</td>
<td>1.57 (1.43–1.72)
</td>
<td>–
</td>
<td>–
</td></tr>
<tr class="sortbottom">
<td colspan="7" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Notes:</b> <a href="/wiki/Meta-analysis" title="Meta-analysis">Meta-analysis</a> of worldwide <a href="/wiki/Epidemiology" title="Epidemiology">epidemiological</a> evidence on <a href="/wiki/Menopausal_hormone_therapy" class="mw-redirect" title="Menopausal hormone therapy">menopausal hormone therapy</a> and <a href="/wiki/Breast_cancer" title="Breast cancer">breast cancer</a> risk by the <a href="/wiki/Collaborative_Group_on_Hormonal_Factors_in_Breast_Cancer" title="Collaborative Group on Hormonal Factors in Breast Cancer">Collaborative Group on Hormonal Factors in Breast Cancer</a> (CGHFBC). Fully adjusted <a href="/wiki/Relative_risk" title="Relative risk">relative risks</a> for current versus never-users of menopausal hormone therapy. <b>Source</b>: See template.
</td></tr></tbody></table>
<table class="wikitable sortable mw-collapsible mw-collapsed" style="margin: 1em auto;">
<caption class="nowrap"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1063604349"/><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Risk_of_breast_cancer_with_menopausal_hormone_therapy_in_large_observational_studies" title="Template:Risk of breast cancer with menopausal hormone therapy in large observational studies"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Risk_of_breast_cancer_with_menopausal_hormone_therapy_in_large_observational_studies" title="Template talk:Risk of breast cancer with menopausal hormone therapy in large observational studies"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Template:Risk_of_breast_cancer_with_menopausal_hormone_therapy_in_large_observational_studies&amp;action=edit"><abbr title="Edit this template">e</abbr></a></li></ul></div> Risk of breast cancer with menopausal hormone therapy in large observational studies (Mirkin, 2018)
</caption>
<tbody><tr>
<th class="unsortable">Study</th>
<th class="unsortable">Therapy</th>
<th class="unsortable"><a href="/wiki/Hazard_ratio" title="Hazard ratio">Hazard ratio</a> (95% <a href="/wiki/Confidence_interval" title="Confidence interval"><abbr title="confidence interval">CI</abbr></a>)
</th></tr>
<tr>
<td rowspan="3">E3N-EPIC: Fournier et al. (2005)</td>
<td>Estrogen alone</td>
<td>1.1 (0.8–1.6)
</td></tr>
<tr>
<td>Estrogen plus <a href="/wiki/Progesterone_(medication)" title="Progesterone (medication)">progesterone</a><br />&#160;&#160;&#160;&#160;Transdermal estrogen<br />&#160;&#160;&#160;&#160;Oral estrogen</td>
<td>0.9 (0.7–1.2)<br />0.9 (0.7–1.2)<br />No events
</td></tr>
<tr>
<td>Estrogen plus progestin<br />&#160;&#160;&#160;&#160;Transdermal estrogen<br />&#160;&#160;&#160;&#160;Oral estrogen</td>
<td>1.4 (1.2–1.7)<br />1.4 (1.2–1.7)<br />1.5 (1.1–1.9)
</td></tr>
<tr>
<td rowspan="4">E3N-EPIC: Fournier et al. (2008)</td>
<td>Oral estrogen alone</td>
<td>1.32 (0.76–2.29)
</td></tr>
<tr>
<td>Oral estrogen plus progestogen<br />&#160;&#160;&#160;&#160;<a href="/wiki/Progesterone_(medication)" title="Progesterone (medication)">Progesterone</a><br />&#160;&#160;&#160;&#160;<a href="/wiki/Dydrogesterone" title="Dydrogesterone">Dydrogesterone</a><br />&#160;&#160;&#160;&#160;<a href="/wiki/Medrogestone" title="Medrogestone">Medrogestone</a><br />&#160;&#160;&#160;&#160;<a href="/wiki/Chlormadinone_acetate" title="Chlormadinone acetate">Chlormadinone acetate</a><br />&#160;&#160;&#160;&#160;<a href="/wiki/Cyproterone_acetate" title="Cyproterone acetate">Cyproterone acetate</a><br />&#160;&#160;&#160;&#160;<a href="/wiki/Promegestone" title="Promegestone">Promegestone</a><br />&#160;&#160;&#160;&#160;<a href="/wiki/Nomegestrol_acetate" title="Nomegestrol acetate">Nomegestrol acetate</a><br />&#160;&#160;&#160;&#160;<a href="/wiki/Norethisterone_acetate" title="Norethisterone acetate">Norethisterone acetate</a><br />&#160;&#160;&#160;&#160;<a href="/wiki/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">Medroxyprogesterone acetate</a></td>
<td><br />Not analyzed<sup>a</sup><br />0.77 (0.36–1.62)<br />2.74 (1.42–5.29)<br />2.02 (1.00–4.06)<br />2.57 (1.81–3.65)<br />1.62 (0.94–2.82)<br />1.10 (0.55–2.21)<br />2.11 (1.56–2.86)<br />1.48 (1.02–2.16)
</td></tr>
<tr>
<td>Transdermal estrogen alone</td>
<td>1.28 (0.98–1.69)
</td></tr>
<tr>
<td>Transdermal estrogen plus progestogen<br />&#160;&#160;&#160;&#160;<a href="/wiki/Progesterone_(medication)" title="Progesterone (medication)">Progesterone</a><br />&#160;&#160;&#160;&#160;<a href="/wiki/Dydrogesterone" title="Dydrogesterone">Dydrogesterone</a><br />&#160;&#160;&#160;&#160;<a href="/wiki/Medrogestone" title="Medrogestone">Medrogestone</a><br />&#160;&#160;&#160;&#160;<a href="/wiki/Chlormadinone_acetate" title="Chlormadinone acetate">Chlormadinone acetate</a><br />&#160;&#160;&#160;&#160;<a href="/wiki/Cyproterone_acetate" title="Cyproterone acetate">Cyproterone acetate</a><br />&#160;&#160;&#160;&#160;<a href="/wiki/Promegestone" title="Promegestone">Promegestone</a><br />&#160;&#160;&#160;&#160;<a href="/wiki/Nomegestrol_acetate" title="Nomegestrol acetate">Nomegestrol acetate</a><br />&#160;&#160;&#160;&#160;<a href="/wiki/Norethisterone_acetate" title="Norethisterone acetate">Norethisterone acetate</a><br />&#160;&#160;&#160;&#160;<a href="/wiki/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">Medroxyprogesterone acetate</a></td>
<td><br />1.08 (0.89–1.31)<br />1.18 (0.95–1.48)<br /> 2.03 (1.39–2.97)<br />1.48 (1.05–2.09)<br />Not analyzed<sup>a</sup><br />1.52 (1.19–1.96)<br />1.60 (1.28–2.01)<br />Not analyzed<sup>a</sup><br />Not analyzed<sup>a</sup>
</td></tr>
<tr>
<td rowspan="3">E3N-EPIC: Fournier et al. (2014)</td>
<td>Estrogen alone</td>
<td>1.17 (0.99–1.38)
</td></tr>
<tr>
<td>Estrogen plus <a href="/wiki/Progesterone_(medication)" title="Progesterone (medication)">progesterone</a> or <a href="/wiki/Dydrogesterone" title="Dydrogesterone">dydrogesterone</a></td>
<td>1.22 (1.11–1.35)
</td></tr>
<tr>
<td>Estrogen plus progestin</td>
<td>1.87 (1.71–2.04)
</td></tr>
<tr>
<td rowspan="2">CECILE: Cordina-Duverger et al. (2013)</td>
<td>Estrogen alone</td>
<td>1.19 (0.69–2.04)
</td></tr>
<tr>
<td>Estrogen plus progestogen<br />&#160;&#160;&#160;&#160;<a href="/wiki/Progesterone_(medication)" title="Progesterone (medication)">Progesterone</a><br />&#160;&#160;&#160;&#160;Progestins<br />&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Progesterone derivatives<br />&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Testosterone derivatives</td>
<td>1.33 (0.92–1.92)<br />0.80 (0.44–1.43)<br />1.72 (1.11–2.65)<br />1.57 (0.99–2.49)<br />3.35 (1.07–10.4)
</td></tr>
<tr class="sortbottom">
<td colspan="3" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Footnotes:</b> <sup>a</sup> = Not analyzed, fewer than 5&#160;cases. <b>Sources</b>: See template.
</td></tr></tbody></table>
<table class="wikitable sortable mw-collapsible mw-collapsed" style="margin: 1em auto;">
<caption class="nowrap"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1063604349"/><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Risk_of_breast_cancer_with_menopausal_hormone_therapy_by_duration_in_large_observational_studies" title="Template:Risk of breast cancer with menopausal hormone therapy by duration in large observational studies"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Risk_of_breast_cancer_with_menopausal_hormone_therapy_by_duration_in_large_observational_studies" title="Template talk:Risk of breast cancer with menopausal hormone therapy by duration in large observational studies"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Template:Risk_of_breast_cancer_with_menopausal_hormone_therapy_by_duration_in_large_observational_studies&amp;action=edit"><abbr title="Edit this template">e</abbr></a></li></ul></div> Risk of breast cancer with menopausal hormone therapy by duration in large observational studies (Mirkin, 2018)
</caption>
<tbody><tr>
<th class="unsortable">Study</th>
<th class="unsortable">Therapy</th>
<th class="unsortable"><a href="/wiki/Hazard_ratio" title="Hazard ratio">Hazard ratio</a> (95% <a href="/wiki/Confidence_interval" title="Confidence interval"><abbr title="confidence interval">CI</abbr></a>)
</th></tr>
<tr>
<td rowspan="3">E3N-EPIC: Fournier et al. (2005)<sup>a</sup></td>
<td>Transdermal estrogen plus <a href="/wiki/Progesterone_(medication)" title="Progesterone (medication)">progesterone</a><br />&#160;&#160;&#160;&#160;&lt;2&#160;years<br />&#160;&#160;&#160;&#160;2–4&#160;years<br />&#160;&#160;&#160;&#160;≥4&#160;years</td>
<td><br />0.9 (0.6–1.4)<br />0.7 (0.4–1.2)<br />1.2 (0.7–2.0)
</td></tr>
<tr>
<td>Transdermal estrogen plus progestin<br />&#160;&#160;&#160;&#160;&lt;2&#160;years<br />&#160;&#160;&#160;&#160;2–4&#160;years<br />&#160;&#160;&#160;&#160;≥4&#160;years</td>
<td><br />1.6 (1.3–2.0)<br />1.4 (1.0–1.8)<br />1.2 (0.8–1.7)
</td></tr>
<tr>
<td>Oral estrogen plus progestin<br />&#160;&#160;&#160;&#160;&lt;2&#160;years<br />&#160;&#160;&#160;&#160;2–4&#160;years<br />&#160;&#160;&#160;&#160;≥4&#160;years</td>
<td><br />1.2 (0.9–1.8)<br />1.6 (1.1–2.3)<br />1.9 (1.2–3.2)
</td></tr>
<tr>
<td rowspan="3">E3N-EPIC: Fournier et al. (2008)</td>
<td>Estrogen plus <a href="/wiki/Progesterone_(medication)" title="Progesterone (medication)">progesterone</a><br />&#160;&#160;&#160;&#160;&lt;2&#160;years<br />&#160;&#160;&#160;&#160;2–4&#160;years<br />&#160;&#160;&#160;&#160;4–6&#160;years<br />&#160;&#160;&#160;&#160;≥6&#160;years</td>
<td><br />0.71 (0.44–1.14)<br />0.95 (0.67–1.36)<br />1.26 (0.87–1.82)<br />1.22 (0.89–1.67)
</td></tr>
<tr>
<td>Estrogen plus <a href="/wiki/Dydrogesterone" title="Dydrogesterone">dydrogesterone</a><br />&#160;&#160;&#160;&#160;&lt;2&#160;years<br />&#160;&#160;&#160;&#160;2–4&#160;years<br />&#160;&#160;&#160;&#160;4–6&#160;years<br />&#160;&#160;&#160;&#160;≥6&#160;years</td>
<td><br />0.84 (0.51–1.38)<br />1.16 (0.79–1.71)<br />1.28 (0.83–1.99)<br />1.32 (0.93–1.86)
</td></tr>
<tr>
<td>Estrogen plus other progestogens<br />&#160;&#160;&#160;&#160;&lt;2&#160;years<br />&#160;&#160;&#160;&#160;2–4&#160;years<br />&#160;&#160;&#160;&#160;4–6&#160;years<br />&#160;&#160;&#160;&#160;≥6&#160;years</td>
<td><br />1.36 (1.07–1.72)<br />1.59 (1.30–1.94)<br />1.79 (1.44–2.23)<br />1.95 (1.62–2.35)
</td></tr>
<tr>
<td rowspan="2">E3N-EPIC: Fournier et al. (2014)</td>
<td>Estrogens plus <a href="/wiki/Progesterone_(medication)" title="Progesterone (medication)">progesterone</a> or <a href="/wiki/Dydrogesterone" title="Dydrogesterone">dydrogesterone</a><br />&#160;&#160;&#160;&#160;&lt;5&#160;years<br />&#160;&#160;&#160;&#160;≥5&#160;years</td>
<td><br />1.13 (0.99–1.29)<br />1.31 (1.15–1.48)
</td></tr>
<tr>
<td>Estrogen plus other progestogens<br />&#160;&#160;&#160;&#160;&lt;5&#160;years<br />&#160;&#160;&#160;&#160;≥5&#160;years</td>
<td><br />1.70 (1.50–1.91)<br />2.02 (1.81–2.26)
</td></tr>
<tr class="sortbottom">
<td colspan="3" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Footnotes:</b> <sup>a</sup> = Oral estrogen plus progesterone was not analyzed because there was a low number of women who used this therapy. <b>Sources</b>: See template.
</td></tr></tbody></table>
<h3><span class="mw-headline" id="Ovarian_cancer">Ovarian cancer</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=8" title="Edit section: Ovarian cancer">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>HRT is associated with an increased risk of <a href="/wiki/Ovarian_cancer" title="Ovarian cancer">ovarian cancer</a>, with women using HRT having about one additional case of ovarian cancer per 1,000 users.<sup id="cite_ref-59" class="reference"><a href="#cite_note-59">&#91;59&#93;</a></sup> This risk is decreased when progestogen therapy is given concomitantly, as opposed to estrogen alone, and also decreases with increasing time since stopping HRT.<sup id="cite_ref-Shi_2016_60-0" class="reference"><a href="#cite_note-Shi_2016-60">&#91;60&#93;</a></sup> Regarding the specific <a href="/wiki/Histology" title="Histology">subtype</a>, there may be a higher risk of <a href="/wiki/Serous_ovarian_cancer" class="mw-redirect" title="Serous ovarian cancer">serous cancer</a>, but no association with <a href="/wiki/Clear-cell_ovarian_carcinoma" title="Clear-cell ovarian carcinoma">clear cell</a>, <a href="/wiki/Endometrioid_tumor" title="Endometrioid tumor">endometrioid</a>, or <a href="/wiki/Ovarian_mucinous_tumor" title="Ovarian mucinous tumor">mucinous ovarian cancer</a>.<sup id="cite_ref-Shi_2016_60-1" class="reference"><a href="#cite_note-Shi_2016-60">&#91;60&#93;</a></sup> Hormonal therapy in ovarian cancer survivors after surgical removal of the ovaries is generally thought to improval survival rates.<sup id="cite_ref-61" class="reference"><a href="#cite_note-61">&#91;61&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Other_malignancies">Other malignancies</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=9" title="Edit section: Other malignancies">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<h4><span class="mw-headline" id="Colorectal_cancer">Colorectal cancer</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=10" title="Edit section: Colorectal cancer">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>In the WHI, women who took combined estrogen-progesterone therapy had a lower risk of getting <a href="/wiki/Colorectal_cancer" title="Colorectal cancer">colorectal cancer</a>. However, the cancers they did have were more likely to have spread to <a href="/wiki/Lymph_nodes" class="mw-redirect" title="Lymph nodes">lymph nodes</a> or distant sites than colorectal cancer in women not taking hormones.<sup id="cite_ref-cancer.org_62-0" class="reference"><a href="#cite_note-cancer.org-62">&#91;62&#93;</a></sup> In colorectal cancer survivors, usage of HRT is thought to lead to lower recurrence risk and overall mortality.<sup id="cite_ref-63" class="reference"><a href="#cite_note-63">&#91;63&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="Cervical_cancer">Cervical cancer</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=11" title="Edit section: Cervical cancer">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>There appears to be a significantly decreased risk of cervical squamos cell cancer in post menopausal women treated with HRT and a weak increase in adenocarcinoma. No studies have reported an increased risk of recurrence when HRT is used with cervical cancer survivors.<sup id="cite_ref-64" class="reference"><a href="#cite_note-64">&#91;64&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Sexual_function">Sexual function</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=12" title="Edit section: Sexual function">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1033289096"/><div role="note" class="hatnote navigation-not-searchable">See also: <a href="/wiki/Testosterone_(medication)#Women" title="Testosterone (medication)">Testosterone (medication) §&#160;Women</a></div>
<div class="thumb tright"><div class="thumbinner" style="width:302px;"><a href="/wiki/File:Vaginal_Mucosa_Normal_vs_Menopause.png" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/8/85/Vaginal_Mucosa_Normal_vs_Menopause.png/300px-Vaginal_Mucosa_Normal_vs_Menopause.png" decoding="async" width="300" height="192" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/8/85/Vaginal_Mucosa_Normal_vs_Menopause.png/450px-Vaginal_Mucosa_Normal_vs_Menopause.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/8/85/Vaginal_Mucosa_Normal_vs_Menopause.png/600px-Vaginal_Mucosa_Normal_vs_Menopause.png 2x" data-file-width="1200" data-file-height="767" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Vaginal_Mucosa_Normal_vs_Menopause.png" class="internal" title="Enlarge"></a></div>Atrophy of vaginal mucosa that occurs with menopause.</div></div></div>
<p>HRT can help with the lack of sexual desire and sexual dysfunction that can occur with menopause. Epidemiological surveys of women between 40–69 years suggest that 75% of women remain sexually active after menopause.<sup id="cite_ref-eden_4-3" class="reference"><a href="#cite_note-eden-4">&#91;4&#93;</a></sup> With increasing life spans, women today are living one third or more of their lives in a postmenopausal state, a period during which healthy sexuality can be integral to their <a href="/wiki/Quality_of_life" title="Quality of life">quality of life</a>.<sup id="cite_ref-miller_65-0" class="reference"><a href="#cite_note-miller-65">&#91;65&#93;</a></sup>
</p><p>Decreased libido and sexual dysfunction are common issues in postmenopausal women, an entity referred to <a href="/wiki/Hypoactive_sexual_desire_disorder" title="Hypoactive sexual desire disorder">hypoactive sexual desire disorder</a> (HSDD); its signs and symptoms can both be improved by HRT.<sup id="cite_ref-ziaei_5-1" class="reference"><a href="#cite_note-ziaei-5">&#91;5&#93;</a></sup><sup id="cite_ref-gonzalez_66-0" class="reference"><a href="#cite_note-gonzalez-66">&#91;66&#93;</a></sup> Several hormonal changes take place during this period, including a decrease in estrogen and an increase in <a href="/wiki/Follicle-stimulating_hormone" title="Follicle-stimulating hormone">follicle-stimulating hormone</a>. For most women, the majority of change occurs during the late perimenopausal and postmenopausal stages.<sup id="cite_ref-eden_4-4" class="reference"><a href="#cite_note-eden-4">&#91;4&#93;</a></sup> Decreases in <a href="/wiki/Sex_hormone-binding_globulin" title="Sex hormone-binding globulin">sex hormone-binding globulin</a> (SHBG) and <a href="/wiki/Inhibin" class="mw-redirect" title="Inhibin">inhibin</a> (A and B) also occur. Testosterone is present in women at a lower level than men, peaking at age 30 and declining gradually with age; there is less variation during the menopausal transition relative to estrogen and progesterone.<sup id="cite_ref-eden_4-5" class="reference"><a href="#cite_note-eden-4">&#91;4&#93;</a></sup>
</p><p>A global consensus position statement has advised that postmenopausal testosterone replacement to premenopausal levels can be effective for HSDD. Safety information for testosterone treatment is not available beyond two years of continuous therapy however and dosing above physiologic levels is not advised.<sup id="cite_ref-Testosterone_Consensus_2019_31-1" class="reference"><a href="#cite_note-Testosterone_Consensus_2019-31">&#91;31&#93;</a></sup> Testosterone patches have been found to restore sexual desire in post menopausal women.<sup id="cite_ref-67" class="reference"><a href="#cite_note-67">&#91;67&#93;</a></sup> There is insufficient data to evaluate the impact of testosterone replacement on heart disease, breast cancer, with most trials having included women taking concomitant estrogen and progesterone and with testosterone therapy itself being relatively short in duration. In the setting of this limited data, testosterone therapy has not been associated with adverse events.<sup id="cite_ref-Testosterone_Consensus_2019_31-2" class="reference"><a href="#cite_note-Testosterone_Consensus_2019-31">&#91;31&#93;</a></sup>
</p><p>Not all women are responsive, especially those with preexisting sexual difficulties.<sup id="cite_ref-sarrel_22-1" class="reference"><a href="#cite_note-sarrel-22">&#91;22&#93;</a></sup> Estrogen replacement can restore vaginal cells, <a href="/wiki/PH" title="PH">pH</a> levels, and blood flow to the vagina, all of which tend to deteriorate at the onset of menopause. <a href="/wiki/Dyspareunia" title="Dyspareunia">Pain or discomfort with sex</a> appears to be the most responsive component to estrogen.<sup id="cite_ref-sarrel_22-2" class="reference"><a href="#cite_note-sarrel-22">&#91;22&#93;</a></sup> It also has been shown to have positive effects on the urinary tract.<sup id="cite_ref-sarrel_22-3" class="reference"><a href="#cite_note-sarrel-22">&#91;22&#93;</a></sup> Estrogen can also reduce vaginal atrophy and increase <a href="/wiki/Sexual_arousal" title="Sexual arousal">sexual arousal</a>, frequency and <a href="/wiki/Female_orgasm" class="mw-redirect" title="Female orgasm">orgasm</a>.<sup id="cite_ref-sarrel_22-4" class="reference"><a href="#cite_note-sarrel-22">&#91;22&#93;</a></sup>
</p><p>The effectiveness of hormone replacement can decline in some women after long-term use.<sup id="cite_ref-sarrel_22-5" class="reference"><a href="#cite_note-sarrel-22">&#91;22&#93;</a></sup> A number of studies have also found that the combined effects of estrogen/androgen replacement therapy can increase libido and arousal over estrogen alone.<sup id="cite_ref-sarrel_22-6" class="reference"><a href="#cite_note-sarrel-22">&#91;22&#93;</a></sup> <a href="/wiki/Tibolone" title="Tibolone">Tibolone</a>, a synthetic steroid with estrogenic, androgenic, and progestogenic properties that is available in Europe, has the ability to improve mood, libido, and physical symptomatology. In various placebo-controlled studies, improvements in vasomotor symptoms, emotional response, sleep disturbances, physical symptoms, and sexual desire have been seen, though it also carries a similar risk profile to conventional HRT.<sup id="cite_ref-ziaei_5-2" class="reference"><a href="#cite_note-ziaei-5">&#91;5&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Neurodegenerative_disorders">Neurodegenerative disorders</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=13" title="Edit section: Neurodegenerative disorders">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>For prevention, the WHI suggested that HRT may increase risk of dementia if initiated after 65 years of age, but have a neutral outcome or be neuroprotective for those between 50–55 years.<sup id="cite_ref-Manson_WHI_2013_26-2" class="reference"><a href="#cite_note-Manson_WHI_2013-26">&#91;26&#93;</a></sup> Other studies in perimenopause have shown HRT to be consistently associated with a lower risk of Alzheimer's.<sup id="cite_ref-Dye_et_al._2012_68-0" class="reference"><a href="#cite_note-Dye_et_al._2012-68">&#91;68&#93;</a></sup><sup id="cite_ref-69" class="reference"><a href="#cite_note-69">&#91;69&#93;</a></sup> With Parkinson's the majority of clinical and epidemiological studies show have demonstrated either no association<sup id="cite_ref-70" class="reference"><a href="#cite_note-70">&#91;70&#93;</a></sup><sup id="cite_ref-71" class="reference"><a href="#cite_note-71">&#91;71&#93;</a></sup> or inconclusive results.<sup id="cite_ref-Dye_et_al._2012_68-1" class="reference"><a href="#cite_note-Dye_et_al._2012-68">&#91;68&#93;</a></sup><sup id="cite_ref-72" class="reference"><a href="#cite_note-72">&#91;72&#93;</a></sup> A Danish study suggested an increased risk of Parkinson's with HRT in cyclical dosing schedules.<sup id="cite_ref-73" class="reference"><a href="#cite_note-73">&#91;73&#93;</a></sup>
</p><p>With regards to treatment, randomized trials have shown that HRT improves executive and attention processes outside of the context of dementia in postmenopausal women, both in those that are asymptomatic and those with mild cognitive impairment.<sup id="cite_ref-74" class="reference"><a href="#cite_note-74">&#91;74&#93;</a></sup><sup id="cite_ref-75" class="reference"><a href="#cite_note-75">&#91;75&#93;</a></sup><sup id="cite_ref-pmid8909345_76-0" class="reference"><a href="#cite_note-pmid8909345-76">&#91;76&#93;</a></sup> Estrogen replacement appears to improve motor symptoms and activities of daily living in post menopausal women with Parkinson's, with significant improvement of <a href="/wiki/Unified_Parkinson%27s_disease_rating_scale" title="Unified Parkinson&#39;s disease rating scale">UPDRS scores</a>.<sup id="cite_ref-77" class="reference"><a href="#cite_note-77">&#91;77&#93;</a></sup> Clinical trials have also shown testosterone replacement to be associated with small statistically significant improvements in verbal learning and memory in postmenopausal women.<sup id="cite_ref-78" class="reference"><a href="#cite_note-78">&#91;78&#93;</a></sup> DHEA has not been found to improve cognitive performance after menopause.<sup id="cite_ref-Androgens_Review_2017_32-1" class="reference"><a href="#cite_note-Androgens_Review_2017-32">&#91;32&#93;</a></sup> Pre-clinical studies indicate that endogenous estrogen and testosterone are neuroprotective and can prevent brain amyloid deposition.<sup id="cite_ref-79" class="reference"><a href="#cite_note-79">&#91;79&#93;</a></sup><sup id="cite_ref-80" class="reference"><a href="#cite_note-80">&#91;80&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Muscle_and_bone">Muscle and bone</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=14" title="Edit section: Muscle and bone">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>There is a significant decrease in <a href="/wiki/Hip_fracture" title="Hip fracture">hip fracture</a> risk during treatment that to a lesser degree persists after HRT is stopped.<sup id="cite_ref-Manson_WHI_2013_26-3" class="reference"><a href="#cite_note-Manson_WHI_2013-26">&#91;26&#93;</a></sup><sup id="cite_ref-81" class="reference"><a href="#cite_note-81">&#91;81&#93;</a></sup> It also helps <a href="/wiki/Collagen" title="Collagen">collagen</a> formation, which in turn improves <a href="/wiki/Intervertebral_disc" title="Intervertebral disc">intervertebral disc</a> and bone strength.<sup id="cite_ref-Ten_82-0" class="reference"><a href="#cite_note-Ten-82">&#91;82&#93;</a></sup>
</p><p>Hormone replacement therapy in the form of estrogen and androgen can be effective at reversing the effects of aging on muscle.<sup id="cite_ref-83" class="reference"><a href="#cite_note-83">&#91;83&#93;</a></sup> Lower testosterone is associated with lower bone density and higher free testosterone is associated with lower hip fracture rates in older women.<sup id="cite_ref-Androgens_Review_2017_32-2" class="reference"><a href="#cite_note-Androgens_Review_2017-32">&#91;32&#93;</a></sup> Testosterone therapy, which can be used for decreased sexual function, can also increase bone mineral density and muscle mass.<sup id="cite_ref-Testosterone_Consensus_2019_31-3" class="reference"><a href="#cite_note-Testosterone_Consensus_2019-31">&#91;31&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Side_effects">Side effects</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=15" title="Edit section: Side effects">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p><a href="/wiki/Side_effects" class="mw-redirect" title="Side effects">Side effects</a> in HRT occur with varying frequency and include:<sup id="cite_ref-84" class="reference"><a href="#cite_note-84">&#91;84&#93;</a></sup>
</p>
<div style="display:flex; flex-direction:row; flex-wrap:wrap; gap: 0.8em; align-items:stretch; justify-content:flex-start"><div>
<h3><span class="mw-headline" id="Common">Common</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=16" title="Edit section: Common">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<ul><li><a href="/wiki/Headache" title="Headache">Headache</a></li>
<li><a href="/wiki/Upset_stomach" class="mw-redirect" title="Upset stomach">Upset stomach</a>, <a href="/wiki/Stomach_cramp" class="mw-redirect" title="Stomach cramp">stomach cramps</a> or <a href="/wiki/Bloating" title="Bloating">bloating</a></li>
<li><a href="/wiki/Diarrhea" title="Diarrhea">Diarrhea</a></li>
<li><a href="/wiki/Appetite" title="Appetite">Appetite</a> and weight changes</li>
<li>Changes in <a href="/wiki/Libido" title="Libido">sex drive</a> or performance</li>
<li><a href="/wiki/Anxiety" title="Anxiety">Nervousness</a></li>
<li>Brown or black patches on the skin</li>
<li><a href="/wiki/Acne" title="Acne">Acne</a></li>
<li>Swelling of hands, feet, or lower legs due to <a href="/wiki/Water_retention_(medicine)" class="mw-redirect" title="Water retention (medicine)">fluid retention</a></li>
<li>Changes in <a href="/wiki/Menstrual_flow" class="mw-redirect" title="Menstrual flow">menstrual flow</a></li>
<li>Breast tenderness, enlargement, or discharge</li>
<li>Sudden difficulty wearing <a href="/wiki/Contact_lenses" class="mw-redirect" title="Contact lenses">contact lenses</a></li></ul>
</div><div>
<h3><span class="mw-headline" id="Uncommon">Uncommon</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=17" title="Edit section: Uncommon">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<ul><li><a href="/wiki/Double_vision" class="mw-redirect" title="Double vision">Double vision</a></li>
<li>Severe <a href="/wiki/Abdominal_pain" title="Abdominal pain">abdominal pain</a></li>
<li>Yellowing of skin or eyes</li>
<li>Severe depression</li>
<li>Unusual bleeding</li>
<li>Loss of appetite</li>
<li><a href="/wiki/Skin_rash" class="mw-redirect" title="Skin rash">Skin rash</a></li>
<li><a href="/wiki/Lassitude" class="mw-redirect" title="Lassitude">Lassitude</a></li>
<li>Fever</li>
<li>Dark-colored urine</li>
<li>Light colored stool</li>
<li><a href="/wiki/Chorea_(disease)" class="mw-redirect" title="Chorea (disease)">Chorea</a><sup id="cite_ref-85" class="reference"><a href="#cite_note-85">&#91;85&#93;</a></sup></li></ul>
</div></div>
<h2><span class="mw-headline" id="Contraindications">Contraindications</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=18" title="Edit section: Contraindications">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The following are absolute and relative contraindications to HRT:<sup id="cite_ref-86" class="reference"><a href="#cite_note-86">&#91;86&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Absolute_contraindications">Absolute contraindications</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=19" title="Edit section: Absolute contraindications">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<ul><li>Undiagnosed vaginal bleeding</li>
<li>Severe <a href="/wiki/Liver_disease" title="Liver disease">liver disease</a></li>
<li><a href="/wiki/Pregnancy" title="Pregnancy">Pregnancy</a></li>
<li>Severe <a href="/wiki/Coronary_artery_disease" title="Coronary artery disease">coronary artery disease</a></li>
<li>Aggressive <a href="/wiki/Breast_cancer" title="Breast cancer">breast</a>, <a href="/wiki/Uterine_cancer" title="Uterine cancer">uterine</a> or <a href="/wiki/Ovarian_cancer" title="Ovarian cancer">ovarian cancer</a></li></ul>
<h3><span class="mw-headline" id="Relative_contraindications">Relative contraindications</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=20" title="Edit section: Relative contraindications">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<ul><li><a href="/wiki/Migraine" title="Migraine">Migraine</a> headaches</li>
<li>History of breast cancer</li>
<li>History of ovarian cancer</li>
<li><a href="/wiki/Venous_thrombosis" title="Venous thrombosis">Venous thrombosis</a></li>
<li>History of <a href="/wiki/Uterine_fibroids" class="mw-redirect" title="Uterine fibroids">uterine fibroids</a></li>
<li>Atypical ductal <a href="/wiki/Hyperplasia" title="Hyperplasia">hyperplasia</a> of the <a href="/wiki/Breast" title="Breast">breast</a></li>
<li>Active <a href="/wiki/Gallbladder" title="Gallbladder">gallbladder</a> disease (<a href="/wiki/Cholangitis" class="mw-redirect" title="Cholangitis">cholangitis</a>, <a href="/wiki/Cholecystitis" title="Cholecystitis">cholecystitis</a>)</li>
<li>Well-differentiated and early <a href="/wiki/Endometrial_cancer" title="Endometrial cancer">endometrial cancer</a> - once treatment for the malignancy is complete, is no longer an absolute contraindication.</li></ul>
<h2><span class="mw-headline" id="History_and_research">History and research</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=21" title="Edit section: History and research">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The extraction of CEEs from the urine of pregnant <a href="/wiki/Mares" class="mw-redirect" title="Mares">mares</a> led to the marketing in 1942 of <a href="/wiki/Premarin" class="mw-redirect" title="Premarin">Premarin</a>, one of the earlier forms of estrogen to be introduced.<sup id="cite_ref-Fugh-Berman2015_87-0" class="reference"><a href="#cite_note-Fugh-Berman2015-87">&#91;87&#93;</a></sup><sup id="cite_ref-HumansOrganization2007_88-0" class="reference"><a href="#cite_note-HumansOrganization2007-88">&#91;88&#93;</a></sup> From that time until the mid-1970s, estrogen was administered without a supplemental progestogen. Beginning in 1975, studies began to show that without a progestogen, unopposed estrogen therapy with Premarin resulted in an 8-fold increased risk of <a href="/wiki/Endometrial_cancer" title="Endometrial cancer">endometrial cancer</a>, eventually causing sales of Premarin to plummet.<sup id="cite_ref-Fugh-Berman2015_87-1" class="reference"><a href="#cite_note-Fugh-Berman2015-87">&#91;87&#93;</a></sup> It was recognized in the early 1980s that the addition of a progestogen to estrogen reduced this risk to the endometrium.<sup id="cite_ref-Fugh-Berman2015_87-2" class="reference"><a href="#cite_note-Fugh-Berman2015-87">&#91;87&#93;</a></sup> This led to the development of combined estrogen–progestogen therapy, most commonly with a combination of conjugated equine estrogen (Premarin) and medroxyprogesterone (Provera).<sup id="cite_ref-Fugh-Berman2015_87-3" class="reference"><a href="#cite_note-Fugh-Berman2015-87">&#91;87&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Trials">Trials</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=22" title="Edit section: Trials">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The Women's Health Initiative trials were conducted between 1991 and 2006 and were the first large, <a href="/wiki/Blind_experiment#Double-blind_trials" class="mw-redirect" title="Blind experiment">double-blind</a>, placebo-controlled clinical trials of HRT in healthy women.<sup id="cite_ref-Fugh-Berman2015_87-4" class="reference"><a href="#cite_note-Fugh-Berman2015-87">&#91;87&#93;</a></sup> Their results were both positive and negative, suggesting that during the time of hormone therapy itself, there are increases in invasive <a href="/wiki/Breast_cancer" title="Breast cancer">breast cancer</a>, <a href="/wiki/Stroke" title="Stroke">stroke</a> and <a href="/wiki/Pulmonary_embolism" title="Pulmonary embolism">lung clots</a>. Other risks include increased <a href="/wiki/Endometrial_cancer" title="Endometrial cancer">endometrial cancer</a>, <a href="/wiki/Gallbladder" title="Gallbladder">gallbladder</a> disease, and <a href="/wiki/Urinary_incontinence" title="Urinary incontinence">urinary incontinence</a>, while benefits include decreased <a href="/wiki/Hip_fracture" title="Hip fracture">hip fractures</a>, decreased incidence of <a href="/wiki/Diabetes_mellitus" class="mw-redirect" title="Diabetes mellitus">diabetes</a>, and improvement of <a href="/wiki/Vasomotor" title="Vasomotor">vasomotor</a> symptoms. There is also an increased risk of <a href="/wiki/Dementia" title="Dementia">dementia</a> with HRT in women over 65, though at younger ages it appears to be neuroprotective. After the cessation of HRT, the WHI continued to observe its participants, and found that most of these risks and benefits dissipated, though some elevation in breast cancer risk did persist.<sup id="cite_ref-Manson_WHI_2013_26-4" class="reference"><a href="#cite_note-Manson_WHI_2013-26">&#91;26&#93;</a></sup> Other studies have also suggested an increased risk of <a href="/wiki/Ovarian_cancer" title="Ovarian cancer">ovarian cancer</a>.<sup id="cite_ref-Shi_2016_60-2" class="reference"><a href="#cite_note-Shi_2016-60">&#91;60&#93;</a></sup>
</p><p>The arm of the WHI receiving combined estrogen and progestin therapy was closed prematurely in 2002 by its <a href="/wiki/Data_Monitoring_Committee" class="mw-redirect" title="Data Monitoring Committee">Data Monitoring Committee</a> (DMC) due to perceived health risks, though this occurred a full year after the data suggesting increased risk became manifest. In 2004, the arm of the WHI in which post-hysterectomy patients were being treated with estrogen alone was also closed by the DMC. Clinical medical practice changed based upon two parallel <a href="/wiki/Women%27s_Health_Initiative" title="Women&#39;s Health Initiative">Women's Health Initiative</a> (WHI) studies of HRT. Prior studies were smaller, and many were of women who electively took hormonal therapy. One portion of the parallel studies followed over 16,000 women for an average of 5.2 years, half of whom took <a href="/wiki/Placebo" title="Placebo">placebo</a>, while the other half took a combination of CEEs and MPA (Prempro). This WHI estrogen-plus-progestin trial was stopped prematurely in 2002 because preliminary results suggested risks of combined CEEs and progestins exceeded their benefits. The first report on the halted WHI estrogen-plus-progestin study came out in July 2002.<sup id="cite_ref-JAMA_89-0" class="reference"><a href="#cite_note-JAMA-89">&#91;89&#93;</a></sup>
</p><p>Initial data from the WHI in 2002 suggested mortality to be lower when HRT was begun earlier, between age 50 to 59, but higher when begun after age 60. In older patients, there was an apparent increased incidence of <a href="/wiki/Breast_cancer" title="Breast cancer">breast cancer</a>, <a href="/wiki/Heart_attack" class="mw-redirect" title="Heart attack">heart attacks</a>, <a href="/wiki/Venous_thrombosis" title="Venous thrombosis">venous thrombosis</a>, and <a href="/wiki/Stroke" title="Stroke">stroke</a>, although a reduced incidence of <a href="/wiki/Colorectal_cancer" title="Colorectal cancer">colorectal cancer</a> and <a href="/wiki/Bone_fracture" title="Bone fracture">bone fracture</a>. At the time,  The WHI recommended that women with non-surgical menopause take the lowest feasible dose of HRT for the shortest possible time to minimize associated risks.<sup id="cite_ref-JAMA_89-1" class="reference"><a href="#cite_note-JAMA-89">&#91;89&#93;</a></sup> Some of the WHI findings were again found in a larger national study done in the <a href="/wiki/United_Kingdom" title="United Kingdom">United Kingdom</a>, known as the <a href="/wiki/Million_Women_Study" title="Million Women Study">Million Women Study</a> (MWS). As a result of these findings, the number of women taking HRT dropped precipitously.<sup id="cite_ref-pmid19196674_90-0" class="reference"><a href="#cite_note-pmid19196674-90">&#91;90&#93;</a></sup> In 2012, the <a href="/wiki/United_States_Preventive_Task_Force" class="mw-redirect" title="United States Preventive Task Force">United States Preventive Task Force</a> (USPSTF) concluded that the harmful effects of combined estrogen and progestin therapy likely exceeded their chronic disease prevention benefits.<sup id="cite_ref-Krea2013_91-0" class="reference"><a href="#cite_note-Krea2013-91">&#91;91&#93;</a></sup><sup id="cite_ref-ReferenceA_92-0" class="reference"><a href="#cite_note-ReferenceA-92">&#91;92&#93;</a></sup>
</p><p>In 2002 when the first WHI follow up study was published, with HRT in post menopausal women, both older and younger age groups had a slightly higher incidence of <a href="/wiki/Breast_cancer" title="Breast cancer">breast cancer</a>, and both <a href="/wiki/Heart_attack" class="mw-redirect" title="Heart attack">heart attack</a> and <a href="/wiki/Stroke" title="Stroke">stroke</a> were increased in older patients, although not in younger participants. Breast cancer was increased in women treated with estrogen and a progestin, but not with estrogen and progesterone or estrogen alone. Treatment with unopposed estrogen (i.e., an estrogen alone without a progestogen) is contraindicated if the uterus is still present, due to its proliferative effect on the <a href="/wiki/Endometrium" title="Endometrium">endometrium</a>. The WHI also found a reduced incidence of colorectal cancer when estrogen and a progestogen were used together, and most importantly, a reduced incidence of bone fractures. Ultimately, the study found disparate results for all cause mortality with HRT, finding it to be lower when HRT was begun during ages 50–59, but higher when begun after age 60. The authors of the study recommended that women with non-surgical menopause take the lowest feasible dose of hormones for the shortest time to minimize risk.<sup id="cite_ref-JAMA_89-2" class="reference"><a href="#cite_note-JAMA-89">&#91;89&#93;</a></sup>
</p><p>The data published by the WHI suggested supplemental estrogen increased risk of <a href="/wiki/Deep_vein_thrombosis" title="Deep vein thrombosis">venous thromboembolism</a> and <a href="/wiki/Breast_cancer" title="Breast cancer">breast cancer</a> but was protective against <a href="/wiki/Osteoporosis" title="Osteoporosis">osteoporosis</a> and <a href="/wiki/Colorectal_cancer" title="Colorectal cancer">colorectal cancer</a>, while the impact on cardiovascular disease was mixed.<sup id="cite_ref-93" class="reference"><a href="#cite_note-93">&#91;93&#93;</a></sup> These results were later supported in trials from the United Kingdom, but not in more recent studies from France and China. Genetic polymorphism appears to be associated with inter-individual variability in metabolic response to HRT in postmenopausal women.<sup id="cite_ref-pmid21117950_94-0" class="reference"><a href="#cite_note-pmid21117950-94">&#91;94&#93;</a></sup><sup id="cite_ref-ChlebowskiAnderson2015_95-0" class="reference"><a href="#cite_note-ChlebowskiAnderson2015-95">&#91;95&#93;</a></sup>
</p>
<table class="wikitable mw-collapsible mw-collapsed" style="font-size: small; margin-left: auto; margin-right: auto; border: none; text-align:center;">
<caption class="nowrap"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1063604349"/><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Results_of_the_Women%27s_Health_Initiative_menopausal_hormone_therapy_randomized_controlled_trials" title="Template:Results of the Women&#39;s Health Initiative menopausal hormone therapy randomized controlled trials"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Results_of_the_Women%27s_Health_Initiative_menopausal_hormone_therapy_randomized_controlled_trials" title="Template talk:Results of the Women&#39;s Health Initiative menopausal hormone therapy randomized controlled trials"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Template:Results_of_the_Women%27s_Health_Initiative_menopausal_hormone_therapy_randomized_controlled_trials&amp;action=edit"><abbr title="Edit this template">e</abbr></a></li></ul></div> <span style="font-family:sans-serif;font-size:105%;color:black;background-color:transparent;;">Results of the Women's Health Initiative (WHI) menopausal hormone therapy randomized controlled trials</span>
</caption>
<tbody><tr>
<th rowspan="2">Clinical outcome
</th>
<th rowspan="2">Hypothesized <br />effect on risk
</th>
<th colspan="3"><a href="/wiki/Estrogen_(medication)" title="Estrogen (medication)">Estrogen</a> and <a href="/wiki/Progestogen_(medication)" title="Progestogen (medication)">progestogen</a><br />(<a href="/wiki/Conjugated_estrogens" title="Conjugated estrogens"><abbr title="conjugated estrogens">CEs</abbr></a> 0.625&#160;mg/day p.o. + <a href="/wiki/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate"><abbr title="medroxyprogesterone acetate">MPA</abbr></a> 2.5&#160;mg/day p.o.)<br />(n = 16,608, with uterus, 5.2–5.6 years follow up)
</th>
<th colspan="3"><a href="/wiki/Estrogen_(medication)" title="Estrogen (medication)">Estrogen</a> alone<br />(<a href="/wiki/Conjugated_estrogens" title="Conjugated estrogens"><abbr title="Conjugated estrogens">CEs</abbr></a> 0.625&#160;mg/day p.o.)<br />(n = 10,739, no uterus, 6.8–7.1 years follow up)
</th></tr>
<tr>
<th width="100px"><a href="/wiki/Hazard_ratio" title="Hazard ratio"><abbr title="Hazard ratio">HR</abbr></a>
</th>
<th width="100px">95% <a href="/wiki/Confidence_interval" title="Confidence interval"><abbr title="Confidence interval">CI</abbr></a>
</th>
<th width="100px"><a href="/wiki/Attributable_risk" title="Attributable risk"><abbr title="Attributable risk">AR</abbr></a>
</th>
<th width="100px"><a href="/wiki/Hazard_ratio" title="Hazard ratio"><abbr title="Hazard ratio">HR</abbr></a>
</th>
<th width="100px">95% <a href="/wiki/Confidence_interval" title="Confidence interval"><abbr title="Confidence interval">CI</abbr></a>
</th>
<th width="100px"><a href="/wiki/Attributable_risk" title="Attributable risk"><abbr title="Attributable risk">AR</abbr></a>
</th></tr>
<tr>
<td style="text-align: left;"><a href="/wiki/Coronary_heart_disease" class="mw-redirect" title="Coronary heart disease">Coronary heart disease</a>
</td>
<td>Decreased
</td>
<td style="background: #ffcccb;">1.24
</td>
<td>1.00–1.54
</td>
<td style="background: #ffcccb;">+6 / 10,000 PYs
</td>
<td style="background: #cffbd4;">0.95
</td>
<td>0.79–1.15
</td>
<td style="background: #cffbd4;">−3 / 10,000 PYs
</td></tr>
<tr>
<td style="text-align: left;"><a href="/wiki/Stroke" title="Stroke">Stroke</a>
</td>
<td>Decreased
</td>
<td style="background: #ffcccb;">1.31
</td>
<td>1.02–1.68
</td>
<td style="background: #ffcccb;">+8 / 10,000 PYs
</td>
<td style="background: #ffcccb;">1.37
</td>
<td>1.09–1.73
</td>
<td style="background: #ffcccb;">+12 / 10,000 PYs
</td></tr>
<tr>
<td style="text-align: left;"><a href="/wiki/Pulmonary_embolism" title="Pulmonary embolism">Pulmonary embolism</a>
</td>
<td>Increased
</td>
<td style="background: #ffcccb;">2.13
</td>
<td>1.45–3.11
</td>
<td style="background: #ffcccb;">+10 / 10,000 PYs
</td>
<td style="background: #ffcccb;">1.37
</td>
<td>0.90–2.07
</td>
<td style="background: #ffcccb;">+4 / 10,000 PYs
</td></tr>
<tr>
<td style="text-align: left;"><a href="/wiki/Venous_thromboembolism" class="mw-redirect" title="Venous thromboembolism">Venous thromboembolism</a>
</td>
<td>Increased
</td>
<td style="background: #ffcccb;">2.06
</td>
<td>1.57–2.70
</td>
<td style="background: #ffcccb;">+18 / 10,000 PYs
</td>
<td style="background: #ffcccb;">1.32
</td>
<td>0.99–1.75
</td>
<td style="background: #ffcccb;">+8 / 10,000 PYs
</td></tr>
<tr>
<td style="text-align: left;"><a href="/wiki/Breast_cancer" title="Breast cancer">Breast cancer</a>
</td>
<td>Increased
</td>
<td style="background: #ffcccb;">1.24
</td>
<td>1.02–1.50
</td>
<td style="background: #ffcccb;">+8 / 10,000 PYs
</td>
<td style="background: #cffbd4;">0.80
</td>
<td>0.62–1.04
</td>
<td style="background: #cffbd4;">−6 / 10,000 PYs
</td></tr>
<tr>
<td style="text-align: left;"><a href="/wiki/Colorectal_cancer" title="Colorectal cancer">Colorectal cancer</a>
</td>
<td>Decreased
</td>
<td style="background: #cffbd4;">0.56
</td>
<td>0.38–0.81
</td>
<td style="background: #cffbd4;">−7 / 10,000 PYs
</td>
<td style="background: #ffcccb;">1.08
</td>
<td>0.75–1.55
</td>
<td style="background: #ffcccb;">+1 / 10,000 PYs
</td></tr>
<tr>
<td style="text-align: left;"><a href="/wiki/Endometrial_cancer" title="Endometrial cancer">Endometrial cancer</a>
</td>
<td>–
</td>
<td style="background: #cffbd4;">0.81
</td>
<td>0.48–1.36
</td>
<td style="background: #cffbd4;">−1 / 10,000 PYs
</td>
<td>–
</td>
<td>–
</td>
<td>–
</td></tr>
<tr>
<td style="text-align: left;"><a href="/wiki/Hip_fracture" title="Hip fracture">Hip fractures</a>
</td>
<td>Decreased
</td>
<td style="background: #cffbd4;">0.67
</td>
<td>0.47–0.96
</td>
<td style="background: #cffbd4;">−5 / 10,000 PYs
</td>
<td style="background: #cffbd4;">0.65
</td>
<td>0.45–0.94
</td>
<td style="background: #cffbd4;">−7 / 10,000 PYs
</td></tr>
<tr>
<td style="text-align: left;">Total <a href="/wiki/Bone_fracture" title="Bone fracture">fractures</a>
</td>
<td>Decreased
</td>
<td style="background: #cffbd4;">0.76
</td>
<td>0.69–0.83
</td>
<td style="background: #cffbd4;">−47 / 10,000 PYs
</td>
<td style="background: #cffbd4;">0.71
</td>
<td>0.64–0.80
</td>
<td style="background: #cffbd4;">−53 / 10,000 PYs
</td></tr>
<tr>
<td style="text-align: left;">Total <a href="/wiki/Mortality_rate" title="Mortality rate">mortality</a>
</td>
<td>Decreased
</td>
<td style="background: #cffbd4;">0.98
</td>
<td>0.82–1.18
</td>
<td style="background: #cffbd4;">−1 / 10,000 PYs
</td>
<td style="background: #ffcccb;">1.04
</td>
<td>0.91–1.12
</td>
<td style="background: #ffcccb;">+3 / 10,000 PYs
</td></tr>
<tr>
<td style="text-align: left;">Global index
</td>
<td>–
</td>
<td style="background: #ffcccb;">1.15
</td>
<td>1.03–1.28
</td>
<td style="background: #ffcccb;">+19 / 10,000 PYs
</td>
<td style="background: #ffcccb;">1.01
</td>
<td>1.09–1.12
</td>
<td style="background: #ffcccb;">+2 / 10,000 PYs
</td></tr>
<tr>
<td style="text-align: left;"><a href="/wiki/Diabetes" title="Diabetes">Diabetes</a>
</td>
<td>–
</td>
<td style="background: #cffbd4;">0.79
</td>
<td>0.67–0.93
</td>
<td>
</td>
<td style="background: #cffbd4;">0.88
</td>
<td>0.77–1.01
</td>
<td>
</td></tr>
<tr>
<td style="text-align: left;"><a href="/wiki/Gallbladder_disease" title="Gallbladder disease">Gallbladder disease</a>
</td>
<td>Increased
</td>
<td style="background: #ffcccb;">1.59
</td>
<td>1.28–1.97
</td>
<td>
</td>
<td style="background: #ffcccb;">1.67
</td>
<td>1.35–2.06
</td>
<td>
</td></tr>
<tr>
<td style="text-align: left;"><a href="/wiki/Stress_incontinence" title="Stress incontinence">Stress incontinence</a>
</td>
<td>–
</td>
<td style="background: #ffcccb;">1.87
</td>
<td>1.61–2.18
</td>
<td>
</td>
<td style="background: #ffcccb;">2.15
</td>
<td>1.77–2.82
</td>
<td>
</td></tr>
<tr>
<td style="text-align: left;"><a href="/wiki/Urge_incontinence" class="mw-redirect" title="Urge incontinence">Urge incontinence</a>
</td>
<td>–
</td>
<td style="background: #ffcccb;">1.15
</td>
<td>0.99–1.34
</td>
<td>
</td>
<td style="background: #ffcccb;">1.32
</td>
<td>1.10–1.58
</td>
<td>
</td></tr>
<tr>
<td style="text-align: left;"><a href="/wiki/Peripheral_artery_disease" title="Peripheral artery disease">Peripheral artery disease</a>
</td>
<td>–
</td>
<td style="background: #cffbd4;">0.89
</td>
<td>0.63–1.25
</td>
<td>
</td>
<td style="background: #ffcccb;">1.32
</td>
<td>0.99–1.77
</td>
<td>
</td></tr>
<tr>
<td style="text-align: left;">Probable <a href="/wiki/Dementia" title="Dementia">dementia</a>
</td>
<td>Decreased
</td>
<td style="background: #ffcccb;">2.05
</td>
<td>1.21–3.48
</td>
<td>
</td>
<td style="background: #ffcccb;">1.49
</td>
<td>0.83–2.66
</td>
<td>
</td></tr>
<tr>
<td colspan="8" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Abbreviations:</b> CEs = <a href="/wiki/Conjugated_estrogens" title="Conjugated estrogens">conjugated estrogens</a>. MPA = <a href="/wiki/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">medroxyprogesterone acetate</a>. p.o. = <a href="/wiki/Per_oral" class="mw-redirect" title="Per oral">per oral</a>. HR = <a href="/wiki/Hazard_ratio" title="Hazard ratio">hazard ratio</a>. AR = <a href="/wiki/Attributable_risk" title="Attributable risk">attributable risk</a>. PYs = <a href="/wiki/Person%E2%80%93years" class="mw-redirect" title="Person–years">person–years</a>. CI = <a href="/wiki/Confidence_interval" title="Confidence interval">confidence interval</a>.  <b>Notes:</b> <a href="/wiki/Sample_size" class="mw-redirect" title="Sample size">Sample sizes</a> (n) include <a href="/wiki/Placebo" title="Placebo">placebo</a> recipients, which were about half of patients. "Global index" is defined for each woman as the time to earliest diagnosis for <a href="/wiki/Coronary_heart_disease" class="mw-redirect" title="Coronary heart disease">coronary heart disease</a>, <a href="/wiki/Stroke" title="Stroke">stroke</a>, <a href="/wiki/Pulmonary_embolism" title="Pulmonary embolism">pulmonary embolism</a>, <a href="/wiki/Breast_cancer" title="Breast cancer">breast cancer</a>, <a href="/wiki/Colorectal_cancer" title="Colorectal cancer">colorectal cancer</a>, <a href="/wiki/Endometrial_cancer" title="Endometrial cancer">endometrial cancer</a> (estrogen plus progestogen group only), <a href="/wiki/Hip_fracture" title="Hip fracture">hip fractures</a>, and <a href="/wiki/Death" title="Death">death</a> from other causes. <b>Sources:</b> See template.
</td></tr></tbody></table>
<p>The WHI reported <a href="/wiki/Statistical_significance" title="Statistical significance">statistically significant</a> increases in rates of <a href="/wiki/Breast_cancer" title="Breast cancer">breast cancer</a>, <a href="/wiki/Coronary_heart_disease" class="mw-redirect" title="Coronary heart disease">coronary heart disease</a>, <a href="/wiki/Stroke" title="Stroke">strokes</a> and <a href="/wiki/Pulmonary_embolism" title="Pulmonary embolism">pulmonary emboli</a>. The study also found statistically significant decreases in rates of <a href="/wiki/Hip_fracture" title="Hip fracture">hip fracture</a> and <a href="/wiki/Colorectal_cancer" title="Colorectal cancer">colorectal cancer</a>. "A year after the study was stopped in 2002, an article was published indicating that estrogen plus progestin also increases the risks of dementia."<sup id="cite_ref-96" class="reference"><a href="#cite_note-96">&#91;96&#93;</a></sup> The conclusion of the study was that the HRT combination presented risks that outweighed its measured benefits. The results were almost universally reported as risks and problems associated with HRT in general, rather than with Prempro, the specific proprietary combination of CEEs and MPA studied.
</p><p>After the increased clotting found in the first WHI results was reported in 2002, the number of Prempro prescriptions filled reduced by almost half. Following the WHI results, a large percentage of HRT users opted out of them, which was quickly followed by a sharp drop in breast cancer rates. The decrease in breast cancer rates has continued in subsequent years.<sup id="cite_ref-97" class="reference"><a href="#cite_note-97">&#91;97&#93;</a></sup> An unknown number of women started taking alternatives to Prempro, such as compounded bioidentical hormones, though researchers have asserted that compounded hormones are not significantly different from conventional hormone therapy.<sup id="cite_ref-98" class="reference"><a href="#cite_note-98">&#91;98&#93;</a></sup>
</p><p>The other portion of the parallel studies featured women who were post <a href="/wiki/Hysterectomy" title="Hysterectomy">hysterectomy</a> and so received either placebo progestogen or CEEs alone. This group did not show the risks demonstrated in the combination hormone study, and the estrogen-only study was not halted in 2002. However, in February 2004 it, too, was halted. While there was a 23% decreased incidence of breast cancer in the estrogen-only study participants, risks of stroke and pulmonary embolism were increased slightly, predominantly in patients who began HRT over the age of 60.<sup id="cite_ref-99" class="reference"><a href="#cite_note-99">&#91;99&#93;</a></sup>
</p><p>Several other large studies and meta-analyses have reported reduced mortality for HRT in women younger than age 60 or within 10 years of menopause, and a debatable or absent effect on mortality in women over 60.<sup id="cite_ref-100" class="reference"><a href="#cite_note-100">&#91;100&#93;</a></sup><sup id="cite_ref-101" class="reference"><a href="#cite_note-101">&#91;101&#93;</a></sup><sup id="cite_ref-102" class="reference"><a href="#cite_note-102">&#91;102&#93;</a></sup><sup id="cite_ref-103" class="reference"><a href="#cite_note-103">&#91;103&#93;</a></sup><sup id="cite_ref-endocrine_17-1" class="reference"><a href="#cite_note-endocrine-17">&#91;17&#93;</a></sup><sup id="cite_ref-104" class="reference"><a href="#cite_note-104">&#91;104&#93;</a></sup>
</p><p>Though research thus far has been substantial, further investigation is needed to fully understand differences in effect for different types of HRT and lengths of time since menopause.<sup id="cite_ref-105" class="reference"><a href="#cite_note-105">&#91;105&#93;</a></sup><sup id="cite_ref-106" class="reference"><a href="#cite_note-106">&#91;106&#93;</a></sup><sup id="cite_ref-Ten_82-1" class="reference"><a href="#cite_note-Ten-82">&#91;82&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Available_forms">Available forms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=23" title="Edit section: Available forms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1033289096"/><div role="note" class="hatnote navigation-not-searchable">See also: <a href="/wiki/Sex-hormonal_agent" title="Sex-hormonal agent">Sex-hormonal agent</a> and <a href="/wiki/List_of_sex-hormonal_medications_available_in_the_United_States" title="List of sex-hormonal medications available in the United States">List of sex-hormonal medications available in the United States</a></div>
<p>There are five major human steroid hormones: estrogens, progestogens, <a href="/wiki/Androgens" class="mw-redirect" title="Androgens">androgens</a>, <a href="/wiki/Mineralocorticoids" class="mw-redirect" title="Mineralocorticoids">mineralocorticoids</a>, and <a href="/wiki/Glucocorticoids" class="mw-redirect" title="Glucocorticoids">glucocorticoids</a>. Estrogens and progestogens are the two most often used in menopause. They are available in a wide variety of FDA approved and non–FDA-approved formulations.<sup id="cite_ref-Mayo_9-1" class="reference"><a href="#cite_note-Mayo-9">&#91;9&#93;</a></sup>
</p><p>In women with intact <a href="/wiki/Uterus" title="Uterus">uteruses</a>, estrogens are almost always given in combination with progestogens, as long-term unopposed estrogen therapy is associated with a markedly increased risk of <a href="/wiki/Endometrial_hyperplasia" title="Endometrial hyperplasia">endometrial hyperplasia</a> and <a href="/wiki/Endometrial_cancer" title="Endometrial cancer">endometrial cancer</a>.<sup id="cite_ref-pmid26444994_1-5" class="reference"><a href="#cite_note-pmid26444994-1">&#91;1&#93;</a></sup><sup id="cite_ref-pmid20566620_2-4" class="reference"><a href="#cite_note-pmid20566620-2">&#91;2&#93;</a></sup>  Conversely, in women who have undergone a <a href="/wiki/Hysterectomy" title="Hysterectomy">hysterectomy</a> or do not have a uterus, a progestogen is not required, and estrogen can be used alone. There are many <a href="/wiki/Combination_drug" title="Combination drug">combined formulations</a> which include both estrogen and progestogen.
</p><p>Specific types of hormone replacement include:<sup id="cite_ref-pmid26444994_1-6" class="reference"><a href="#cite_note-pmid26444994-1">&#91;1&#93;</a></sup><sup id="cite_ref-pmid20566620_2-5" class="reference"><a href="#cite_note-pmid20566620-2">&#91;2&#93;</a></sup>
</p>
<ul><li><a href="/wiki/Estrogen_(medication)" title="Estrogen (medication)">Estrogens</a> – <a href="/wiki/Bioidentical" class="mw-redirect" title="Bioidentical">bioidentical</a> estrogens like <a href="/wiki/Estradiol_(medication)" title="Estradiol (medication)">estradiol</a> and <a href="/wiki/Estriol_(medication)" title="Estriol (medication)">estriol</a>, animal-derived estrogens like <a href="/wiki/Conjugated_estrogens" title="Conjugated estrogens">conjugated estrogens</a> (CEEs), and <a href="/wiki/Synthetic_compound" class="mw-redirect" title="Synthetic compound">synthetic</a> estrogens like <a href="/wiki/Ethinylestradiol" title="Ethinylestradiol">ethinylestradiol</a></li>
<li><a href="/wiki/Progestogen" title="Progestogen">Progestogens</a> – bioidentical <a href="/wiki/Progesterone_(medication)" title="Progesterone (medication)">progesterone</a>, and <a href="/wiki/Progestin" class="mw-redirect" title="Progestin">progestins</a> (synthetic progestogens) like <a href="/wiki/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">medroxyprogesterone acetate</a> (MPA), <a href="/wiki/Norethisterone" title="Norethisterone">norethisterone</a>, and <a href="/wiki/Dydrogesterone" title="Dydrogesterone">dydrogesterone</a></li>
<li><a href="/wiki/Androgen" title="Androgen">Androgens</a> – bioidentical <a href="/wiki/Testosterone_(medication)" title="Testosterone (medication)">testosterone</a> and <a href="/wiki/Dehydroepiandrosterone" title="Dehydroepiandrosterone">dehydroepiandrosterone</a> (DHEA), and synthetic <a href="/wiki/Anabolic_steroid" title="Anabolic steroid">anabolic steroids</a> like <a href="/wiki/Methyltestosterone" title="Methyltestosterone">methyltestosterone</a> and <a href="/wiki/Nandrolone_decanoate" title="Nandrolone decanoate">nandrolone decanoate</a><sup id="cite_ref-pmid12730248_107-0" class="reference"><a href="#cite_note-pmid12730248-107">&#91;107&#93;</a></sup><sup id="cite_ref-pmid18488873_108-0" class="reference"><a href="#cite_note-pmid18488873-108">&#91;108&#93;</a></sup></li></ul>
<p><a href="/wiki/Tibolone" title="Tibolone">Tibolone</a> &#8211; a synthetic medication available in Europe but not the United States&#8211; is more effective than <a href="/wiki/Placebo" title="Placebo">placebo</a> but less effective than combination hormone therapy in postmenopausal women. It may have a decreased risk of breast and colorectal cancer, though conversely it can be associated with vaginal bleeding, endometrial cancer, and increase the risk of stroke in women over age 60 years.<sup id="cite_ref-Formoso_109-0" class="reference"><a href="#cite_note-Formoso-109">&#91;109&#93;</a></sup><sup id="cite_ref-110" class="reference"><a href="#cite_note-110">&#91;110&#93;</a></sup>
</p><p><a href="/wiki/Vaginal_estrogen" title="Vaginal estrogen">Vaginal estrogen</a> can improve local <a href="/wiki/Atrophy" title="Atrophy">atrophy</a> and dryness, with fewer systemic effects than estrogens delivered by other routes.<sup id="cite_ref-mayo2011_111-0" class="reference"><a href="#cite_note-mayo2011-111">&#91;111&#93;</a></sup> Sometimes an androgen, generally testosterone, can be added to treat diminished <a href="/wiki/Libido" title="Libido">libido</a>.<sup id="cite_ref-112" class="reference"><a href="#cite_note-112">&#91;112&#93;</a></sup><sup id="cite_ref-113" class="reference"><a href="#cite_note-113">&#91;113&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Continuous_versus_cyclic">Continuous versus cyclic</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=24" title="Edit section: Continuous versus cyclic">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Dosage is often varied cyclically to more closely mimic the ovarian hormone cycle, with estrogens taken daily and progestogens taken for about two weeks every month or every other month, a schedule referred to as 'cyclic' or 'sequentially combined'. Alternatively, 'continuous combined' HRT can be given with a constant daily hormonal dosage.<sup id="cite_ref-114" class="reference"><a href="#cite_note-114">&#91;114&#93;</a></sup> Continuous combined HRT is associated with less complex endometrial hyerplasia than cyclic.<sup id="cite_ref-115" class="reference"><a href="#cite_note-115">&#91;115&#93;</a></sup> Impact on breast density appears to be similar in both regimen timings.<sup id="cite_ref-116" class="reference"><a href="#cite_note-116">&#91;116&#93;</a></sup>
</p>
<table class="wikitable mw-collapsible mw-collapsed" style="font-size: small; text-align:left; margin-left:auto; margin-right:auto; border:none;">
<caption class="nowrap" style="font-size: 105%;"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1063604349"/><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Estrogen_dosages_for_menopausal_hormone_therapy" title="Template:Estrogen dosages for menopausal hormone therapy"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Estrogen_dosages_for_menopausal_hormone_therapy" title="Template talk:Estrogen dosages for menopausal hormone therapy"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Template:Estrogen_dosages_for_menopausal_hormone_therapy&amp;action=edit"><abbr title="Edit this template">e</abbr></a></li></ul></div> Estrogen dosages for menopausal hormone therapy
</caption>
<tbody><tr>
<th>Route/form</th>
<th>Estrogen</th>
<th>Low</th>
<th>Standard</th>
<th>High
</th></tr>
<tr>
<td rowspan="8"><a href="/wiki/Oral_administration" title="Oral administration">Oral</a></td>
<td><a href="/wiki/Estradiol_(medication)" title="Estradiol (medication)">Estradiol</a></td>
<td>0.5–1 mg/day</td>
<td>1–2 mg/day</td>
<td>2–4 mg/day
</td></tr>
<tr>
<td><a href="/wiki/Estradiol_valerate" title="Estradiol valerate">Estradiol valerate</a></td>
<td>0.5–1 mg/day</td>
<td>1–2 mg/day</td>
<td>2–4 mg/day
</td></tr>
<tr>
<td><a href="/wiki/Estradiol_acetate" title="Estradiol acetate">Estradiol acetate</a></td>
<td>0.45–0.9 mg/day</td>
<td>0.9–1.8 mg/day</td>
<td>1.8–3.6 mg/day
</td></tr>
<tr>
<td><a href="/wiki/Conjugated_estrogens" title="Conjugated estrogens">Conjugated estrogens</a></td>
<td>0.3–0.45 mg/day</td>
<td>0.625 mg/day</td>
<td>0.9–1.25 mg/day
</td></tr>
<tr>
<td><a href="/wiki/Esterified_estrogens" title="Esterified estrogens">Esterified estrogens</a></td>
<td>0.3–0.45 mg/day</td>
<td>0.625 mg/day</td>
<td>0.9–1.25 mg/day
</td></tr>
<tr>
<td><a href="/wiki/Estropipate" title="Estropipate">Estropipate</a></td>
<td>0.75 mg/day</td>
<td>1.5 mg/day</td>
<td>3 mg/day
</td></tr>
<tr>
<td><a href="/wiki/Estriol_(medication)" title="Estriol (medication)">Estriol</a></td>
<td>1–2 mg/day</td>
<td>2–4 mg/day</td>
<td>4–8 mg/day
</td></tr>
<tr>
<td><a href="/wiki/Ethinylestradiol" title="Ethinylestradiol">Ethinylestradiol</a><sup>a</sup></td>
<td>2.5–10 μg/day</td>
<td>5–20 μg/day</td>
<td>–
</td></tr>
<tr>
<td><a href="/wiki/Nasal_spray" title="Nasal spray">Nasal spray</a></td>
<td><a href="/wiki/Estradiol_(medication)" title="Estradiol (medication)">Estradiol</a></td>
<td>150 μg/day</td>
<td>300 μg/day</td>
<td>600 μg/day
</td></tr>
<tr>
<td><a href="/wiki/Transdermal_patch" title="Transdermal patch">Transdermal patch</a></td>
<td><a href="/wiki/Estradiol_(medication)" title="Estradiol (medication)">Estradiol</a></td>
<td>25 μg/day<sup>b</sup></td>
<td>50 μg/day<sup>b</sup></td>
<td>100 μg/day<sup>b</sup>
</td></tr>
<tr>
<td><a href="/wiki/Transdermal_gel" class="mw-redirect" title="Transdermal gel">Transdermal gel</a></td>
<td><a href="/wiki/Estradiol_(medication)" title="Estradiol (medication)">Estradiol</a></td>
<td>0.5 mg/day</td>
<td>1–1.5 mg/day</td>
<td>2–3 mg/day
</td></tr>
<tr>
<td rowspan="2"><a href="/wiki/Vaginal_administration" class="mw-redirect" title="Vaginal administration">Vaginal</a></td>
<td><a href="/wiki/Estradiol_(medication)" title="Estradiol (medication)">Estradiol</a></td>
<td>25 μg/day</td>
<td>–</td>
<td>–
</td></tr>
<tr>
<td><a href="/wiki/Estriol_(medication)" title="Estriol (medication)">Estriol</a></td>
<td>30 μg/day</td>
<td>0.5 mg 2x/week</td>
<td>0.5 mg/day
</td></tr>
<tr>
<td rowspan="3"><a href="/wiki/Intramuscular" class="mw-redirect" title="Intramuscular"><abbr title="Intramuscular">IM</abbr></a> or <a href="/wiki/Subcutaneous_injection" title="Subcutaneous injection"><abbr title="subcutaneous">SC</abbr> injection</a></td>
<td><a href="/wiki/Estradiol_valerate" title="Estradiol valerate">Estradiol valerate</a></td>
<td>–</td>
<td>–</td>
<td>4 mg 1x/4 weeks
</td></tr>
<tr>
<td><a href="/wiki/Estradiol_cypionate" title="Estradiol cypionate">Estradiol cypionate</a></td>
<td>1 mg 1x/3–4 weeks</td>
<td>3 mg 1x/3–4 weeks</td>
<td>5 mg 1x/3–4 weeks
</td></tr>
<tr>
<td><a href="/wiki/Estradiol_benzoate" title="Estradiol benzoate">Estradiol benzoate</a></td>
<td>0.5 mg 1x/week</td>
<td>1 mg 1x/week</td>
<td>1.5 mg 1x/week
</td></tr>
<tr>
<td><a href="/wiki/Subcutaneous_implant" title="Subcutaneous implant"><abbr title="Subcutaneous">SC</abbr> implant</a></td>
<td><a href="/wiki/Estradiol_(medication)" title="Estradiol (medication)">Estradiol</a></td>
<td>25 mg 1x/6 months</td>
<td>50 mg 1x/6 months</td>
<td>100 mg 1x/6 months
</td></tr>
<tr class="sortbottom">
<td colspan="8" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Footnotes:</b> <sup>a</sup> = No longer used or recommended, due to health concerns. <sup>b</sup> = As a single patch applied once or twice per week (worn for 3–4 days or 7 days), depending on the formulation. <b>Note:</b> Dosages are not necessarily equivalent. <b>Sources:</b> See template.
</td></tr></tbody></table>
<h3><span class="mw-headline" id="Route_of_administration">Route of administration</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=25" title="Edit section: Route of administration">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Blausen_0585_IUD.png" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/1/18/Blausen_0585_IUD.png/220px-Blausen_0585_IUD.png" decoding="async" width="220" height="165" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/1/18/Blausen_0585_IUD.png/330px-Blausen_0585_IUD.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/18/Blausen_0585_IUD.png/440px-Blausen_0585_IUD.png 2x" data-file-width="1024" data-file-height="768" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Blausen_0585_IUD.png" class="internal" title="Enlarge"></a></div>An intrauterine device can be used to receive HRT.</div></div></div>
<p>The medications used in menopausal HRT are available in numerous different <a href="/wiki/Pharmaceutical_formulation" title="Pharmaceutical formulation">formulations</a> for use by a variety of different <a href="/wiki/Routes_of_administration" class="mw-redirect" title="Routes of administration">routes of administration</a>:<sup id="cite_ref-pmid26444994_1-7" class="reference"><a href="#cite_note-pmid26444994-1">&#91;1&#93;</a></sup><sup id="cite_ref-pmid20566620_2-6" class="reference"><a href="#cite_note-pmid20566620-2">&#91;2&#93;</a></sup>
</p>
<ul><li><a href="/wiki/Oral_administration" title="Oral administration">Oral administration</a> – <a href="/wiki/Tablet_(pharmacy)" title="Tablet (pharmacy)">tablets</a>, <a href="/wiki/Capsule_(pharmacy)" title="Capsule (pharmacy)">capsules</a></li>
<li><a href="/wiki/Transdermal_administration" class="mw-redirect" title="Transdermal administration">Transdermal administration</a> – <a href="/wiki/Transdermal_patch" title="Transdermal patch">patches</a>, <a href="/wiki/Transdermal_gel" class="mw-redirect" title="Transdermal gel">gels</a>, <a href="/wiki/Cream_(pharmacy)" title="Cream (pharmacy)">creams</a></li>
<li><a href="/wiki/Vaginal_administration" class="mw-redirect" title="Vaginal administration">Vaginal administration</a> – tablets, creams, <a href="/wiki/Suppository" title="Suppository">suppositories</a>, <a href="/wiki/Vaginal_ring" title="Vaginal ring">rings</a></li>
<li><a href="/wiki/Intramuscular_injection" title="Intramuscular injection">Intramuscular</a> or <a href="/wiki/Subcutaneous_injection" title="Subcutaneous injection">subcutaneous injection</a> – <a href="/wiki/Solution_(chemistry)" title="Solution (chemistry)">solutions</a> in <a href="/wiki/Vial" title="Vial">vials</a> or <a href="/wiki/Ampoule" title="Ampoule">ampoules</a></li>
<li><a href="/wiki/Subcutaneous_implant" title="Subcutaneous implant">Subcutaneous implant</a> – <a href="/wiki/Surgery" title="Surgery">surgically-inserted</a> pellets placed into <a href="/wiki/Adipose_tissue" title="Adipose tissue">fat tissue</a></li>
<li>Less commonly <a href="/wiki/Sublingual_administration" title="Sublingual administration">sublingual</a>, <a href="/wiki/Buccal_administration" title="Buccal administration">buccal</a>, <a href="/wiki/Intranasal_administration" class="mw-redirect" title="Intranasal administration">intranasal</a>, and <a href="/wiki/Rectal_administration" title="Rectal administration">rectal administration</a>, as well as <a href="/wiki/Intrauterine_device" title="Intrauterine device">intrauterine devices</a></li></ul>
<p>More recently developed forms of drug delivery are alleged to have increased local effect lower dosing, fewer side effects, and constant rather than cyclical serum hormone levels.<sup id="cite_ref-pmid26444994_1-8" class="reference"><a href="#cite_note-pmid26444994-1">&#91;1&#93;</a></sup><sup id="cite_ref-pmid20566620_2-7" class="reference"><a href="#cite_note-pmid20566620-2">&#91;2&#93;</a></sup> Transdermal and vaginal estrogen, in particular, avoid <a href="/wiki/First_pass_metabolism" class="mw-redirect" title="First pass metabolism">first pass metabolism</a> through the liver. This in turn prevents an increase in clotting factors and accumulation of anti-estrogenic metabolites, resulting in fewer adverse side effects, particularly with regard to cardiovascular disease and stroke.<sup id="cite_ref-ReferenceB_117-0" class="reference"><a href="#cite_note-ReferenceB-117">&#91;117&#93;</a></sup>
</p><p>Injectable forms of estradiol are no longer recommended in menopausal hormone therapy due to the availability of other formulations.<sup id="cite_ref-MartinBarbieri2021_118-0" class="reference"><a href="#cite_note-MartinBarbieri2021-118">&#91;118&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Bioidentical_hormone_therapy">Bioidentical hormone therapy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=26" title="Edit section: Bioidentical hormone therapy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1033289096"/><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Bioidentical_hormone_therapy" class="mw-redirect" title="Bioidentical hormone therapy">Bioidentical hormone therapy</a></div>
<p><a href="/wiki/Bioidentical_hormone_therapy" class="mw-redirect" title="Bioidentical hormone therapy">Bioidentical hormone therapy</a> (BHT) is the usage of hormones that are chemically identical to those produced in the body. Although proponents of BHT claim advantages over non-bioidentical or conventional hormone therapy, the FDA does not recognize the term 'bioidentical hormone', stating there is no scientific evidence that these hormones are identical to their <a href="/wiki/Endogenous" class="mw-redirect" title="Endogenous">naturally</a> occurring counterparts.<sup id="cite_ref-pmid21464264_11-1" class="reference"><a href="#cite_note-pmid21464264-11">&#91;11&#93;</a></sup><sup id="cite_ref-FDA2008_119-0" class="reference"><a href="#cite_note-FDA2008-119">&#91;119&#93;</a></sup> There are, however, FDA approved products containing hormones classified as 'bioidentical'.<sup id="cite_ref-cobin_12-2" class="reference"><a href="#cite_note-cobin-12">&#91;12&#93;</a></sup><sup id="cite_ref-Mayo_9-2" class="reference"><a href="#cite_note-Mayo-9">&#91;9&#93;</a></sup>
</p><p>Bioidentical hormones can be used in either <i>pharmaceutical</i> or <i>compounded</i> preparations, with the latter generally not recommended by regulatory bodies due to their lack of standardization and regulatory oversight.<sup id="cite_ref-pmid21464264_11-2" class="reference"><a href="#cite_note-pmid21464264-11">&#91;11&#93;</a></sup> Most classifications of bioidentical hormones do not take into account manufacturing, source, or delivery method of the products, and so describe both non-FDA approved compounded products and FDA approved pharmaceuticals as 'bioidentical'.<sup id="cite_ref-Mayo_9-3" class="reference"><a href="#cite_note-Mayo-9">&#91;9&#93;</a></sup> The <i>British Menopause Society</i> has issued a <a href="/wiki/Medical_consensus" title="Medical consensus">consensus statement</a> endorsing the distinction between "compounded" forms (cBHRT), described as unregulated, custom made by specialty pharmacies and subject to heavy marketing and "regulated" pharmaceutical grade forms (rBHRT), which undergo formal oversight by entities such as the <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">FDA</a> and form the basis of most clinical trials.<sup id="cite_ref-BMS_54-1" class="reference"><a href="#cite_note-BMS-54">&#91;54&#93;</a></sup> Some practitioners recommending compounded bioidentical HRT also utilize salivary or serum hormonal testing to monitor response to therapy, a practice not endorsed by current clinical guidelines in the United States and Europe.<sup id="cite_ref-120" class="reference"><a href="#cite_note-120">&#91;120&#93;</a></sup>
</p><p>Bioidentical hormones in pharmaceuticals may have very limited clinical data, with no randomized controlled prospective trials to date comparing them to their animal derived counterparts. Some pre-clinical data has suggested a decreased risk of <a href="/wiki/Venous_thromboembolism" class="mw-redirect" title="Venous thromboembolism">venous thromboembolism</a>, <a href="/wiki/Cardiovascular_disease" title="Cardiovascular disease">cardiovascular disease</a>, and <a href="/wiki/Breast_cancer" title="Breast cancer">breast cancer</a>.<sup id="cite_ref-pmid21464264_11-3" class="reference"><a href="#cite_note-pmid21464264-11">&#91;11&#93;</a></sup> As of 2012, guidelines from the <a href="/wiki/North_American_Menopause_Society" title="North American Menopause Society">North American Menopause Society</a>, the <a href="/wiki/Endocrine_Society" title="Endocrine Society">Endocrine Society</a>, the <a href="/wiki/International_Menopause_Society" title="International Menopause Society">International Menopause Society</a>, and the <a href="/wiki/European_Menopause_and_Andropause_Society" title="European Menopause and Andropause Society">European Menopause and Andropause Society</a> endorsed the reduced risk of bioidentical pharmaceuticals for those with increased clotting risk.<sup id="cite_ref-pmid21464264_11-4" class="reference"><a href="#cite_note-pmid21464264-11">&#91;11&#93;</a></sup><sup id="cite_ref-pmid24398406_121-0" class="reference"><a href="#cite_note-pmid24398406-121">&#91;121&#93;</a></sup>
</p><p>A retrospective Cox proportional hazards analysis has suggested that, in distinction to previous studies, conjugated equine estrogen and medroxyprogesterone acetate are associated with a risk reduction in breast cancer, while bioidentical hormone therapy is associated with slightly increased risk.<sup id="cite_ref-Conjugated_equine_estrogen_and_medr_43-3" class="reference"><a href="#cite_note-Conjugated_equine_estrogen_and_medr-43">&#91;43&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="Compounding">Compounding</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=27" title="Edit section: Compounding">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>Compounding for HRT is generally discouraged by the FDA and medical industry in the United States due to a lack of regulation and standardized dosing.<sup id="cite_ref-pmid21464264_11-5" class="reference"><a href="#cite_note-pmid21464264-11">&#91;11&#93;</a></sup><sup id="cite_ref-FDA2008_119-1" class="reference"><a href="#cite_note-FDA2008-119">&#91;119&#93;</a></sup> The <a href="/wiki/U._S._Congress" class="mw-redirect" title="U. S. Congress">U. S. Congress</a> did grant the FDA explicit but limited oversight of compounded drugs in a 1997 amendment to the <a href="/wiki/Federal_Food,_Drug,_and_Cosmetic_Act" title="Federal Food, Drug, and Cosmetic Act">Federal Food, Drug, and Cosmetic Act</a> (FDCA), but they have encountered obstacles in this role since that time. After 64 patient deaths and 750 harmed patients from a 2012 meningitis outbreak due to contaminated steroid injections, Congress passed the 2013 <a href="/wiki/Drug_Quality_and_Security_Act" title="Drug Quality and Security Act">Drug Quality and Security Act</a>, authorizing creation by the FDA of a voluntary registration for facilities that manufactured compounded drugs, and reinforcing FDCA regulations for traditional compounding.<sup id="cite_ref-122" class="reference"><a href="#cite_note-122">&#91;122&#93;</a></sup> The DQSA and its reinforcement of provision §503A of the FDCA solidifies FDA authority to enforce FDCA regulation of against compounders of bioidentical hormone therapy.<sup id="cite_ref-123" class="reference"><a href="#cite_note-123">&#91;123&#93;</a></sup>
</p><p>In the United Kingdom, on the other hand, compounding is a regulated activity. The <a href="/wiki/Medicines_and_Healthcare_products_Regulatory_Agency" title="Medicines and Healthcare products Regulatory Agency">Medicines and Healthcare products Regulatory Agency</a> regulates compounding performed under a Manufacturing Specials license and the <a href="/wiki/General_Pharmaceutical_Council" title="General Pharmaceutical Council">General Pharmaceutical Council</a> regulates compounding performed within a pharmacy. All testosterone prescribed in the <a href="/wiki/United_Kingdom" title="United Kingdom">United Kingdom</a> is bioidentical, with its use supported by the <a href="/wiki/National_Health_Service" title="National Health Service">National Health Service</a>. There is also marketing authorisation for male testosterone products. <a href="/wiki/National_Institute_for_Health_and_Care_Excellence" title="National Institute for Health and Care Excellence">National Institute for Health and Care Excellence</a> guideline 1.4.8 states: "consider testosterone supplementation for menopausal women with low sexual desire if HRT alone is not effective". The footnote adds: "at the time of publication (November 2015), testosterone did not have a United Kingdom marketing authorisation for this indication in women. Bio-identical progesterone is used in IVF treatment and for pregnant women who are at risk of premature labour."
</p>
<h2><span class="mw-headline" id="Society_and_public_perception">Society and public perception</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=28" title="Edit section: Society and public perception">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Wyeth_controversy">Wyeth controversy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=29" title="Edit section: Wyeth controversy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1033289096"/><div role="note" class="hatnote navigation-not-searchable">See also: <a href="/wiki/Medical_ghostwriter" title="Medical ghostwriter">Medical ghostwriter</a></div>
<p><a href="/wiki/Wyeth" title="Wyeth">Wyeth</a>, now a <a href="/wiki/Subsidiary" title="Subsidiary">subsidiary</a> of <a href="/wiki/Pfizer" title="Pfizer">Pfizer</a>, was a <a href="/wiki/Pharmaceutical_company" class="mw-redirect" title="Pharmaceutical company">pharmaceutical company</a> that marketed the HRT products Premarin (CEEs) and Prempro (CEEs + MPA).<sup id="cite_ref-Singer2009_124-0" class="reference"><a href="#cite_note-Singer2009-124">&#91;124&#93;</a></sup><sup id="cite_ref-pmid20838656_125-0" class="reference"><a href="#cite_note-pmid20838656-125">&#91;125&#93;</a></sup> In 2009, <a href="/wiki/Litigation" class="mw-redirect" title="Litigation">litigation</a> involving Wyeth resulted in the release of 1,500&#160;documents that revealed practices concerning its promotion of these medications.<sup id="cite_ref-Singer2009_124-1" class="reference"><a href="#cite_note-Singer2009-124">&#91;124&#93;</a></sup><sup id="cite_ref-pmid20838656_125-1" class="reference"><a href="#cite_note-pmid20838656-125">&#91;125&#93;</a></sup><sup id="cite_ref-MayMay2012_126-0" class="reference"><a href="#cite_note-MayMay2012-126">&#91;126&#93;</a></sup> The documents showed that Wyeth commissioned dozens of <a href="/wiki/Ghostwriting" class="mw-redirect" title="Ghostwriting">ghostwritten</a> <a href="/wiki/Literature_review" title="Literature review">reviews</a> and commentaries that were published in <a href="/wiki/Medical_journal" title="Medical journal">medical journals</a> in order to promote unproven benefits of its HRT products, downplay their harms and risks, and cast competing therapies in a negative light.<sup id="cite_ref-Singer2009_124-2" class="reference"><a href="#cite_note-Singer2009-124">&#91;124&#93;</a></sup><sup id="cite_ref-pmid20838656_125-2" class="reference"><a href="#cite_note-pmid20838656-125">&#91;125&#93;</a></sup><sup id="cite_ref-MayMay2012_126-1" class="reference"><a href="#cite_note-MayMay2012-126">&#91;126&#93;</a></sup> Starting in the mid-1990s and continuing for over a decade, Wyeth pursued an aggressive "publication plan" strategy to promote its HRT products through the use of ghostwritten publications.<sup id="cite_ref-MayMay2012_126-2" class="reference"><a href="#cite_note-MayMay2012-126">&#91;126&#93;</a></sup> It worked mainly with DesignWrite, a medical writing firm.<sup id="cite_ref-MayMay2012_126-3" class="reference"><a href="#cite_note-MayMay2012-126">&#91;126&#93;</a></sup> Between 1998 and 2005, Wyeth had 26&#160;papers promoting its HRT products published in scientific journals.<sup id="cite_ref-Singer2009_124-3" class="reference"><a href="#cite_note-Singer2009-124">&#91;124&#93;</a></sup>
</p><p>These favorable publications emphasized the benefits and downplayed the risks of its HRT products, especially the "misconception" of the association of its products with breast cancer.<sup id="cite_ref-MayMay2012_126-4" class="reference"><a href="#cite_note-MayMay2012-126">&#91;126&#93;</a></sup> The publications defended unsupported cardiovascular "benefits" of its products, downplayed risks such as breast cancer, and promoted <a href="/wiki/Off-label" class="mw-redirect" title="Off-label">off-label</a> and unproven uses like prevention of dementia, <a href="/wiki/Parkinson%27s_disease" title="Parkinson&#39;s disease">Parkinson's disease</a>, <a href="/wiki/Vision_problems" class="mw-redirect" title="Vision problems">vision problems</a>, and <a href="/wiki/Wrinkle" title="Wrinkle">wrinkles</a>.<sup id="cite_ref-pmid20838656_125-3" class="reference"><a href="#cite_note-pmid20838656-125">&#91;125&#93;</a></sup> In addition, Wyeth emphasized negative messages against the SERM <a href="/wiki/Raloxifene" title="Raloxifene">raloxifene</a> for osteoporosis, instructed writers to stress the fact that "alternative therapies have increased in usage since the WHI even though there is little evidence that they are effective or safe...", called into question the quality and therapeutic equivalence of approved generic CEE products, and made efforts to spread the notion that the unique risks of CEEs and MPA were a class effect of all forms of menopausal HRT: "Overall, these data indicate that the benefit/risk analysis that was reported in the Women's Health Initiative can be generalized to all postmenopausal hormone replacement therapy products."<sup id="cite_ref-pmid20838656_125-4" class="reference"><a href="#cite_note-pmid20838656-125">&#91;125&#93;</a></sup>
</p><p>Following the publication of the WHI data in 2002, the stock prices for the pharmaceutical industry plummeted, and huge numbers of women stopped using HRT.<sup id="cite_ref-pmid28801526_127-0" class="reference"><a href="#cite_note-pmid28801526-127">&#91;127&#93;</a></sup> The stocks of Wyeth, which supplied the Premarin and Prempro that were used in the WHI trials, decreased by more than 50%, and never fully recovered.<sup id="cite_ref-pmid28801526_127-1" class="reference"><a href="#cite_note-pmid28801526-127">&#91;127&#93;</a></sup> Some of their articles in response promoted themes such as the following: "the WHI was flawed; the WHI was a controversial trial; the population studied in the WHI was inappropriate or was not representative of the general population of menopausal women; results of clinical trials should not guide treatment for individuals; observational studies are as good as or better than randomized clinical trials; animal studies can guide clinical decision-making; the risks associated with hormone therapy have been exaggerated; the benefits of hormone therapy have been or will be proven, and the recent studies are an aberration."<sup id="cite_ref-Fugh-Berman2015_87-5" class="reference"><a href="#cite_note-Fugh-Berman2015-87">&#91;87&#93;</a></sup> Similar findings were observed in a 2010 analysis of 114 editorials, reviews, guidelines, and letters by five industry-paid authors.<sup id="cite_ref-Fugh-Berman2015_87-6" class="reference"><a href="#cite_note-Fugh-Berman2015-87">&#91;87&#93;</a></sup> These publications promoted positive themes and challenged and criticized unfavorable trials such as the WHI and MWS.<sup id="cite_ref-Fugh-Berman2015_87-7" class="reference"><a href="#cite_note-Fugh-Berman2015-87">&#91;87&#93;</a></sup> In 2009, Wyeth was acquired by Pfizer in a deal valued at US$68 billion.<sup id="cite_ref-SorkinWilson2009_128-0" class="reference"><a href="#cite_note-SorkinWilson2009-128">&#91;128&#93;</a></sup><sup id="cite_ref-Chiang2009_129-0" class="reference"><a href="#cite_note-Chiang2009-129">&#91;129&#93;</a></sup> Pfizer, a company that produces Provera and Depo-Provera (MPA) and has also engaged in medical ghostwriting, continues to market Premarin and Prempro, which remain best-selling medications.<sup id="cite_ref-Fugh-Berman2015_87-8" class="reference"><a href="#cite_note-Fugh-Berman2015-87">&#91;87&#93;</a></sup><sup id="cite_ref-MayMay2012_126-5" class="reference"><a href="#cite_note-MayMay2012-126">&#91;126&#93;</a></sup>
</p><p>According to Fugh-Berman (2010), "Today, despite definitive scientific data to the contrary, many gynecologists still believe that the benefits of [HRT] outweigh the risks in asymptomatic women. This non-evidence–based perception may be the result of decades of carefully orchestrated corporate influence on medical literature."<sup id="cite_ref-pmid20838656_125-5" class="reference"><a href="#cite_note-pmid20838656-125">&#91;125&#93;</a></sup> As many as 50% of physicians have expressed skepticism about large trials like the WHI and HERS.<sup id="cite_ref-pmid21949743_130-0" class="reference"><a href="#cite_note-pmid21949743-130">&#91;130&#93;</a></sup> The positive perceptions of many physicians of HRT in spite of large trials showing risks that potentially outweigh any benefits may be due to the efforts of pharmaceutical companies like Wyeth.<sup id="cite_ref-MayMay2012_126-6" class="reference"><a href="#cite_note-MayMay2012-126">&#91;126&#93;</a></sup><sup id="cite_ref-Fugh-Berman2015_87-9" class="reference"><a href="#cite_note-Fugh-Berman2015-87">&#91;87&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Popularity">Popularity</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=30" title="Edit section: Popularity">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The 1990s showed a dramatic decline in prescription rates, though more recently they have begun to rise again.<sup id="cite_ref-ReferenceB_117-1" class="reference"><a href="#cite_note-ReferenceB-117">&#91;117&#93;</a></sup><sup id="cite_ref-131" class="reference"><a href="#cite_note-131">&#91;131&#93;</a></sup> Transdermal therapy, in part due to its lack of increase in venous thromboembolism, is now often the first choice for HRT in the <a href="/wiki/United_Kingdom" title="United Kingdom">United Kingdom</a>. Conjugate equine estrogen, in distinction, has a potentially higher thrombosis risk and is now not commonly used in the UK, replaced by estradiol based compounds with lower thrombosis risk. Oral progestogen combinations such as medroxyprogesterone acetate have changed to dyhydrogesterone, due to a lack of association of the latter with venous clot.<sup id="cite_ref-132" class="reference"><a href="#cite_note-132">&#91;132&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=31" title="Edit section: See also">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul><li><a href="/wiki/Hormone_therapy" title="Hormone therapy">Hormone therapy</a></li>
<li><a href="/wiki/Androgen_replacement_therapy" title="Androgen replacement therapy">Androgen replacement therapy</a></li>
<li><a href="/wiki/Transgender_hormone_therapy" title="Transgender hormone therapy">Transgender hormone therapy</a></li></ul>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=32" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<style data-mw-deduplicate="TemplateStyles:r1011085734">.mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}</style><div class="reflist">
<div class="mw-references-wrap mw-references-columns"><ol class="references">
<li id="cite_note-pmid26444994-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid26444994_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid26444994_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid26444994_1-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid26444994_1-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid26444994_1-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid26444994_1-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid26444994_1-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid26444994_1-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-pmid26444994_1-8"><sup><i><b>i</b></i></sup></a></span> <span class="reference-text"><style data-mw-deduplicate="TemplateStyles:r1067248974">.mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:#d33}.mw-parser-output .cs1-visible-error{color:#d33}.mw-parser-output .cs1-maint{display:none;color:#3a3;margin-left:0.3em}.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style><cite id="CITEREFStuenkelDavisGompelLumsden2015" class="citation journal cs1">Stuenkel CA, Davis SR, Gompel A, Lumsden MA, Murad MH, Pinkerton JV, Santen RJ (November 2015). <a rel="nofollow" class="external text" href="http://eprints.gla.ac.uk/113696/1/113696.pdf">"Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline"</a> <span class="cs1-format">(PDF)</span>. <i>J. Clin. Endocrinol. Metab</i>. <b>100</b> (11): 3975–4011. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fjc.2015-2236">10.1210/jc.2015-2236</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26444994">26444994</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Clin.+Endocrinol.+Metab.&amp;rft.atitle=Treatment+of+Symptoms+of+the+Menopause%3A+An+Endocrine+Society+Clinical+Practice+Guideline&amp;rft.volume=100&amp;rft.issue=11&amp;rft.pages=3975-4011&amp;rft.date=2015-11&amp;rft_id=info%3Adoi%2F10.1210%2Fjc.2015-2236&amp;rft_id=info%3Apmid%2F26444994&amp;rft.aulast=Stuenkel&amp;rft.aufirst=CA&amp;rft.au=Davis%2C+SR&amp;rft.au=Gompel%2C+A&amp;rft.au=Lumsden%2C+MA&amp;rft.au=Murad%2C+MH&amp;rft.au=Pinkerton%2C+JV&amp;rft.au=Santen%2C+RJ&amp;rft_id=http%3A%2F%2Feprints.gla.ac.uk%2F113696%2F1%2F113696.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid20566620-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid20566620_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid20566620_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid20566620_2-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid20566620_2-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid20566620_2-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid20566620_2-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid20566620_2-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid20566620_2-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSantenAllredArdoinArcher2010" class="citation journal cs1">Santen RJ, Allred DC, Ardoin SP, Archer DF, Boyd N, Braunstein GD, Burger HG, Colditz GA, Davis SR, Gambacciani M, Gower BA, Henderson VW, Jarjour WN, Karas RH, Kleerekoper M, Lobo RA, Manson JE, Marsden J, Martin KA, Martin L, Pinkerton JV, Rubinow DR, Teede H, Thiboutot DM, Utian WH (July 2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6287288">"Postmenopausal hormone therapy: an Endocrine Society scientific statement"</a>. <i>J. Clin. Endocrinol. Metab</i>. <b>95</b> (7 Suppl 1): s1–s66. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fjc.2009-2509">10.1210/jc.2009-2509</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6287288">6287288</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20566620">20566620</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Clin.+Endocrinol.+Metab.&amp;rft.atitle=Postmenopausal+hormone+therapy%3A+an+Endocrine+Society+scientific+statement&amp;rft.volume=95&amp;rft.issue=7+Suppl+1&amp;rft.pages=s1-s66&amp;rft.date=2010-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6287288%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F20566620&amp;rft_id=info%3Adoi%2F10.1210%2Fjc.2009-2509&amp;rft.aulast=Santen&amp;rft.aufirst=RJ&amp;rft.au=Allred%2C+DC&amp;rft.au=Ardoin%2C+SP&amp;rft.au=Archer%2C+DF&amp;rft.au=Boyd%2C+N&amp;rft.au=Braunstein%2C+GD&amp;rft.au=Burger%2C+HG&amp;rft.au=Colditz%2C+GA&amp;rft.au=Davis%2C+SR&amp;rft.au=Gambacciani%2C+M&amp;rft.au=Gower%2C+BA&amp;rft.au=Henderson%2C+VW&amp;rft.au=Jarjour%2C+WN&amp;rft.au=Karas%2C+RH&amp;rft.au=Kleerekoper%2C+M&amp;rft.au=Lobo%2C+RA&amp;rft.au=Manson%2C+JE&amp;rft.au=Marsden%2C+J&amp;rft.au=Martin%2C+KA&amp;rft.au=Martin%2C+L&amp;rft.au=Pinkerton%2C+JV&amp;rft.au=Rubinow%2C+DR&amp;rft.au=Teede%2C+H&amp;rft.au=Thiboutot%2C+DM&amp;rft.au=Utian%2C+WH&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6287288&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-Maturitas-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-Maturitas_3-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFShusterRhodesGostoutGrossardt2010" class="citation journal cs1">Shuster, Lynne T.; Rhodes, Deborah J.; Gostout, Bobbie S.; Grossardt, Brandon R.; Rocca, Walter A. (2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2815011">"Premature menopause or early menopause: Long-term health consequences"</a>. <i><a href="/wiki/Maturitas" title="Maturitas">Maturitas</a></i>. <b>65</b> (2): 161–166. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.maturitas.2009.08.003">10.1016/j.maturitas.2009.08.003</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/0378-5122">0378-5122</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2815011">2815011</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19733988">19733988</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Maturitas&amp;rft.atitle=Premature+menopause+or+early+menopause%3A+Long-term+health+consequences&amp;rft.volume=65&amp;rft.issue=2&amp;rft.pages=161-166&amp;rft.date=2010&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2815011%23id-name%3DPMC&amp;rft.issn=0378-5122&amp;rft_id=info%3Apmid%2F19733988&amp;rft_id=info%3Adoi%2F10.1016%2Fj.maturitas.2009.08.003&amp;rft.aulast=Shuster&amp;rft.aufirst=Lynne+T.&amp;rft.au=Rhodes%2C+Deborah+J.&amp;rft.au=Gostout%2C+Bobbie+S.&amp;rft.au=Grossardt%2C+Brandon+R.&amp;rft.au=Rocca%2C+Walter+A.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2815011&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-eden-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-eden_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-eden_4-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-eden_4-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-eden_4-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-eden_4-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-eden_4-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation journal cs1">Eden KJ, Wylie KR (1 July 2009). <a rel="nofollow" class="external text" href="https://doi.org/10.2217%2FWHE.09.24">"Quality of sexual life and menopause"</a>. <i>Women's Health</i>. <b>6</b> (4): 385–396. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.2217%2FWHE.09.24">10.2217/WHE.09.24</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19586430">19586430</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Women%27s+Health&amp;rft.atitle=Quality+of+sexual+life+and+menopause&amp;rft.volume=6&amp;rft.issue=4&amp;rft.pages=385-396&amp;rft.date=2009-07-01&amp;rft_id=info%3Adoi%2F10.2217%2FWHE.09.24&amp;rft_id=info%3Apmid%2F19586430&amp;rft_id=%2F%2Fdoi.org%2F10.2217%252FWHE.09.24&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span><span class="cs1-maint citation-comment"><code class="cs1-code">{{<a href="/wiki/Template:Cite_journal" title="Template:Cite journal">cite journal</a>}}</code>:  CS1 maint: uses authors parameter (<a href="/wiki/Category:CS1_maint:_uses_authors_parameter" title="Category:CS1 maint: uses authors parameter">link</a>)</span></span>
</li>
<li id="cite_note-ziaei-5"><span class="mw-cite-backlink">^ <a href="#cite_ref-ziaei_5-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ziaei_5-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-ziaei_5-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFZiaei_S.,_Moghasemi_M.,_Faghihzadeh_S.2010" class="citation journal cs1">Ziaei S., Moghasemi M., Faghihzadeh S. (2010). "Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women". <i>Climacteric</i>. <b>13</b> (3): 147–156. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.maturitas.2006.04.014">10.1016/j.maturitas.2006.04.014</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/16730929">16730929</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Climacteric&amp;rft.atitle=Comparative+effects+of+conventional+hormone+replacement+therapy+and+tibolone+on+climacteric+symptoms+and+sexual+dysfunction+in+postmenopausal+women&amp;rft.volume=13&amp;rft.issue=3&amp;rft.pages=147-156&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1016%2Fj.maturitas.2006.04.014&amp;rft_id=info%3Apmid%2F16730929&amp;rft.au=Ziaei+S.%2C+Moghasemi+M.%2C+Faghihzadeh+S.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span><span class="cs1-maint citation-comment"><code class="cs1-code">{{<a href="/wiki/Template:Cite_journal" title="Template:Cite journal">cite journal</a>}}</code>:  CS1 maint: multiple names: authors list (<a href="/wiki/Category:CS1_maint:_multiple_names:_authors_list" title="Category:CS1 maint: multiple names: authors list">link</a>)</span></span>
</li>
<li id="cite_note-WHI_18_year_follow_up-6"><span class="mw-cite-backlink">^ <a href="#cite_ref-WHI_18_year_follow_up_6-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-WHI_18_year_follow_up_6-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-WHI_18_year_follow_up_6-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-WHI_18_year_follow_up_6-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMansonAragakiRossouwAnderson2017" class="citation journal cs1">Manson, JE; Aragaki, AK; Rossouw, JE; Anderson, GL; Prentice, RL; LaCroix, AZ; Chlebowski, RT; Howard, BV; Thomson, CA; Margolis, KL; Lewis, CE; Stefanick, ML; Jackson, RD; Johnson, KC; Martin, LW; Shumaker, SA; Espeland, MA; Wactawski-Wende, J; WHI, Investigators. (12 September 2017). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5728370">"Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials"</a>. <i>JAMA</i>. <b>318</b> (10): 927–938. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjama.2017.11217">10.1001/jama.2017.11217</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5728370">5728370</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28898378">28898378</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Menopausal+Hormone+Therapy+and+Long-term+All-Cause+and+Cause-Specific+Mortality%3A+The+Women%27s+Health+Initiative+Randomized+Trials.&amp;rft.volume=318&amp;rft.issue=10&amp;rft.pages=927-938&amp;rft.date=2017-09-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5728370%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28898378&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.2017.11217&amp;rft.aulast=Manson&amp;rft.aufirst=JE&amp;rft.au=Aragaki%2C+AK&amp;rft.au=Rossouw%2C+JE&amp;rft.au=Anderson%2C+GL&amp;rft.au=Prentice%2C+RL&amp;rft.au=LaCroix%2C+AZ&amp;rft.au=Chlebowski%2C+RT&amp;rft.au=Howard%2C+BV&amp;rft.au=Thomson%2C+CA&amp;rft.au=Margolis%2C+KL&amp;rft.au=Lewis%2C+CE&amp;rft.au=Stefanick%2C+ML&amp;rft.au=Jackson%2C+RD&amp;rft.au=Johnson%2C+KC&amp;rft.au=Martin%2C+LW&amp;rft.au=Shumaker%2C+SA&amp;rft.au=Espeland%2C+MA&amp;rft.au=Wactawski-Wende%2C+J&amp;rft.au=WHI%2C+Investigators.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5728370&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFLangerHodisLoboAllison2021" class="citation journal cs1">Langer, RD; Hodis, HN; Lobo, RA; Allison, MA (February 2021). <a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F13697137.2020.1851183">"Hormone replacement therapy - where are we now?"</a>. <i>Climacteric&#160;: The Journal of the International Menopause Society</i>. <b>24</b> (1): 3–10. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F13697137.2020.1851183">10.1080/13697137.2020.1851183</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/33403881">33403881</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:230783545">230783545</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Climacteric+%3A+The+Journal+of+the+International+Menopause+Society&amp;rft.atitle=Hormone+replacement+therapy+-+where+are+we+now%3F&amp;rft.volume=24&amp;rft.issue=1&amp;rft.pages=3-10&amp;rft.date=2021-02&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A230783545%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F33403881&amp;rft_id=info%3Adoi%2F10.1080%2F13697137.2020.1851183&amp;rft.aulast=Langer&amp;rft.aufirst=RD&amp;rft.au=Hodis%2C+HN&amp;rft.au=Lobo%2C+RA&amp;rft.au=Allison%2C+MA&amp;rft_id=%2F%2Fdoi.org%2F10.1080%252F13697137.2020.1851183&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-Lokkegard_2017-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-Lokkegard_2017_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Lokkegard_2017_8-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Lokkegard_2017_8-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFLøkkegaardNielsenKeiding2017" class="citation journal cs1">Løkkegaard, E; Nielsen, LH; Keiding, N (August 2017). <a rel="nofollow" class="external text" href="https://doi.org/10.1161%2FSTROKEAHA.117.017132">"Risk of Stroke With Various Types of Menopausal Hormone Therapies: A National Cohort Study"</a>. <i>Stroke</i>. <b>48</b> (8): 2266–2269. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1161%2FSTROKEAHA.117.017132">10.1161/STROKEAHA.117.017132</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28626058">28626058</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:207579406">207579406</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Stroke&amp;rft.atitle=Risk+of+Stroke+With+Various+Types+of+Menopausal+Hormone+Therapies%3A+A+National+Cohort+Study.&amp;rft.volume=48&amp;rft.issue=8&amp;rft.pages=2266-2269&amp;rft.date=2017-08&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A207579406%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F28626058&amp;rft_id=info%3Adoi%2F10.1161%2FSTROKEAHA.117.017132&amp;rft.aulast=L%C3%B8kkegaard&amp;rft.aufirst=E&amp;rft.au=Nielsen%2C+LH&amp;rft.au=Keiding%2C+N&amp;rft_id=%2F%2Fdoi.org%2F10.1161%252FSTROKEAHA.117.017132&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-Mayo-9"><span class="mw-cite-backlink">^ <a href="#cite_ref-Mayo_9-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Mayo_9-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Mayo_9-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Mayo_9-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFFilesKoPruthi2011" class="citation journal cs1">Files, JA; Ko, MG; Pruthi, S (July 2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3127562">"Bioidentical hormone therapy"</a>. <i>Mayo Clinic Proceedings</i>. <b>86</b> (7): 673–80, quiz 680. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.4065%2Fmcp.2010.0714">10.4065/mcp.2010.0714</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3127562">3127562</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21531972">21531972</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mayo+Clinic+Proceedings&amp;rft.atitle=Bioidentical+hormone+therapy.&amp;rft.volume=86&amp;rft.issue=7&amp;rft.pages=673-80%2C+quiz+680&amp;rft.date=2011-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3127562%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21531972&amp;rft_id=info%3Adoi%2F10.4065%2Fmcp.2010.0714&amp;rft.aulast=Files&amp;rft.aufirst=JA&amp;rft.au=Ko%2C+MG&amp;rft.au=Pruthi%2C+S&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3127562&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-clev-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-clev_10-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://my.clevelandclinic.org/health/articles/15660-bioidentical-hormones">"Bioidentical hormones"</a>. Cleveland Clinic. 12 December 2012.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Bioidentical+hormones&amp;rft.pub=Cleveland+Clinic&amp;rft.date=2012-12-12&amp;rft_id=https%3A%2F%2Fmy.clevelandclinic.org%2Fhealth%2Farticles%2F15660-bioidentical-hormones&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid21464264-11"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid21464264_11-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid21464264_11-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid21464264_11-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid21464264_11-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid21464264_11-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid21464264_11-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFConaway2011" class="citation journal cs1">Conaway E (March 2011). <a rel="nofollow" class="external text" href="http://jaoa.org/article.aspx?articleid=2094168">"Bioidentical hormones: an evidence-based review for primary care providers"</a>. <i>J Am Osteopath Assoc</i>. <b>111</b> (3): 153–64. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21464264">21464264</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Am+Osteopath+Assoc&amp;rft.atitle=Bioidentical+hormones%3A+an+evidence-based+review+for+primary+care+providers&amp;rft.volume=111&amp;rft.issue=3&amp;rft.pages=153-64&amp;rft.date=2011-03&amp;rft_id=info%3Apmid%2F21464264&amp;rft.aulast=Conaway&amp;rft.aufirst=E&amp;rft_id=http%3A%2F%2Fjaoa.org%2Farticle.aspx%3Farticleid%3D2094168&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-cobin-12"><span class="mw-cite-backlink">^ <a href="#cite_ref-cobin_12-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-cobin_12-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-cobin_12-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFCobinGoodmanAACE_Reproductive_Endocrinology_Scientific2017" class="citation journal cs1">Cobin, RH; Goodman, NF; AACE Reproductive Endocrinology Scientific, Committee. (1 July 2017). <a rel="nofollow" class="external text" href="https://www.aace.com/files/position-statements/ep171828ps.pdf">"Position Statement on Menopause - 2017 Update"</a> <span class="cs1-format">(PDF)</span>. <i>Endocrine Practice</i>. <b>23</b> (7): 869–880. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.4158%2FEP171828.PS">10.4158/EP171828.PS</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28703650">28703650</a><span class="reference-accessdate">. Retrieved <span class="nowrap">1 March</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Endocrine+Practice&amp;rft.atitle=Position+Statement+on+Menopause+-+2017+Update&amp;rft.volume=23&amp;rft.issue=7&amp;rft.pages=869-880&amp;rft.date=2017-07-01&amp;rft_id=info%3Adoi%2F10.4158%2FEP171828.PS&amp;rft_id=info%3Apmid%2F28703650&amp;rft.aulast=Cobin&amp;rft.aufirst=RH&amp;rft.au=Goodman%2C+NF&amp;rft.au=AACE+Reproductive+Endocrinology+Scientific%2C+Committee.&amp;rft_id=https%3A%2F%2Fwww.aace.com%2Ffiles%2Fposition-statements%2Fep171828ps.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-FDA-13"><span class="mw-cite-backlink">^ <a href="#cite_ref-FDA_13-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FDA_13-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20130530190045/http://www.uspreventiveservicestaskforce.org/uspstf12/menohrt/menohrtart.htm">"USPTF Consensus Statement"</a>. 2012. Archived from <a rel="nofollow" class="external text" href="https://www.uspreventiveservicestaskforce.org/uspstf12/menohrt/menohrtart.htm">the original</a> on 2013-05-30<span class="reference-accessdate">. Retrieved <span class="nowrap">2013-05-14</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=USPTF+Consensus+Statement&amp;rft.date=2012&amp;rft_id=http%3A%2F%2Fwww.uspreventiveservicestaskforce.org%2Fuspstf12%2Fmenohrt%2Fmenohrtart.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-14">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFLewis" class="citation web cs1">Lewis, Ricki. <a rel="nofollow" class="external text" href="https://www.medscape.com/viewarticle/818280">"ACOG Revises Guidelines on Treating Menopause Symptoms"</a>. <i>login.medscape.com</i>. Medscape<span class="reference-accessdate">. Retrieved <span class="nowrap">4 March</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=login.medscape.com&amp;rft.atitle=ACOG+Revises+Guidelines+on+Treating+Menopause+Symptoms&amp;rft.aulast=Lewis&amp;rft.aufirst=Ricki&amp;rft_id=https%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F818280&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Gynecologic-Practice/Hormone-Therapy-and-Heart-Disease">"Hormone Therapy and Heart Disease - ACOG"</a>. <i>www.acog.org</i>. Committee on Gynecologic Practice<span class="reference-accessdate">. Retrieved <span class="nowrap">4 March</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.acog.org&amp;rft.atitle=Hormone+Therapy+and+Heart+Disease+-+ACOG&amp;rft_id=https%3A%2F%2Fwww.acog.org%2FClinical-Guidance-and-Publications%2FCommittee-Opinions%2FCommittee-on-Gynecologic-Practice%2FHormone-Therapy-and-Heart-Disease&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.medscape.com/viewarticle/869397">"Medscape"</a>. <i>www.medscape.com</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.medscape.com&amp;rft.atitle=Medscape&amp;rft_id=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F869397&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-endocrine-17"><span class="mw-cite-backlink">^ <a href="#cite_ref-endocrine_17-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-endocrine_17-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSantenUtian2010" class="citation journal cs1 cs1-prop-long-vol">Santen, RJ; Utian, WH (2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6287288">"Executive Summary: Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement"</a>. <i>J Clin Endocrinol Metab</i>. 95 S1–S66 (Supplement 1): s1–s66. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fjc.2009-2509">10.1210/jc.2009-2509</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6287288">6287288</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20566620">20566620</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Clin+Endocrinol+Metab&amp;rft.atitle=Executive+Summary%3A+Postmenopausal+Hormone+Therapy%3A+An+Endocrine+Society+Scientific+Statement&amp;rft.volume=95+S1%E2%80%93S66&amp;rft.issue=Supplement+1&amp;rft.pages=s1-s66&amp;rft.date=2010&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6287288%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F20566620&amp;rft_id=info%3Adoi%2F10.1210%2Fjc.2009-2509&amp;rft.aulast=Santen&amp;rft.aufirst=RJ&amp;rft.au=Utian%2C+WH&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6287288&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-marjoribanks-18"><span class="mw-cite-backlink">^ <a href="#cite_ref-marjoribanks_18-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-marjoribanks_18-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-marjoribanks_18-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-marjoribanks_18-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMarjoribanksFarquharRobertsLethaby2017" class="citation journal cs1">Marjoribanks, Jane; Farquhar, Cindy; Roberts, Helen; Lethaby, Anne; Lee, Jasmine (17 Jan 2017). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6465148">"Long-term hormone therapy for perimenopausal and postmenopausal women"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>1</b>: CD004143. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD004143.pub5">10.1002/14651858.CD004143.pub5</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1469-493X">1469-493X</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6465148">6465148</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28093732">28093732</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Long-term+hormone+therapy+for+perimenopausal+and+postmenopausal+women&amp;rft.volume=1&amp;rft.pages=CD004143&amp;rft.date=2017-01-17&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6465148%23id-name%3DPMC&amp;rft.issn=1469-493X&amp;rft_id=info%3Apmid%2F28093732&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD004143.pub5&amp;rft.aulast=Marjoribanks&amp;rft.aufirst=Jane&amp;rft.au=Farquhar%2C+Cindy&amp;rft.au=Roberts%2C+Helen&amp;rft.au=Lethaby%2C+Anne&amp;rft.au=Lee%2C+Jasmine&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6465148&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-nhs-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-nhs_19-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.nhs.uk/conditions/menopause/treatment/">"Menopause treatments"</a>. National Health Service, United Kingdom. 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">2018-02-23</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Menopause+treatments&amp;rft.pub=National+Health+Service%2C+United+Kingdom&amp;rft.date=2019&amp;rft_id=https%3A%2F%2Fwww.nhs.uk%2Fconditions%2Fmenopause%2Ftreatment%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid12762829-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid12762829_20-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFRaine-FenningBrincatMuscat-Baron2003" class="citation journal cs1">Raine-Fenning NJ, Brincat MP, Muscat-Baron Y (2003). "Skin aging and menopause&#160;: implications for treatment". <i>Am J Clin Dermatol</i>. <b>4</b> (6): 371–8. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2165%2F00128071-200304060-00001">10.2165/00128071-200304060-00001</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/12762829">12762829</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:20392538">20392538</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Am+J+Clin+Dermatol&amp;rft.atitle=Skin+aging+and+menopause+%3A+implications+for+treatment&amp;rft.volume=4&amp;rft.issue=6&amp;rft.pages=371-8&amp;rft.date=2003&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A20392538%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F12762829&amp;rft_id=info%3Adoi%2F10.2165%2F00128071-200304060-00001&amp;rft.aulast=Raine-Fenning&amp;rft.aufirst=NJ&amp;rft.au=Brincat%2C+MP&amp;rft.au=Muscat-Baron%2C+Y&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid22533363-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid22533363_21-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFZouboulisMakrantonaki2012" class="citation journal cs1">Zouboulis CC, Makrantonaki E (June 2012). "Hormonal therapy of intrinsic aging". <i>Rejuvenation Res</i>. <b>15</b> (3): 302–12. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1089%2Frej.2011.1249">10.1089/rej.2011.1249</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/22533363">22533363</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Rejuvenation+Res&amp;rft.atitle=Hormonal+therapy+of+intrinsic+aging&amp;rft.volume=15&amp;rft.issue=3&amp;rft.pages=302-12&amp;rft.date=2012-06&amp;rft_id=info%3Adoi%2F10.1089%2Frej.2011.1249&amp;rft_id=info%3Apmid%2F22533363&amp;rft.aulast=Zouboulis&amp;rft.aufirst=CC&amp;rft.au=Makrantonaki%2C+E&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-sarrel-22"><span class="mw-cite-backlink">^ <a href="#cite_ref-sarrel_22-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-sarrel_22-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-sarrel_22-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-sarrel_22-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-sarrel_22-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-sarrel_22-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-sarrel_22-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text">Sarrel, P.M. (2000). Effects of hormone replacement therapy on sexual psychophysiology and behavior in postmenopause. Journal of Women’s Health and Gender-Based Medicine, 9, 25-32</span>
</li>
<li id="cite_note-BoardmanHartley2015-23"><span class="mw-cite-backlink">^ <a href="#cite_ref-BoardmanHartley2015_23-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-BoardmanHartley2015_23-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-BoardmanHartley2015_23-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-BoardmanHartley2015_23-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-BoardmanHartley2015_23-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBoardmanHartleyEisingaMain2015" class="citation journal cs1">Boardman, HM; Hartley, L; Eisinga, A; Main, C; Roqué i Figuls, M; Bonfill Cosp, X; Gabriel Sanchez, R; Knight, B (10 March 2015). <a rel="nofollow" class="external text" href="https://semanticscholar.org/paper/ca6ab03a39fb55f28caf4b2925dda015257e7e66">"Hormone therapy for preventing cardiovascular disease in post-menopausal women"</a>. <i>The Cochrane Database of Systematic Reviews</i> (3): CD002229. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD002229.pub4">10.1002/14651858.CD002229.pub4</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1469-493X">1469-493X</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25754617">25754617</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:22188456">22188456</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Hormone+therapy+for+preventing+cardiovascular+disease+in+post-menopausal+women.&amp;rft.issue=3&amp;rft.pages=CD002229&amp;rft.date=2015-03-10&amp;rft.issn=1469-493X&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A22188456%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F25754617&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD002229.pub4&amp;rft.aulast=Boardman&amp;rft.aufirst=HM&amp;rft.au=Hartley%2C+L&amp;rft.au=Eisinga%2C+A&amp;rft.au=Main%2C+C&amp;rft.au=Roqu%C3%A9+i+Figuls%2C+M&amp;rft.au=Bonfill+Cosp%2C+X&amp;rft.au=Gabriel+Sanchez%2C+R&amp;rft.au=Knight%2C+B&amp;rft_id=https%3A%2F%2Fsemanticscholar.org%2Fpaper%2Fca6ab03a39fb55f28caf4b2925dda015257e7e66&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFHodisMackHendersonShoupe2016" class="citation journal cs1">Hodis, HN; Mack, WJ; Henderson, VW; Shoupe, D; Budoff, MJ; Hwang-Levine, J; Li, Y; Feng, M; Dustin, L; Kono, N; Stanczyk, FZ; Selzer, RH; Azen, SP; ELITE Research, Group. (31 March 2016). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4921205">"Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol"</a>. <i>The New England Journal of Medicine</i>. <b>374</b> (13): 1221–31. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1056%2FNEJMoa1505241">10.1056/NEJMoa1505241</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4921205">4921205</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/27028912">27028912</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=Vascular+Effects+of+Early+versus+Late+Postmenopausal+Treatment+with+Estradiol.&amp;rft.volume=374&amp;rft.issue=13&amp;rft.pages=1221-31&amp;rft.date=2016-03-31&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4921205%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F27028912&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa1505241&amp;rft.aulast=Hodis&amp;rft.aufirst=HN&amp;rft.au=Mack%2C+WJ&amp;rft.au=Henderson%2C+VW&amp;rft.au=Shoupe%2C+D&amp;rft.au=Budoff%2C+MJ&amp;rft.au=Hwang-Levine%2C+J&amp;rft.au=Li%2C+Y&amp;rft.au=Feng%2C+M&amp;rft.au=Dustin%2C+L&amp;rft.au=Kono%2C+N&amp;rft.au=Stanczyk%2C+FZ&amp;rft.au=Selzer%2C+RH&amp;rft.au=Azen%2C+SP&amp;rft.au=ELITE+Research%2C+Group.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4921205&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFWriting_Group_on_Behalf_of_Workshop_Consensus2009" class="citation journal cs1">Writing Group on Behalf of Workshop Consensus (October 2009). "Aging, menopause, cardiovascular disease and HRT. International Menopause Society Consensus Statement". <i>Climacteric</i>. <b>12</b> (5): 368–77. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F13697130903195606">10.1080/13697130903195606</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19811229">19811229</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:218865937">218865937</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Climacteric&amp;rft.atitle=Aging%2C+menopause%2C+cardiovascular+disease+and+HRT.+International+Menopause+Society+Consensus+Statement.&amp;rft.volume=12&amp;rft.issue=5&amp;rft.pages=368-77&amp;rft.date=2009-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A218865937%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F19811229&amp;rft_id=info%3Adoi%2F10.1080%2F13697130903195606&amp;rft.au=Writing+Group+on+Behalf+of+Workshop+Consensus&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-Manson_WHI_2013-26"><span class="mw-cite-backlink">^ <a href="#cite_ref-Manson_WHI_2013_26-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Manson_WHI_2013_26-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Manson_WHI_2013_26-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Manson_WHI_2013_26-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Manson_WHI_2013_26-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMansonChlebowskiStefanickAragaki2013" class="citation journal cs1">Manson, JE; Chlebowski, RT; Stefanick, ML; Aragaki, AK; Rossouw, JE; Prentice, RL; Anderson, G; Howard, BV; Thomson, CA; LaCroix, AZ; Wactawski-Wende, J; Jackson, RD; Limacher, M; Margolis, KL; Wassertheil-Smoller, S; Beresford, SA; Cauley, JA; Eaton, CB; Gass, M; Hsia, J; Johnson, KC; Kooperberg, C; Kuller, LH; Lewis, CE; Liu, S; Martin, LW; Ockene, JK; O'Sullivan, MJ; Powell, LH; Simon, MS; Van Horn, L; Vitolins, MZ; Wallace, RB (2 October 2013). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3963523">"Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials"</a>. <i>JAMA</i>. <b>310</b> (13): 1353–68. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjama.2013.278040">10.1001/jama.2013.278040</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3963523">3963523</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24084921">24084921</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Menopausal+hormone+therapy+and+health+outcomes+during+the+intervention+and+extended+poststopping+phases+of+the+Women%27s+Health+Initiative+randomized+trials.&amp;rft.volume=310&amp;rft.issue=13&amp;rft.pages=1353-68&amp;rft.date=2013-10-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3963523%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F24084921&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.2013.278040&amp;rft.aulast=Manson&amp;rft.aufirst=JE&amp;rft.au=Chlebowski%2C+RT&amp;rft.au=Stefanick%2C+ML&amp;rft.au=Aragaki%2C+AK&amp;rft.au=Rossouw%2C+JE&amp;rft.au=Prentice%2C+RL&amp;rft.au=Anderson%2C+G&amp;rft.au=Howard%2C+BV&amp;rft.au=Thomson%2C+CA&amp;rft.au=LaCroix%2C+AZ&amp;rft.au=Wactawski-Wende%2C+J&amp;rft.au=Jackson%2C+RD&amp;rft.au=Limacher%2C+M&amp;rft.au=Margolis%2C+KL&amp;rft.au=Wassertheil-Smoller%2C+S&amp;rft.au=Beresford%2C+SA&amp;rft.au=Cauley%2C+JA&amp;rft.au=Eaton%2C+CB&amp;rft.au=Gass%2C+M&amp;rft.au=Hsia%2C+J&amp;rft.au=Johnson%2C+KC&amp;rft.au=Kooperberg%2C+C&amp;rft.au=Kuller%2C+LH&amp;rft.au=Lewis%2C+CE&amp;rft.au=Liu%2C+S&amp;rft.au=Martin%2C+LW&amp;rft.au=Ockene%2C+JK&amp;rft.au=O%27Sullivan%2C+MJ&amp;rft.au=Powell%2C+LH&amp;rft.au=Simon%2C+MS&amp;rft.au=Van+Horn%2C+L&amp;rft.au=Vitolins%2C+MZ&amp;rft.au=Wallace%2C+RB&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3963523&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-Hormone_replacement_therapy_after_s-27"><span class="mw-cite-backlink">^ <a href="#cite_ref-Hormone_replacement_therapy_after_s_27-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Hormone_replacement_therapy_after_s_27-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSaeaibPeeyananjarassriLiabsuetrakulBuhachat2020" class="citation journal cs1">Saeaib, N; Peeyananjarassri, K; Liabsuetrakul, T; Buhachat, R; Myriokefalitaki, E (28 January 2020). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC7027384">"Hormone replacement therapy after surgery for epithelial ovarian cancer"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>1</b>: CD012559. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD012559.pub2">10.1002/14651858.CD012559.pub2</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC7027384">7027384</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/31989588">31989588</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Hormone+replacement+therapy+after+surgery+for+epithelial+ovarian+cancer.&amp;rft.volume=1&amp;rft.pages=CD012559&amp;rft.date=2020-01-28&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7027384%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F31989588&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD012559.pub2&amp;rft.aulast=Saeaib&amp;rft.aufirst=N&amp;rft.au=Peeyananjarassri%2C+K&amp;rft.au=Liabsuetrakul%2C+T&amp;rft.au=Buhachat%2C+R&amp;rft.au=Myriokefalitaki%2C+E&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7027384&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid20807164-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20807164_28-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDarabiRabbaniAniZarean2011" class="citation journal cs1">Darabi, M.; Rabbani, M.; Ani, M.; Zarean, E.; Panjehpour, M.; Movahedian, A. (2011). "Increased leukocyte ABCA1 gene expression in post-menopausal women on hormone replacement therapy". <i>Gynecological Endocrinology</i>. <b>27</b> (9): 701–705. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3109%2F09513590.2010.507826">10.3109/09513590.2010.507826</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20807164">20807164</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:203464">203464</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Gynecological+Endocrinology&amp;rft.atitle=Increased+leukocyte+ABCA1+gene+expression+in+post-menopausal+women+on+hormone+replacement+therapy&amp;rft.volume=27&amp;rft.issue=9&amp;rft.pages=701-705&amp;rft.date=2011&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A203464%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F20807164&amp;rft_id=info%3Adoi%2F10.3109%2F09513590.2010.507826&amp;rft.aulast=Darabi&amp;rft.aufirst=M.&amp;rft.au=Rabbani%2C+M.&amp;rft.au=Ani%2C+M.&amp;rft.au=Zarean%2C+E.&amp;rft.au=Panjehpour%2C+M.&amp;rft.au=Movahedian%2C+A.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGregersenHøibraatenHolvenLøvdahl2019" class="citation journal cs1">Gregersen, I; Høibraaten, E; Holven, KB; Løvdahl, L; Ueland, T; Mowinckel, MC; Dahl, TB; Aukrust, P; Halvorsen, B; Sandset, PM (December 2019). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.thromres.2019.10.005">"Effect of hormone replacement therapy on atherogenic lipid profile in postmenopausal women"</a>. <i>Thrombosis Research</i>. <b>184</b>: 1–7. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.thromres.2019.10.005">10.1016/j.thromres.2019.10.005</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/31677448">31677448</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Thrombosis+Research&amp;rft.atitle=Effect+of+hormone+replacement+therapy+on+atherogenic+lipid+profile+in+postmenopausal+women.&amp;rft.volume=184&amp;rft.pages=1-7&amp;rft.date=2019-12&amp;rft_id=info%3Adoi%2F10.1016%2Fj.thromres.2019.10.005&amp;rft_id=info%3Apmid%2F31677448&amp;rft.aulast=Gregersen&amp;rft.aufirst=I&amp;rft.au=H%C3%B8ibraaten%2C+E&amp;rft.au=Holven%2C+KB&amp;rft.au=L%C3%B8vdahl%2C+L&amp;rft.au=Ueland%2C+T&amp;rft.au=Mowinckel%2C+MC&amp;rft.au=Dahl%2C+TB&amp;rft.au=Aukrust%2C+P&amp;rft.au=Halvorsen%2C+B&amp;rft.au=Sandset%2C+PM&amp;rft_id=%2F%2Fdoi.org%2F10.1016%252Fj.thromres.2019.10.005&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSpoletiniVitalePellicciaFossati2014" class="citation journal cs1">Spoletini, I; Vitale, C; Pelliccia, F; Fossati, C; Rosano, GM (December 2014). "Androgens and cardiovascular disease in postmenopausal women: a systematic review". <i>Climacteric&#160;: The Journal of the International Menopause Society</i>. <b>17</b> (6): 625–34. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3109%2F13697137.2014.887669">10.3109/13697137.2014.887669</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24559253">24559253</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:33413274">33413274</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Climacteric+%3A+The+Journal+of+the+International+Menopause+Society&amp;rft.atitle=Androgens+and+cardiovascular+disease+in+postmenopausal+women%3A+a+systematic+review.&amp;rft.volume=17&amp;rft.issue=6&amp;rft.pages=625-34&amp;rft.date=2014-12&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A33413274%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F24559253&amp;rft_id=info%3Adoi%2F10.3109%2F13697137.2014.887669&amp;rft.aulast=Spoletini&amp;rft.aufirst=I&amp;rft.au=Vitale%2C+C&amp;rft.au=Pelliccia%2C+F&amp;rft.au=Fossati%2C+C&amp;rft.au=Rosano%2C+GM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-Testosterone_Consensus_2019-31"><span class="mw-cite-backlink">^ <a href="#cite_ref-Testosterone_Consensus_2019_31-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Testosterone_Consensus_2019_31-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Testosterone_Consensus_2019_31-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Testosterone_Consensus_2019_31-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDavisBaberPanayBitzer2019" class="citation journal cs1">Davis, SR; Baber, R; Panay, N; Bitzer, J; Perez, SC; Islam, RM; Kaunitz, AM; Kingsberg, SA; Lambrinoudaki, I; Liu, J; Parish, SJ; Pinkerton, J; Rymer, J; Simon, JA; Vignozzi, L; Wierman, ME (September 2019). <a rel="nofollow" class="external text" href="https://www.openaccessrepository.it/record/43710">"Global Consensus Position Statement on the Use of Testosterone Therapy for Women"</a>. <i>The Journal of Sexual Medicine</i>. <b>16</b> (9): 1331–1337. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jsxm.2019.07.012">10.1016/j.jsxm.2019.07.012</a>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//hdl.handle.net/2158%2F1176450">2158/1176450</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/31488288">31488288</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:201845588">201845588</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Sexual+Medicine&amp;rft.atitle=Global+Consensus+Position+Statement+on+the+Use+of+Testosterone+Therapy+for+Women.&amp;rft.volume=16&amp;rft.issue=9&amp;rft.pages=1331-1337&amp;rft.date=2019-09&amp;rft_id=info%3Ahdl%2F2158%2F1176450&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A201845588%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F31488288&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jsxm.2019.07.012&amp;rft.aulast=Davis&amp;rft.aufirst=SR&amp;rft.au=Baber%2C+R&amp;rft.au=Panay%2C+N&amp;rft.au=Bitzer%2C+J&amp;rft.au=Perez%2C+SC&amp;rft.au=Islam%2C+RM&amp;rft.au=Kaunitz%2C+AM&amp;rft.au=Kingsberg%2C+SA&amp;rft.au=Lambrinoudaki%2C+I&amp;rft.au=Liu%2C+J&amp;rft.au=Parish%2C+SJ&amp;rft.au=Pinkerton%2C+J&amp;rft.au=Rymer%2C+J&amp;rft.au=Simon%2C+JA&amp;rft.au=Vignozzi%2C+L&amp;rft.au=Wierman%2C+ME&amp;rft_id=https%3A%2F%2Fwww.openaccessrepository.it%2Frecord%2F43710&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-Androgens_Review_2017-32"><span class="mw-cite-backlink">^ <a href="#cite_ref-Androgens_Review_2017_32-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Androgens_Review_2017_32-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Androgens_Review_2017_32-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFShifrenDavis2017" class="citation journal cs1">Shifren, JL; Davis, SR (August 2017). "Androgens in postmenopausal women: a review". <i>Menopause</i>. <b>24</b> (8): 970–979. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FGME.0000000000000903">10.1097/GME.0000000000000903</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28609390">28609390</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:39876534">39876534</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Menopause&amp;rft.atitle=Androgens+in+postmenopausal+women%3A+a+review.&amp;rft.volume=24&amp;rft.issue=8&amp;rft.pages=970-979&amp;rft.date=2017-08&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A39876534%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F28609390&amp;rft_id=info%3Adoi%2F10.1097%2FGME.0000000000000903&amp;rft.aulast=Shifren&amp;rft.aufirst=JL&amp;rft.au=Davis%2C+SR&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-Scarabin_341–345-33"><span class="mw-cite-backlink">^ <a href="#cite_ref-Scarabin_341–345_33-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Scarabin_341–345_33-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFScarabin2018" class="citation journal cs1">Scarabin, P.-Y. (August 2018). "Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis". <i>Climacteric</i>. <b>21</b> (4): 341–345. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F13697137.2018.1446931">10.1080/13697137.2018.1446931</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1473-0804">1473-0804</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/29570359">29570359</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:4229701">4229701</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Climacteric&amp;rft.atitle=Progestogens+and+venous+thromboembolism+in+menopausal+women%3A+an+updated+oral+versus+transdermal+estrogen+meta-analysis&amp;rft.volume=21&amp;rft.issue=4&amp;rft.pages=341-345&amp;rft.date=2018-08&amp;rft.issn=1473-0804&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A4229701%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F29570359&amp;rft_id=info%3Adoi%2F10.1080%2F13697137.2018.1446931&amp;rft.aulast=Scarabin&amp;rft.aufirst=P.-Y.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-34">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFOliéCanonicoScarabin2010" class="citation journal cs1">Olié, V. R.; Canonico, M.; Scarabin, P. Y. (2010). "Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women". <i>Current Opinion in Hematology</i>. <b>17</b> (5): 457–463. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FMOH.0b013e32833c07bc">10.1097/MOH.0b013e32833c07bc</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20601871">20601871</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:205827003">205827003</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Opinion+in+Hematology&amp;rft.atitle=Risk+of+venous+thrombosis+with+oral+versus+transdermal+estrogen+therapy+among+postmenopausal+women&amp;rft.volume=17&amp;rft.issue=5&amp;rft.pages=457-463&amp;rft.date=2010&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A205827003%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F20601871&amp;rft_id=info%3Adoi%2F10.1097%2FMOH.0b013e32833c07bc&amp;rft.aulast=Oli%C3%A9&amp;rft.aufirst=V.+R.&amp;rft.au=Canonico%2C+M.&amp;rft.au=Scarabin%2C+P.+Y.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-35">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFRott2014" class="citation journal cs1">Rott, H (2014). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4155999">"Prevention and treatment of venous thromboembolism during HRT: current perspectives"</a>. <i>International Journal of General Medicine</i>. <b>7</b>: 433–40. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2147%2FIJGM.S46310">10.2147/IJGM.S46310</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4155999">4155999</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25210472">25210472</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Journal+of+General+Medicine&amp;rft.atitle=Prevention+and+treatment+of+venous+thromboembolism+during+HRT%3A+current+perspectives.&amp;rft.volume=7&amp;rft.pages=433-40&amp;rft.date=2014&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4155999%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F25210472&amp;rft_id=info%3Adoi%2F10.2147%2FIJGM.S46310&amp;rft.aulast=Rott&amp;rft.aufirst=H&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4155999&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-Carras_PLOIS_2017-36"><span class="mw-cite-backlink">^ <a href="#cite_ref-Carras_PLOIS_2017_36-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Carras_PLOIS_2017_36-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFCarrasquillaFrumentoBerglundBorgfeldt2017" class="citation journal cs1">Carrasquilla GD, Frumento P, Berglund A, Borgfeldt C, Bottai M, Chiavenna C, Eliasson M, Engström G, Hallmans G, Jansson JH, Magnusson PK, Nilsson PM, Pedersen NL, Wolk A, Leander K (November 2017). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5693286">"Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies"</a>. <i>PLOS Med</i>. <b>14</b> (11): e1002445. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1371%2Fjournal.pmed.1002445">10.1371/journal.pmed.1002445</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5693286">5693286</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/29149179">29149179</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLOS+Med.&amp;rft.atitle=Postmenopausal+hormone+therapy+and+risk+of+stroke%3A+A+pooled+analysis+of+data+from+population-based+cohort+studies&amp;rft.volume=14&amp;rft.issue=11&amp;rft.pages=e1002445&amp;rft.date=2017-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5693286%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F29149179&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pmed.1002445&amp;rft.aulast=Carrasquilla&amp;rft.aufirst=GD&amp;rft.au=Frumento%2C+P&amp;rft.au=Berglund%2C+A&amp;rft.au=Borgfeldt%2C+C&amp;rft.au=Bottai%2C+M&amp;rft.au=Chiavenna%2C+C&amp;rft.au=Eliasson%2C+M&amp;rft.au=Engstr%C3%B6m%2C+G&amp;rft.au=Hallmans%2C+G&amp;rft.au=Jansson%2C+JH&amp;rft.au=Magnusson%2C+PK&amp;rft.au=Nilsson%2C+PM&amp;rft.au=Pedersen%2C+NL&amp;rft.au=Wolk%2C+A&amp;rft.au=Leander%2C+K&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5693286&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-37">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFChlebowskiAndersonSartoHaque2016" class="citation journal cs1">Chlebowski, RT; Anderson, GL; Sarto, GE; Haque, R; Runowicz, CD; Aragaki, AK; Thomson, CA; Howard, BV; Wactawski-Wende, J; Chen, C; Rohan, TE; Simon, MS; Reed, SD; Manson, JE (March 2016). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5072373">"Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women's Health Initiative Randomized Trial"</a>. <i>Journal of the National Cancer Institute</i>. <b>108</b> (3): djv350. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fjnci%2Fdjv350">10.1093/jnci/djv350</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5072373">5072373</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26668177">26668177</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+National+Cancer+Institute&amp;rft.atitle=Continuous+Combined+Estrogen+Plus+Progestin+and+Endometrial+Cancer%3A+The+Women%27s+Health+Initiative+Randomized+Trial.&amp;rft.volume=108&amp;rft.issue=3&amp;rft.pages=djv350&amp;rft.date=2016-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5072373%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26668177&amp;rft_id=info%3Adoi%2F10.1093%2Fjnci%2Fdjv350&amp;rft.aulast=Chlebowski&amp;rft.aufirst=RT&amp;rft.au=Anderson%2C+GL&amp;rft.au=Sarto%2C+GE&amp;rft.au=Haque%2C+R&amp;rft.au=Runowicz%2C+CD&amp;rft.au=Aragaki%2C+AK&amp;rft.au=Thomson%2C+CA&amp;rft.au=Howard%2C+BV&amp;rft.au=Wactawski-Wende%2C+J&amp;rft.au=Chen%2C+C&amp;rft.au=Rohan%2C+TE&amp;rft.au=Simon%2C+MS&amp;rft.au=Reed%2C+SD&amp;rft.au=Manson%2C+JE&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5072373&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-38">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFArcher2001" class="citation journal cs1">Archer, DF (2001). "The effect of the duration of progestin use on the occurrence of endometrial cancer in postmenopausal women". <i>Menopause</i>. <b>8</b> (4): 245–51. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2F00042192-200107000-00005">10.1097/00042192-200107000-00005</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/11449081">11449081</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:38526018">38526018</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Menopause&amp;rft.atitle=The+effect+of+the+duration+of+progestin+use+on+the+occurrence+of+endometrial+cancer+in+postmenopausal+women.&amp;rft.volume=8&amp;rft.issue=4&amp;rft.pages=245-51&amp;rft.date=2001&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A38526018%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11449081&amp;rft_id=info%3Adoi%2F10.1097%2F00042192-200107000-00005&amp;rft.aulast=Archer&amp;rft.aufirst=DF&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-Progestogerone-39"><span class="mw-cite-backlink">^ <a href="#cite_ref-Progestogerone_39-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Progestogerone_39-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Progestogerone_39-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFKimKuritaBulun2013" class="citation journal cs1">Kim, JJ; Kurita, T; Bulun, SE (February 2013). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3565104">"Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer"</a>. <i>Endocrine Reviews</i>. <b>34</b> (1): 130–62. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fer.2012-1043">10.1210/er.2012-1043</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3565104">3565104</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/23303565">23303565</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Endocrine+Reviews&amp;rft.atitle=Progesterone+action+in+endometrial+cancer%2C+endometriosis%2C+uterine+fibroids%2C+and+breast+cancer.&amp;rft.volume=34&amp;rft.issue=1&amp;rft.pages=130-62&amp;rft.date=2013-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3565104%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F23303565&amp;rft_id=info%3Adoi%2F10.1210%2Fer.2012-1043&amp;rft.aulast=Kim&amp;rft.aufirst=JJ&amp;rft.au=Kurita%2C+T&amp;rft.au=Bulun%2C+SE&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3565104&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-40">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFYoung,_RobertArlan_F.,_Jr_FullerFuller,_Arlan_F.Michael_V._Seiden2004" class="citation book cs1">Young, Robert; Arlan F., Jr Fuller; Fuller, Arlan F.; Michael V. Seiden (2004). <i>Uterine cancer</i>. Hamilton, Ont: B.C. Decker. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-55009-163-2" title="Special:BookSources/978-1-55009-163-2"><bdi>978-1-55009-163-2</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Uterine+cancer&amp;rft.place=Hamilton%2C+Ont&amp;rft.pub=B.C.+Decker&amp;rft.date=2004&amp;rft.isbn=978-1-55009-163-2&amp;rft.au=Young%2C+Robert&amp;rft.au=Arlan+F.%2C+Jr+Fuller&amp;rft.au=Fuller%2C+Arlan+F.&amp;rft.au=Michael+V.+Seiden&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-41">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFZangSahlinMasironiEriksson2007" class="citation journal cs1">Zang, H; Sahlin, L; Masironi, B; Eriksson, E; Lindén Hirschberg, A (June 2007). <a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fjc.2006-2171">"Effects of testosterone treatment on endometrial proliferation in postmenopausal women"</a>. <i>The Journal of Clinical Endocrinology and Metabolism</i>. <b>92</b> (6): 2169–75. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fjc.2006-2171">10.1210/jc.2006-2171</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/17341565">17341565</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Clinical+Endocrinology+and+Metabolism&amp;rft.atitle=Effects+of+testosterone+treatment+on+endometrial+proliferation+in+postmenopausal+women.&amp;rft.volume=92&amp;rft.issue=6&amp;rft.pages=2169-75&amp;rft.date=2007-06&amp;rft_id=info%3Adoi%2F10.1210%2Fjc.2006-2171&amp;rft_id=info%3Apmid%2F17341565&amp;rft.aulast=Zang&amp;rft.aufirst=H&amp;rft.au=Sahlin%2C+L&amp;rft.au=Masironi%2C+B&amp;rft.au=Eriksson%2C+E&amp;rft.au=Lind%C3%A9n+Hirschberg%2C+A&amp;rft_id=%2F%2Fdoi.org%2F10.1210%252Fjc.2006-2171&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-42">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation journal cs1">"Endometrial cancer risk was lower in women who used continuous combined HRT than in non-users". <i>Evidence-based Obstetrics &amp; Gynecology</i>. <b>8</b> (1–2): 68–69. March 2006. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.ebobgyn.2006.01.011">10.1016/j.ebobgyn.2006.01.011</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1361-259X">1361-259X</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Evidence-based+Obstetrics+%26+Gynecology&amp;rft.atitle=Endometrial+cancer+risk+was+lower+in+women+who+used+continuous+combined+HRT+than+in+non-users&amp;rft.volume=8&amp;rft.issue=1%E2%80%932&amp;rft.pages=68-69&amp;rft.date=2006-03&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ebobgyn.2006.01.011&amp;rft.issn=1361-259X&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-Conjugated_equine_estrogen_and_medr-43"><span class="mw-cite-backlink">^ <a href="#cite_ref-Conjugated_equine_estrogen_and_medr_43-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Conjugated_equine_estrogen_and_medr_43-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Conjugated_equine_estrogen_and_medr_43-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Conjugated_equine_estrogen_and_medr_43-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFZengJiangLiWells2018" class="citation journal cs1">Zeng, Z; Jiang, X; Li, X; Wells, A; Luo, Y; Neapolitan, R (2018). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5955567">"Conjugated equine estrogen and medroxyprogesterone acetate are associated with decreased risk of breast cancer relative to bioidentical hormone therapy and controls"</a>. <i>PLOS ONE</i>. <b>13</b> (5): e0197064. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2018PLoSO..1397064Z">2018PLoSO..1397064Z</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1371%2Fjournal.pone.0197064">10.1371/journal.pone.0197064</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5955567">5955567</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/29768475">29768475</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLOS+ONE&amp;rft.atitle=Conjugated+equine+estrogen+and+medroxyprogesterone+acetate+are+associated+with+decreased+risk+of+breast+cancer+relative+to+bioidentical+hormone+therapy+and+controls.&amp;rft.volume=13&amp;rft.issue=5&amp;rft.pages=e0197064&amp;rft.date=2018&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5955567%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F29768475&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0197064&amp;rft_id=info%3Abibcode%2F2018PLoSO..1397064Z&amp;rft.aulast=Zeng&amp;rft.aufirst=Z&amp;rft.au=Jiang%2C+X&amp;rft.au=Li%2C+X&amp;rft.au=Wells%2C+A&amp;rft.au=Luo%2C+Y&amp;rft.au=Neapolitan%2C+R&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5955567&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-Breast_cancer_and_progesterone-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-Breast_cancer_and_progesterone_44-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFFournierBerrinoClavel-Chapelon2007" class="citation journal cs1">Fournier, A. S.; Berrino, F.; Clavel-Chapelon, F. O. (2007). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2211383">"Unequal risks for breast cancer associated with different hormone replacement therapies: Results from the E3N cohort study"</a>. <i>Breast Cancer Research and Treatment</i>. <b>107</b> (1): 103–111. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs10549-007-9523-x">10.1007/s10549-007-9523-x</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2211383">2211383</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/17333341">17333341</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Breast+Cancer+Research+and+Treatment&amp;rft.atitle=Unequal+risks+for+breast+cancer+associated+with+different+hormone+replacement+therapies%3A+Results+from+the+E3N+cohort+study&amp;rft.volume=107&amp;rft.issue=1&amp;rft.pages=103-111&amp;rft.date=2007&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2211383%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F17333341&amp;rft_id=info%3Adoi%2F10.1007%2Fs10549-007-9523-x&amp;rft.aulast=Fournier&amp;rft.aufirst=A.+S.&amp;rft.au=Berrino%2C+F.&amp;rft.au=Clavel-Chapelon%2C+F.+O.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2211383&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-45">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBeralReevesBullGreen2011" class="citation journal cs1">Beral, V; Reeves, G; Bull, D; Green, J; Million Women Study, Collaborators. (16 February 2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3039726">"Breast cancer risk in relation to the interval between menopause and starting hormone therapy"</a>. <i>Journal of the National Cancer Institute</i>. <b>103</b> (4): 296–305. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fjnci%2Fdjq527">10.1093/jnci/djq527</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3039726">3039726</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21278356">21278356</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+National+Cancer+Institute&amp;rft.atitle=Breast+cancer+risk+in+relation+to+the+interval+between+menopause+and+starting+hormone+therapy.&amp;rft.volume=103&amp;rft.issue=4&amp;rft.pages=296-305&amp;rft.date=2011-02-16&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3039726%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21278356&amp;rft_id=info%3Adoi%2F10.1093%2Fjnci%2Fdjq527&amp;rft.aulast=Beral&amp;rft.aufirst=V&amp;rft.au=Reeves%2C+G&amp;rft.au=Bull%2C+D&amp;rft.au=Green%2C+J&amp;rft.au=Million+Women+Study%2C+Collaborators.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3039726&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span> <span class="cs1-visible-error citation-comment"><code class="cs1-code">{{<a href="/wiki/Template:Cite_journal" title="Template:Cite journal">cite journal</a>}}</code>: </span><span class="cs1-visible-error citation-comment"><code class="cs1-code">&#124;first5=</code> has generic name (<a href="/wiki/Help:CS1_errors#generic_name" title="Help:CS1 errors">help</a>)</span></span>
</li>
<li id="cite_note-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-46">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFLetendreLopes2012" class="citation journal cs1">Letendre, I.; Lopes, P. (2012). "Ménopause et risques carcinologiques". <i>Journal de Gynécologie Obstétrique et Biologie de la Reproduction</i>. <b>41</b> (7): F33–F37. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jgyn.2012.09.006">10.1016/j.jgyn.2012.09.006</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/23062839">23062839</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+de+Gyn%C3%A9cologie+Obst%C3%A9trique+et+Biologie+de+la+Reproduction&amp;rft.atitle=M%C3%A9nopause+et+risques+carcinologiques&amp;rft.volume=41&amp;rft.issue=7&amp;rft.pages=F33-F37&amp;rft.date=2012&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jgyn.2012.09.006&amp;rft_id=info%3Apmid%2F23062839&amp;rft.aulast=Letendre&amp;rft.aufirst=I.&amp;rft.au=Lopes%2C+P.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-47">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFChlebowskiAndersonAragakiManson2020" class="citation journal cs1">Chlebowski, RT; Anderson, GL; Aragaki, AK; Manson, JE; Stefanick, ML; Pan, K; Barrington, W; Kuller, LH; Simon, MS; Lane, D; Johnson, KC; Rohan, TE; Gass, MLS; Cauley, JA; Paskett, ED; Sattari, M; Prentice, RL (28 July 2020). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC7388026">"Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials"</a>. <i>JAMA</i>. <b>324</b> (4): 369–380. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjama.2020.9482">10.1001/jama.2020.9482</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC7388026">7388026</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/32721007">32721007</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Association+of+Menopausal+Hormone+Therapy+With+Breast+Cancer+Incidence+and+Mortality+During+Long-term+Follow-up+of+the+Women%27s+Health+Initiative+Randomized+Clinical+Trials.&amp;rft.volume=324&amp;rft.issue=4&amp;rft.pages=369-380&amp;rft.date=2020-07-28&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7388026%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F32721007&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.2020.9482&amp;rft.aulast=Chlebowski&amp;rft.aufirst=RT&amp;rft.au=Anderson%2C+GL&amp;rft.au=Aragaki%2C+AK&amp;rft.au=Manson%2C+JE&amp;rft.au=Stefanick%2C+ML&amp;rft.au=Pan%2C+K&amp;rft.au=Barrington%2C+W&amp;rft.au=Kuller%2C+LH&amp;rft.au=Simon%2C+MS&amp;rft.au=Lane%2C+D&amp;rft.au=Johnson%2C+KC&amp;rft.au=Rohan%2C+TE&amp;rft.au=Gass%2C+MLS&amp;rft.au=Cauley%2C+JA&amp;rft.au=Paskett%2C+ED&amp;rft.au=Sattari%2C+M&amp;rft.au=Prentice%2C+RL&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7388026&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-Anderson04-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-Anderson04_48-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFAndersonLimacherAssafBassford2004" class="citation journal cs1">Anderson, G. L.; Limacher, M.; Assaf, A. R.; Bassford, T.; Beresford, S. A.; Black, H.; Bonds, D.; Brunner, R.; Brzyski, R.; Caan, B.; Chlebowski, R.; Curb, D.; Gass, M.; Hays, J.; Heiss, G.; Hendrix, S.; Howard, B. V.; Hsia, J.; Hubbell, A.; Jackson, R.; Johnson, K. C.; Judd, H.; Kotchen, J. M.; Kuller, L.; Lacroix, A. Z.; Lane, D.; Langer, R. D.; Lasser, N.; Lewis, C. E.; Manson, J. (2004). <a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjama.291.14.1701">"Effects of Conjugated Equine Estrogen in Postmenopausal Women with Hysterectomy: The Women's Health Initiative Randomized Controlled Trial"</a>. <i>JAMA: The Journal of the American Medical Association</i>. <b>291</b> (14): 1701–1712. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjama.291.14.1701">10.1001/jama.291.14.1701</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/15082697">15082697</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA%3A+The+Journal+of+the+American+Medical+Association&amp;rft.atitle=Effects+of+Conjugated+Equine+Estrogen+in+Postmenopausal+Women+with+Hysterectomy%3A+The+Women%27s+Health+Initiative+Randomized+Controlled+Trial&amp;rft.volume=291&amp;rft.issue=14&amp;rft.pages=1701-1712&amp;rft.date=2004&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.291.14.1701&amp;rft_id=info%3Apmid%2F15082697&amp;rft.aulast=Anderson&amp;rft.aufirst=G.+L.&amp;rft.au=Limacher%2C+M.&amp;rft.au=Assaf%2C+A.+R.&amp;rft.au=Bassford%2C+T.&amp;rft.au=Beresford%2C+S.+A.&amp;rft.au=Black%2C+H.&amp;rft.au=Bonds%2C+D.&amp;rft.au=Brunner%2C+R.&amp;rft.au=Brzyski%2C+R.&amp;rft.au=Caan%2C+B.&amp;rft.au=Chlebowski%2C+R.&amp;rft.au=Curb%2C+D.&amp;rft.au=Gass%2C+M.&amp;rft.au=Hays%2C+J.&amp;rft.au=Heiss%2C+G.&amp;rft.au=Hendrix%2C+S.&amp;rft.au=Howard%2C+B.+V.&amp;rft.au=Hsia%2C+J.&amp;rft.au=Hubbell%2C+A.&amp;rft.au=Jackson%2C+R.&amp;rft.au=Johnson%2C+K.+C.&amp;rft.au=Judd%2C+H.&amp;rft.au=Kotchen%2C+J.+M.&amp;rft.au=Kuller%2C+L.&amp;rft.au=Lacroix%2C+A.+Z.&amp;rft.au=Lane%2C+D.&amp;rft.au=Langer%2C+R.+D.&amp;rft.au=Lasser%2C+N.&amp;rft.au=Lewis%2C+C.+E.&amp;rft.au=Manson%2C+J.&amp;rft_id=%2F%2Fdoi.org%2F10.1001%252Fjama.291.14.1701&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-49">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFStefanick_MLAnderson_GLMargolis_KL2006" class="citation journal cs1">Stefanick ML; Anderson GL; Margolis KL;  et&#160;al. (2006). <a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjama.295.14.1647">"Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy"</a>. <i>JAMA</i>. <b>295</b> (14): 1647–57. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjama.295.14.1647">10.1001/jama.295.14.1647</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/16609086">16609086</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Effects+of+conjugated+equine+estrogens+on+breast+cancer+and+mammography+screening+in+postmenopausal+women+with+hysterectomy&amp;rft.volume=295&amp;rft.issue=14&amp;rft.pages=1647-57&amp;rft.date=2006&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.295.14.1647&amp;rft_id=info%3Apmid%2F16609086&amp;rft.au=Stefanick+ML&amp;rft.au=Anderson+GL&amp;rft.au=Margolis+KL&amp;rft_id=%2F%2Fdoi.org%2F10.1001%252Fjama.295.14.1647&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-50">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation journal cs1"><a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fjnci%2Fdjt264">"Association between hormone replacement therapy use and breast cancer risk varies by race/ethnicity, body mass index, and breast density"</a>. <i>JNCI Journal of the National Cancer Institute</i>. <b>105</b> (18). 2013. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fjnci%2Fdjt264">10.1093/jnci/djt264</a></span>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/0027-8874">0027-8874</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JNCI+Journal+of+the+National+Cancer+Institute&amp;rft.atitle=Association+between+hormone+replacement+therapy+use+and+breast+cancer+risk+varies+by+race%2Fethnicity%2C+body+mass+index%2C+and+breast+density&amp;rft.volume=105&amp;rft.issue=18&amp;rft.date=2013&amp;rft_id=info%3Adoi%2F10.1093%2Fjnci%2Fdjt264&amp;rft.issn=0027-8874&amp;rft_id=%2F%2Fdoi.org%2F10.1093%252Fjnci%252Fdjt264&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span>
<ul><li>In turn citing: <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFHouHongWangOlopade2013" class="citation journal cs1">Hou, N.; Hong, S.; Wang, W.; Olopade, O. I.; Dignam, J. J.; Huo, D. (2013). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3776262">"Hormone Replacement Therapy and Breast Cancer: Heterogeneous Risks by Race, Weight, and Breast Density"</a>. <i>JNCI Journal of the National Cancer Institute</i>. <b>105</b> (18): 1365–1372. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fjnci%2Fdjt207">10.1093/jnci/djt207</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/0027-8874">0027-8874</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3776262">3776262</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24003037">24003037</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JNCI+Journal+of+the+National+Cancer+Institute&amp;rft.atitle=Hormone+Replacement+Therapy+and+Breast+Cancer%3A+Heterogeneous+Risks+by+Race%2C+Weight%2C+and+Breast+Density&amp;rft.volume=105&amp;rft.issue=18&amp;rft.pages=1365-1372&amp;rft.date=2013&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3776262%23id-name%3DPMC&amp;rft.issn=0027-8874&amp;rft_id=info%3Apmid%2F24003037&amp;rft_id=info%3Adoi%2F10.1093%2Fjnci%2Fdjt207&amp;rft.aulast=Hou&amp;rft.aufirst=N.&amp;rft.au=Hong%2C+S.&amp;rft.au=Wang%2C+W.&amp;rft.au=Olopade%2C+O.+I.&amp;rft.au=Dignam%2C+J.+J.&amp;rft.au=Huo%2C+D.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3776262&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></li></ul>
</span></li>
<li id="cite_note-pmid23336704-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid23336704_51-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFKuhlSchneider2013" class="citation journal cs1 cs1-prop-long-vol">Kuhl, H.; Schneider, H. P. G. (2013). "Progesterone&#160;– promoter or inhibitor of breast cancer". <i>Climacteric</i>. 16 Suppl 1: 54–68. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3109%2F13697137.2013.768806">10.3109/13697137.2013.768806</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/23336704">23336704</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:20808536">20808536</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Climacteric&amp;rft.atitle=Progesterone+%E2%80%93+promoter+or+inhibitor+of+breast+cancer&amp;rft.volume=16+Suppl+1&amp;rft.pages=54-68&amp;rft.date=2013&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A20808536%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F23336704&amp;rft_id=info%3Adoi%2F10.3109%2F13697137.2013.768806&amp;rft.aulast=Kuhl&amp;rft.aufirst=H.&amp;rft.au=Schneider%2C+H.+P.+G.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-52">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFAzamLangeHuynhAro2018" class="citation journal cs1">Azam, S; Lange, T; Huynh, S; Aro, AR; von Euler-Chelpin, M; Vejborg, I; Tjønneland, A; Lynge, E; Andersen, ZJ (June 2018). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5938298">"Hormone replacement therapy, mammographic density, and breast cancer risk: a cohort study"</a>. <i>Cancer Causes &amp; Control</i>. <b>29</b> (6): 495–505. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs10552-018-1033-0">10.1007/s10552-018-1033-0</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5938298">5938298</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/29671181">29671181</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Causes+%26+Control&amp;rft.atitle=Hormone+replacement+therapy%2C+mammographic+density%2C+and+breast+cancer+risk%3A+a+cohort+study.&amp;rft.volume=29&amp;rft.issue=6&amp;rft.pages=495-505&amp;rft.date=2018-06&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5938298%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F29671181&amp;rft_id=info%3Adoi%2F10.1007%2Fs10552-018-1033-0&amp;rft.aulast=Azam&amp;rft.aufirst=S&amp;rft.au=Lange%2C+T&amp;rft.au=Huynh%2C+S&amp;rft.au=Aro%2C+AR&amp;rft.au=von+Euler-Chelpin%2C+M&amp;rft.au=Vejborg%2C+I&amp;rft.au=Tj%C3%B8nneland%2C+A&amp;rft.au=Lynge%2C+E&amp;rft.au=Andersen%2C+ZJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5938298&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-53">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFStuteWildtNeulen2018" class="citation journal cs1">Stute, P; Wildt, L; Neulen, J (April 2018). <a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F13697137.2017.1421925">"The impact of micronized progesterone on breast cancer risk: a systematic review"</a>. <i>Climacteric&#160;: The Journal of the International Menopause Society</i>. <b>21</b> (2): 111–122. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F13697137.2017.1421925">10.1080/13697137.2017.1421925</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/29384406">29384406</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:3642971">3642971</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Climacteric+%3A+The+Journal+of+the+International+Menopause+Society&amp;rft.atitle=The+impact+of+micronized+progesterone+on+breast+cancer+risk%3A+a+systematic+review.&amp;rft.volume=21&amp;rft.issue=2&amp;rft.pages=111-122&amp;rft.date=2018-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A3642971%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F29384406&amp;rft_id=info%3Adoi%2F10.1080%2F13697137.2017.1421925&amp;rft.aulast=Stute&amp;rft.aufirst=P&amp;rft.au=Wildt%2C+L&amp;rft.au=Neulen%2C+J&amp;rft_id=%2F%2Fdoi.org%2F10.1080%252F13697137.2017.1421925&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-BMS-54"><span class="mw-cite-backlink">^ <a href="#cite_ref-BMS_54-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-BMS_54-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFPanayMedical_Advisory_Council_of_the_British_Menopause2019" class="citation journal cs1">Panay, N; Medical Advisory Council of the British Menopause, Society. (June 2019). "BMS - Consensus statement: Bioidentical HRT". <i>Post Reproductive Health</i>. <b>25</b> (2): 61–63. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F2053369119841844">10.1177/2053369119841844</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/31192760">31192760</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:189816648">189816648</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Post+Reproductive+Health&amp;rft.atitle=BMS+-+Consensus+statement%3A+Bioidentical+HRT.&amp;rft.volume=25&amp;rft.issue=2&amp;rft.pages=61-63&amp;rft.date=2019-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A189816648%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F31192760&amp;rft_id=info%3Adoi%2F10.1177%2F2053369119841844&amp;rft.aulast=Panay&amp;rft.aufirst=N&amp;rft.au=Medical+Advisory+Council+of+the+British+Menopause%2C+Society.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-55">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="https://www.ranzcog.edu.au/doc/management-of-the-menopause-after-breast-cancer.html">Management of the menopause after breast cancer</a> <a rel="nofollow" class="external text" href="https://archive.today/20160407214503/https://www.ranzcog.edu.au/doc/management-of-the-menopause-after-breast-cancer.html">Archived</a> 2016-04-07 at <a href="/wiki/Archive.today" title="Archive.today">archive.today</a>, from The Royal Australian and New Zealand College of Obstetricians and Gynaecologists. College Statement C-Gyn 15. 1st Endorsed: February 2003. Current: November 2011. Review: November 2014</span>
</li>
<li id="cite_note-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-56">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGordhandasNorquistPenningtonYung2019" class="citation journal cs1">Gordhandas, S; Norquist, BM; Pennington, KP; Yung, RL; Laya, MB; Swisher, EM (April 2019). "Hormone replacement therapy after risk reducing salpingo-oophorectomy in patients with BRCA1 or BRCA2 mutations; a systematic review of risks and benefits". <i>Gynecologic Oncology</i>. <b>153</b> (1): 192–200. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.ygyno.2018.12.014">10.1016/j.ygyno.2018.12.014</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/30661763">30661763</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:58593390">58593390</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Gynecologic+Oncology&amp;rft.atitle=Hormone+replacement+therapy+after+risk+reducing+salpingo-oophorectomy+in+patients+with+BRCA1+or+BRCA2+mutations%3B+a+systematic+review+of+risks+and+benefits.&amp;rft.volume=153&amp;rft.issue=1&amp;rft.pages=192-200&amp;rft.date=2019-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A58593390%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F30661763&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ygyno.2018.12.014&amp;rft.aulast=Gordhandas&amp;rft.aufirst=S&amp;rft.au=Norquist%2C+BM&amp;rft.au=Pennington%2C+KP&amp;rft.au=Yung%2C+RL&amp;rft.au=Laya%2C+MB&amp;rft.au=Swisher%2C+EM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-57">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFHeinigSchwarzHaug2021" class="citation journal cs1">Heinig, M; Schwarz, S; Haug, U (16 February 2021). "Self-selection for mammography screening according to use of hormone replacement therapy: A systematic literature review". <i>Cancer Epidemiology</i>. <b>71</b> (Pt A): 101812. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.canep.2020.101812">10.1016/j.canep.2020.101812</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/33608235">33608235</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:231970420">231970420</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Epidemiology&amp;rft.atitle=Self-selection+for+mammography+screening+according+to+use+of+hormone+replacement+therapy%3A+A+systematic+literature+review.&amp;rft.volume=71&amp;rft.issue=Pt+A&amp;rft.pages=101812&amp;rft.date=2021-02-16&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A231970420%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F33608235&amp;rft_id=info%3Adoi%2F10.1016%2Fj.canep.2020.101812&amp;rft.aulast=Heinig&amp;rft.aufirst=M&amp;rft.au=Schwarz%2C+S&amp;rft.au=Haug%2C+U&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-58"><span class="mw-cite-backlink"><b><a href="#cite_ref-58">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFKotsopoulosNarod2012" class="citation journal cs1">Kotsopoulos, J; Narod, SA (January 2012). "Androgens and breast cancer". <i>Steroids</i>. <b>77</b> (1–2): 1–9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.steroids.2011.10.002">10.1016/j.steroids.2011.10.002</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/22015396">22015396</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:32022318">32022318</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Steroids&amp;rft.atitle=Androgens+and+breast+cancer.&amp;rft.volume=77&amp;rft.issue=1%E2%80%932&amp;rft.pages=1-9&amp;rft.date=2012-01&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A32022318%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F22015396&amp;rft_id=info%3Adoi%2F10.1016%2Fj.steroids.2011.10.002&amp;rft.aulast=Kotsopoulos&amp;rft.aufirst=J&amp;rft.au=Narod%2C+SA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-59">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFCollaborative_Group_on_Epidemiological_Studies_of_Ovarian_Cancer2015" class="citation journal cs1">Collaborative Group on Epidemiological Studies of Ovarian Cancer (12 February 2015). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4427760">"Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies"</a>. <i>The Lancet</i>. <b>385</b> (9980): 1835–1842. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0140-6736%2814%2961687-1">10.1016/S0140-6736(14)61687-1</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4427760">4427760</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25684585">25684585</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet&amp;rft.atitle=Menopausal+hormone+use+and+ovarian+cancer+risk%3A+individual+participant+meta-analysis+of+52+epidemiological+studies&amp;rft.volume=385&amp;rft.issue=9980&amp;rft.pages=1835-1842&amp;rft.date=2015-02-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4427760%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F25684585&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2814%2961687-1&amp;rft.au=Collaborative+Group+on+Epidemiological+Studies+of+Ovarian+Cancer&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4427760&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-Shi_2016-60"><span class="mw-cite-backlink">^ <a href="#cite_ref-Shi_2016_60-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Shi_2016_60-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Shi_2016_60-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFShiWuLi2016" class="citation journal cs1">Shi, LF; Wu, Y; Li, CY (April 2016). "Hormone therapy and risk of ovarian cancer in postmenopausal women: a systematic review and meta-analysis". <i>Menopause</i>. <b>23</b> (4): 417–24. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FGME.0000000000000550">10.1097/GME.0000000000000550</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26506499">26506499</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:32195397">32195397</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Menopause&amp;rft.atitle=Hormone+therapy+and+risk+of+ovarian+cancer+in+postmenopausal+women%3A+a+systematic+review+and+meta-analysis.&amp;rft.volume=23&amp;rft.issue=4&amp;rft.pages=417-24&amp;rft.date=2016-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A32195397%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F26506499&amp;rft_id=info%3Adoi%2F10.1097%2FGME.0000000000000550&amp;rft.aulast=Shi&amp;rft.aufirst=LF&amp;rft.au=Wu%2C+Y&amp;rft.au=Li%2C+CY&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-61">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGuidozzi2013" class="citation journal cs1">Guidozzi, F (December 2013). "Estrogen therapy in gynecological cancer survivors". <i>Climacteric&#160;: The Journal of the International Menopause Society</i>. <b>16</b> (6): 611–7. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3109%2F13697137.2013.806471">10.3109/13697137.2013.806471</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/23952524">23952524</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:38122562">38122562</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Climacteric+%3A+The+Journal+of+the+International+Menopause+Society&amp;rft.atitle=Estrogen+therapy+in+gynecological+cancer+survivors.&amp;rft.volume=16&amp;rft.issue=6&amp;rft.pages=611-7&amp;rft.date=2013-12&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A38122562%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F23952524&amp;rft_id=info%3Adoi%2F10.3109%2F13697137.2013.806471&amp;rft.aulast=Guidozzi&amp;rft.aufirst=F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-cancer.org-62"><span class="mw-cite-backlink"><b><a href="#cite_ref-cancer.org_62-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.cancer.org/cancer/cancer-causes/medical-treatments/menopausal-hormone-replacement-therapy-and-cancer-risk.html">"Menopausal Hormone Therapy and Cancer Risk"</a>. www.cancer.org<span class="reference-accessdate">. Retrieved <span class="nowrap">4 March</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Menopausal+Hormone+Therapy+and+Cancer+Risk&amp;rft.pub=www.cancer.org&amp;rft_id=https%3A%2F%2Fwww.cancer.org%2Fcancer%2Fcancer-causes%2Fmedical-treatments%2Fmenopausal-hormone-replacement-therapy-and-cancer-risk.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-63">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFJangHuangLeung2019" class="citation journal cs1">Jang, YC; Huang, HL; Leung, CY (9 December 2019). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6902524">"Association of hormone replacement therapy with mortality in colorectal cancer survivor: a systematic review and meta-analysis"</a>. <i>BMC Cancer</i>. <b>19</b> (1): 1199. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1186%2Fs12885-019-6428-0">10.1186/s12885-019-6428-0</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6902524">6902524</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/31818262">31818262</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMC+Cancer&amp;rft.atitle=Association+of+hormone+replacement+therapy+with+mortality+in+colorectal+cancer+survivor%3A+a+systematic+review+and+meta-analysis.&amp;rft.volume=19&amp;rft.issue=1&amp;rft.pages=1199&amp;rft.date=2019-12-09&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6902524%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F31818262&amp;rft_id=info%3Adoi%2F10.1186%2Fs12885-019-6428-0&amp;rft.aulast=Jang&amp;rft.aufirst=YC&amp;rft.au=Huang%2C+HL&amp;rft.au=Leung%2C+CY&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6902524&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-64">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFVargiuAmarRosatiDinoi2020" class="citation journal cs1">Vargiu, V; Amar, ID; Rosati, A; Dinoi, G; Turco, LC; Capozzi, VA; Scambia, G; Villa, P (25 November 2020). "Hormone replacement therapy and cervical cancer: a systematic review of the literature". <i>Climacteric&#160;: The Journal of the International Menopause Society</i>. <b>24</b> (2): 120–127. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F13697137.2020.1826426">10.1080/13697137.2020.1826426</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/33236658">33236658</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:227166430">227166430</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Climacteric+%3A+The+Journal+of+the+International+Menopause+Society&amp;rft.atitle=Hormone+replacement+therapy+and+cervical+cancer%3A+a+systematic+review+of+the+literature.&amp;rft.volume=24&amp;rft.issue=2&amp;rft.pages=120-127&amp;rft.date=2020-11-25&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A227166430%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F33236658&amp;rft_id=info%3Adoi%2F10.1080%2F13697137.2020.1826426&amp;rft.aulast=Vargiu&amp;rft.aufirst=V&amp;rft.au=Amar%2C+ID&amp;rft.au=Rosati%2C+A&amp;rft.au=Dinoi%2C+G&amp;rft.au=Turco%2C+LC&amp;rft.au=Capozzi%2C+VA&amp;rft.au=Scambia%2C+G&amp;rft.au=Villa%2C+P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-miller-65"><span class="mw-cite-backlink"><b><a href="#cite_ref-miller_65-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMiller_M.M.Franklin_K.B.J.1999" class="citation journal cs1">Miller M.M.; Franklin K.B.J. (1999). "Theoretical basis for the benefit of postmenopausal estrogen substitution". <i>Experimental Gerontology</i>. <b>34</b> (5): 587–604. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0531-5565%2899%2900032-7">10.1016/S0531-5565(99)00032-7</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/10530785">10530785</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:43031351">43031351</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Experimental+Gerontology&amp;rft.atitle=Theoretical+basis+for+the+benefit+of+postmenopausal+estrogen+substitution&amp;rft.volume=34&amp;rft.issue=5&amp;rft.pages=587-604&amp;rft.date=1999&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A43031351%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F10530785&amp;rft_id=info%3Adoi%2F10.1016%2FS0531-5565%2899%2900032-7&amp;rft.au=Miller+M.M.&amp;rft.au=Franklin+K.B.J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-gonzalez-66"><span class="mw-cite-backlink"><b><a href="#cite_ref-gonzalez_66-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGonzalez_M.,_Viagara_G.,_Caba_F.,_Molina_E.2004" class="citation journal cs1">Gonzalez M., Viagara G., Caba F., Molina E. (2004). "Sexual function, menopause and hormone replacement therapy (HRT)". <i>The European Menopause Journal</i>. <b>48</b> (4): 411–420. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.maturitas.2003.10.005">10.1016/j.maturitas.2003.10.005</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/15283933">15283933</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+European+Menopause+Journal&amp;rft.atitle=Sexual+function%2C+menopause+and+hormone+replacement+therapy+%28HRT%29&amp;rft.volume=48&amp;rft.issue=4&amp;rft.pages=411-420&amp;rft.date=2004&amp;rft_id=info%3Adoi%2F10.1016%2Fj.maturitas.2003.10.005&amp;rft_id=info%3Apmid%2F15283933&amp;rft.au=Gonzalez+M.%2C+Viagara+G.%2C+Caba+F.%2C+Molina+E.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span><span class="cs1-maint citation-comment"><code class="cs1-code">{{<a href="/wiki/Template:Cite_journal" title="Template:Cite journal">cite journal</a>}}</code>:  CS1 maint: multiple names: authors list (<a href="/wiki/Category:CS1_maint:_multiple_names:_authors_list" title="Category:CS1 maint: multiple names: authors list">link</a>)</span></span>
</li>
<li id="cite_note-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-67">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFJohansenLindén_HirschbergMoen2020" class="citation journal cs1">Johansen, N; Lindén Hirschberg, A; Moen, MH (August 2020). "The role of testosterone in menopausal hormone treatment. What is the evidence?". <i>Acta Obstetricia et Gynecologica Scandinavica</i>. <b>99</b> (8): 966–969. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Faogs.13819">10.1111/aogs.13819</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/32027015">32027015</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:211050248">211050248</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Acta+Obstetricia+et+Gynecologica+Scandinavica&amp;rft.atitle=The+role+of+testosterone+in+menopausal+hormone+treatment.+What+is+the+evidence%3F&amp;rft.volume=99&amp;rft.issue=8&amp;rft.pages=966-969&amp;rft.date=2020-08&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A211050248%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F32027015&amp;rft_id=info%3Adoi%2F10.1111%2Faogs.13819&amp;rft.aulast=Johansen&amp;rft.aufirst=N&amp;rft.au=Lind%C3%A9n+Hirschberg%2C+A&amp;rft.au=Moen%2C+MH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-Dye_et_al._2012-68"><span class="mw-cite-backlink">^ <a href="#cite_ref-Dye_et_al._2012_68-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Dye_et_al._2012_68-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDyeMillerSingerLevine2012" class="citation journal cs1">Dye, RV; Miller, KJ; Singer, EJ; Levine, AJ (2012). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3324889">"Hormone replacement therapy and risk for neurodegenerative diseases"</a>. <i>International Journal of Alzheimer's Disease</i>. <b>2012</b>: 258454. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1155%2F2012%2F258454">10.1155/2012/258454</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3324889">3324889</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/22548198">22548198</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Journal+of+Alzheimer%27s+Disease&amp;rft.atitle=Hormone+replacement+therapy+and+risk+for+neurodegenerative+diseases.&amp;rft.volume=2012&amp;rft.pages=258454&amp;rft.date=2012&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3324889%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F22548198&amp;rft_id=info%3Adoi%2F10.1155%2F2012%2F258454&amp;rft.aulast=Dye&amp;rft.aufirst=RV&amp;rft.au=Miller%2C+KJ&amp;rft.au=Singer%2C+EJ&amp;rft.au=Levine%2C+AJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3324889&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-69"><span class="mw-cite-backlink"><b><a href="#cite_ref-69">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFCampdelacreu2014" class="citation journal cs1">Campdelacreu, J (November 2014). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.nrl.2012.04.001">"Parkinson disease and Alzheimer disease: environmental risk factors"</a>. <i>Neurologia (Barcelona, Spain)</i>. <b>29</b> (9): 541–9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.nrl.2012.04.001">10.1016/j.nrl.2012.04.001</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/22703631">22703631</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurologia+%28Barcelona%2C+Spain%29&amp;rft.atitle=Parkinson+disease+and+Alzheimer+disease%3A+environmental+risk+factors.&amp;rft.volume=29&amp;rft.issue=9&amp;rft.pages=541-9&amp;rft.date=2014-11&amp;rft_id=info%3Adoi%2F10.1016%2Fj.nrl.2012.04.001&amp;rft_id=info%3Apmid%2F22703631&amp;rft.aulast=Campdelacreu&amp;rft.aufirst=J&amp;rft_id=%2F%2Fdoi.org%2F10.1016%252Fj.nrl.2012.04.001&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-70">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFNicolettiNicolettiArabiaAnnesi2011" class="citation journal cs1">Nicoletti, A; Nicoletti, G; Arabia, G; Annesi, G; De Mari, M; Lamberti, P; Grasso, L; Marconi, R; Epifanio, A; Morgante, L; Cozzolino, A; Barone, P; Quattrone, A; Zappia, M (December 2011). "Reproductive factors and Parkinson's disease: a multicenter case-control study". <i>Movement Disorders</i>. <b>26</b> (14): 2563–6. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fmds.23951">10.1002/mds.23951</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21956541">21956541</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:40143658">40143658</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Movement+Disorders&amp;rft.atitle=Reproductive+factors+and+Parkinson%27s+disease%3A+a+multicenter+case-control+study.&amp;rft.volume=26&amp;rft.issue=14&amp;rft.pages=2563-6&amp;rft.date=2011-12&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A40143658%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F21956541&amp;rft_id=info%3Adoi%2F10.1002%2Fmds.23951&amp;rft.aulast=Nicoletti&amp;rft.aufirst=A&amp;rft.au=Nicoletti%2C+G&amp;rft.au=Arabia%2C+G&amp;rft.au=Annesi%2C+G&amp;rft.au=De+Mari%2C+M&amp;rft.au=Lamberti%2C+P&amp;rft.au=Grasso%2C+L&amp;rft.au=Marconi%2C+R&amp;rft.au=Epifanio%2C+A&amp;rft.au=Morgante%2C+L&amp;rft.au=Cozzolino%2C+A&amp;rft.au=Barone%2C+P&amp;rft.au=Quattrone%2C+A&amp;rft.au=Zappia%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-71"><span class="mw-cite-backlink"><b><a href="#cite_ref-71">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFNoyceBestwickSilveira-MoriyamaHawkes2012" class="citation journal cs1">Noyce, AJ; Bestwick, JP; Silveira-Moriyama, L; Hawkes, CH; Giovannoni, G; Lees, AJ; Schrag, A (December 2012). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3556649">"Meta-analysis of early nonmotor features and risk factors for Parkinson disease"</a>. <i>Annals of Neurology</i>. <b>72</b> (6): 893–901. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fana.23687">10.1002/ana.23687</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3556649">3556649</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/23071076">23071076</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Neurology&amp;rft.atitle=Meta-analysis+of+early+nonmotor+features+and+risk+factors+for+Parkinson+disease.&amp;rft.volume=72&amp;rft.issue=6&amp;rft.pages=893-901&amp;rft.date=2012-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3556649%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F23071076&amp;rft_id=info%3Adoi%2F10.1002%2Fana.23687&amp;rft.aulast=Noyce&amp;rft.aufirst=AJ&amp;rft.au=Bestwick%2C+JP&amp;rft.au=Silveira-Moriyama%2C+L&amp;rft.au=Hawkes%2C+CH&amp;rft.au=Giovannoni%2C+G&amp;rft.au=Lees%2C+AJ&amp;rft.au=Schrag%2C+A&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3556649&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-72"><span class="mw-cite-backlink"><b><a href="#cite_ref-72">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFWangLiQiuWen2015" class="citation journal cs1">Wang, P; Li, J; Qiu, S; Wen, H; Du, J (2015). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4317144">"Hormone replacement therapy and Parkinson's disease risk in women: a meta-analysis of 14 observational studies"</a>. <i>Neuropsychiatric Disease and Treatment</i>. <b>11</b>: 59–66. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2147%2FNDT.S69918">10.2147/NDT.S69918</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4317144">4317144</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25657580">25657580</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuropsychiatric+Disease+and+Treatment&amp;rft.atitle=Hormone+replacement+therapy+and+Parkinson%27s+disease+risk+in+women%3A+a+meta-analysis+of+14+observational+studies.&amp;rft.volume=11&amp;rft.pages=59-66&amp;rft.date=2015&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4317144%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F25657580&amp;rft_id=info%3Adoi%2F10.2147%2FNDT.S69918&amp;rft.aulast=Wang&amp;rft.aufirst=P&amp;rft.au=Li%2C+J&amp;rft.au=Qiu%2C+S&amp;rft.au=Wen%2C+H&amp;rft.au=Du%2C+J&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4317144&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-73"><span class="mw-cite-backlink"><b><a href="#cite_ref-73">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFRugbjergChristensenTjønnelandOlsen2013" class="citation journal cs1">Rugbjerg, K; Christensen, J; Tjønneland, A; Olsen, JH (April 2013). "Exposure to estrogen and women's risk for Parkinson's disease: a prospective cohort study in Denmark". <i>Parkinsonism &amp; Related Disorders</i>. <b>19</b> (4): 457–60. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.parkreldis.2013.01.008">10.1016/j.parkreldis.2013.01.008</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/23402992">23402992</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Parkinsonism+%26+Related+Disorders&amp;rft.atitle=Exposure+to+estrogen+and+women%27s+risk+for+Parkinson%27s+disease%3A+a+prospective+cohort+study+in+Denmark.&amp;rft.volume=19&amp;rft.issue=4&amp;rft.pages=457-60&amp;rft.date=2013-04&amp;rft_id=info%3Adoi%2F10.1016%2Fj.parkreldis.2013.01.008&amp;rft_id=info%3Apmid%2F23402992&amp;rft.aulast=Rugbjerg&amp;rft.aufirst=K&amp;rft.au=Christensen%2C+J&amp;rft.au=Tj%C3%B8nneland%2C+A&amp;rft.au=Olsen%2C+JH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-74"><span class="mw-cite-backlink"><b><a href="#cite_ref-74">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFYoonChinKimShin2018" class="citation journal cs1">Yoon, BK; Chin, J; Kim, JW; Shin, MH; Ahn, S; Lee, DY; Seo, SW; Na, DL (August 2018). "Menopausal hormone therapy and mild cognitive impairment: a randomized, placebo-controlled trial". <i>Menopause</i>. <b>25</b> (8): 870–876. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FGME.0000000000001140">10.1097/GME.0000000000001140</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/29846283">29846283</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:44174553">44174553</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Menopause&amp;rft.atitle=Menopausal+hormone+therapy+and+mild+cognitive+impairment%3A+a+randomized%2C+placebo-controlled+trial.&amp;rft.volume=25&amp;rft.issue=8&amp;rft.pages=870-876&amp;rft.date=2018-08&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A44174553%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F29846283&amp;rft_id=info%3Adoi%2F10.1097%2FGME.0000000000001140&amp;rft.aulast=Yoon&amp;rft.aufirst=BK&amp;rft.au=Chin%2C+J&amp;rft.au=Kim%2C+JW&amp;rft.au=Shin%2C+MH&amp;rft.au=Ahn%2C+S&amp;rft.au=Lee%2C+DY&amp;rft.au=Seo%2C+SW&amp;rft.au=Na%2C+DL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-75"><span class="mw-cite-backlink"><b><a href="#cite_ref-75">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFRasgonGeistKennaWroolie2014" class="citation journal cs1">Rasgon, NL; Geist, CL; Kenna, HA; Wroolie, TE; Williams, KE; Silverman, DH (2014). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3951184">"Prospective randomized trial to assess effects of continuing hormone therapy on cerebral function in postmenopausal women at risk for dementia"</a>. <i>PLOS ONE</i>. <b>9</b> (3): e89095. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2014PLoSO...989095R">2014PLoSO...989095R</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1371%2Fjournal.pone.0089095">10.1371/journal.pone.0089095</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3951184">3951184</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24622517">24622517</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLOS+ONE&amp;rft.atitle=Prospective+randomized+trial+to+assess+effects+of+continuing+hormone+therapy+on+cerebral+function+in+postmenopausal+women+at+risk+for+dementia.&amp;rft.volume=9&amp;rft.issue=3&amp;rft.pages=e89095&amp;rft.date=2014&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3951184%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F24622517&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0089095&amp;rft_id=info%3Abibcode%2F2014PLoSO...989095R&amp;rft.aulast=Rasgon&amp;rft.aufirst=NL&amp;rft.au=Geist%2C+CL&amp;rft.au=Kenna%2C+HA&amp;rft.au=Wroolie%2C+TE&amp;rft.au=Williams%2C+KE&amp;rft.au=Silverman%2C+DH&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3951184&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid8909345-76"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid8909345_76-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSchmidtFazekasReinhartKapeller1996" class="citation journal cs1">Schmidt R, Fazekas F, Reinhart B, Kapeller P, Fazekas G, Offenbacher H, Eber B, Schumacher M, Freidl W (November 1996). "Estrogen replacement therapy in older women: a neuropsychological and brain MRI study". <i>Journal of the American Geriatrics Society</i>. <b>44</b> (11): 1307–13. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1532-5415.1996.tb01400.x">10.1111/j.1532-5415.1996.tb01400.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/8909345">8909345</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:22921797">22921797</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+American+Geriatrics+Society&amp;rft.atitle=Estrogen+replacement+therapy+in+older+women%3A+a+neuropsychological+and+brain+MRI+study&amp;rft.volume=44&amp;rft.issue=11&amp;rft.pages=1307-13&amp;rft.date=1996-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A22921797%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F8909345&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1532-5415.1996.tb01400.x&amp;rft.aulast=Schmidt&amp;rft.aufirst=R&amp;rft.au=Fazekas%2C+F&amp;rft.au=Reinhart%2C+B&amp;rft.au=Kapeller%2C+P&amp;rft.au=Fazekas%2C+G&amp;rft.au=Offenbacher%2C+H&amp;rft.au=Eber%2C+B&amp;rft.au=Schumacher%2C+M&amp;rft.au=Freidl%2C+W&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-77"><span class="mw-cite-backlink"><b><a href="#cite_ref-77">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFParkinson_Study_Group_POETRY2011" class="citation journal cs1">Parkinson Study Group POETRY, Investigators. (December 2011). "A randomized pilot trial of estrogen replacement therapy in post-menopausal women with Parkinson's disease". <i>Parkinsonism &amp; Related Disorders</i>. <b>17</b> (10): 757–60. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.parkreldis.2011.07.007">10.1016/j.parkreldis.2011.07.007</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21824799">21824799</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Parkinsonism+%26+Related+Disorders&amp;rft.atitle=A+randomized+pilot+trial+of+estrogen+replacement+therapy+in+post-menopausal+women+with+Parkinson%27s+disease.&amp;rft.volume=17&amp;rft.issue=10&amp;rft.pages=757-60&amp;rft.date=2011-12&amp;rft_id=info%3Adoi%2F10.1016%2Fj.parkreldis.2011.07.007&amp;rft_id=info%3Apmid%2F21824799&amp;rft.aulast=Parkinson+Study+Group+POETRY&amp;rft.aufirst=Investigators.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-78"><span class="mw-cite-backlink"><b><a href="#cite_ref-78">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDiamanti-KandarakisDattiloMacutDuntas2017" class="citation journal cs1">Diamanti-Kandarakis, E; Dattilo, M; Macut, D; Duntas, L; Gonos, ES; Goulis, DG; Gantenbein, CK; Kapetanou, M; Koukkou, E; Lambrinoudaki, I; Michalaki, M; Eftekhari-Nader, S; Pasquali, R; Peppa, M; Tzanela, M; Vassilatou, E; Vryonidou, A (June 2017). <a rel="nofollow" class="external text" href="https://doi.org/10.1530%2FEJE-16-1061">"Mechanisms in Endocrinology: Aging and anti-aging: a Combo-Endocrinology overview"</a>. <i>European Journal of Endocrinology</i>. <b>176</b> (6): R283–R308. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1530%2FEJE-16-1061">10.1530/EJE-16-1061</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28264815">28264815</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Endocrinology&amp;rft.atitle=Mechanisms+in+Endocrinology%3A+Aging+and+anti-aging%3A+a+Combo-Endocrinology+overview.&amp;rft.volume=176&amp;rft.issue=6&amp;rft.pages=R283-R308&amp;rft.date=2017-06&amp;rft_id=info%3Adoi%2F10.1530%2FEJE-16-1061&amp;rft_id=info%3Apmid%2F28264815&amp;rft.aulast=Diamanti-Kandarakis&amp;rft.aufirst=E&amp;rft.au=Dattilo%2C+M&amp;rft.au=Macut%2C+D&amp;rft.au=Duntas%2C+L&amp;rft.au=Gonos%2C+ES&amp;rft.au=Goulis%2C+DG&amp;rft.au=Gantenbein%2C+CK&amp;rft.au=Kapetanou%2C+M&amp;rft.au=Koukkou%2C+E&amp;rft.au=Lambrinoudaki%2C+I&amp;rft.au=Michalaki%2C+M&amp;rft.au=Eftekhari-Nader%2C+S&amp;rft.au=Pasquali%2C+R&amp;rft.au=Peppa%2C+M&amp;rft.au=Tzanela%2C+M&amp;rft.au=Vassilatou%2C+E&amp;rft.au=Vryonidou%2C+A&amp;rft_id=%2F%2Fdoi.org%2F10.1530%252FEJE-16-1061&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-79"><span class="mw-cite-backlink"><b><a href="#cite_ref-79">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFVestPike2013" class="citation journal cs1">Vest, RS; Pike, CJ (February 2013). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3413783">"Gender, sex steroid hormones, and Alzheimer's disease"</a>. <i>Hormones and Behavior</i>. <b>63</b> (2): 301–7. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.yhbeh.2012.04.006">10.1016/j.yhbeh.2012.04.006</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3413783">3413783</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/22554955">22554955</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hormones+and+Behavior&amp;rft.atitle=Gender%2C+sex+steroid+hormones%2C+and+Alzheimer%27s+disease.&amp;rft.volume=63&amp;rft.issue=2&amp;rft.pages=301-7&amp;rft.date=2013-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3413783%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F22554955&amp;rft_id=info%3Adoi%2F10.1016%2Fj.yhbeh.2012.04.006&amp;rft.aulast=Vest&amp;rft.aufirst=RS&amp;rft.au=Pike%2C+CJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3413783&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-80"><span class="mw-cite-backlink"><b><a href="#cite_ref-80">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFPikeCarrollRosarioBarron2009" class="citation journal cs1">Pike, CJ; Carroll, JC; Rosario, ER; Barron, AM (July 2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2728624">"Protective actions of sex steroid hormones in Alzheimer's disease"</a>. <i>Frontiers in Neuroendocrinology</i>. <b>30</b> (2): 239–58. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.yfrne.2009.04.015">10.1016/j.yfrne.2009.04.015</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2728624">2728624</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19427328">19427328</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Frontiers+in+Neuroendocrinology&amp;rft.atitle=Protective+actions+of+sex+steroid+hormones+in+Alzheimer%27s+disease.&amp;rft.volume=30&amp;rft.issue=2&amp;rft.pages=239-58&amp;rft.date=2009-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2728624%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F19427328&amp;rft_id=info%3Adoi%2F10.1016%2Fj.yfrne.2009.04.015&amp;rft.aulast=Pike&amp;rft.aufirst=CJ&amp;rft.au=Carroll%2C+JC&amp;rft.au=Rosario%2C+ER&amp;rft.au=Barron%2C+AM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2728624&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-81"><span class="mw-cite-backlink"><b><a href="#cite_ref-81">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFZhuJiangSunShu2016" class="citation journal cs1">Zhu, L; Jiang, X; Sun, Y; Shu, W (April 2016). "Effect of hormone therapy on the risk of bone fractures: a systematic review and meta-analysis of randomized controlled trials". <i>Menopause</i>. <b>23</b> (4): 461–70. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FGME.0000000000000519">10.1097/GME.0000000000000519</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26529613">26529613</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:26110755">26110755</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Menopause&amp;rft.atitle=Effect+of+hormone+therapy+on+the+risk+of+bone+fractures%3A+a+systematic+review+and+meta-analysis+of+randomized+controlled+trials.&amp;rft.volume=23&amp;rft.issue=4&amp;rft.pages=461-70&amp;rft.date=2016-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A26110755%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F26529613&amp;rft_id=info%3Adoi%2F10.1097%2FGME.0000000000000519&amp;rft.aulast=Zhu&amp;rft.aufirst=L&amp;rft.au=Jiang%2C+X&amp;rft.au=Sun%2C+Y&amp;rft.au=Shu%2C+W&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-Ten-82"><span class="mw-cite-backlink">^ <a href="#cite_ref-Ten_82-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Ten_82-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFStudd_J2010" class="citation journal cs1">Studd J (March 2010). <a rel="nofollow" class="external text" href="https://semanticscholar.org/paper/35f42df732e8b9041df4756a78b337b58adf6cdb">"Ten reasons to be happy about hormone replacement therapy: a guide for patients"</a>. <i>Menopause Int</i>. <b>16</b> (1): 44–6. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1258%2Fmi.2010.010001">10.1258/mi.2010.010001</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20424287">20424287</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:33414205">33414205</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Menopause+Int.&amp;rft.atitle=Ten+reasons+to+be+happy+about+hormone+replacement+therapy%3A+a+guide+for+patients&amp;rft.volume=16&amp;rft.issue=1&amp;rft.pages=44-6&amp;rft.date=2010-03&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A33414205%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F20424287&amp;rft_id=info%3Adoi%2F10.1258%2Fmi.2010.010001&amp;rft.au=Studd+J&amp;rft_id=https%3A%2F%2Fsemanticscholar.org%2Fpaper%2F35f42df732e8b9041df4756a78b337b58adf6cdb&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-83"><span class="mw-cite-backlink"><b><a href="#cite_ref-83">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFTiidus2011" class="citation journal cs1">Tiidus, PM (August 2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4261347">"Benefits of estrogen replacement for skeletal muscle mass and function in post-menopausal females: evidence from human and animal studies"</a>. <i>The Eurasian Journal of Medicine</i>. <b>43</b> (2): 109–14. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.5152%2Feajm.2011.24">10.5152/eajm.2011.24</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4261347">4261347</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25610174">25610174</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Eurasian+Journal+of+Medicine&amp;rft.atitle=Benefits+of+estrogen+replacement+for+skeletal+muscle+mass+and+function+in+post-menopausal+females%3A+evidence+from+human+and+animal+studies.&amp;rft.volume=43&amp;rft.issue=2&amp;rft.pages=109-14&amp;rft.date=2011-08&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4261347%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F25610174&amp;rft_id=info%3Adoi%2F10.5152%2Feajm.2011.24&amp;rft.aulast=Tiidus&amp;rft.aufirst=PM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4261347&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-84"><span class="mw-cite-backlink"><b><a href="#cite_ref-84">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDeleruyelle2017" class="citation journal cs1">Deleruyelle, LJ (2017). "Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3". <i>International Journal of Pharmaceutical Compounding</i>. <b>21</b> (1): 6–16. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28346192">28346192</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Journal+of+Pharmaceutical+Compounding&amp;rft.atitle=Menopausal+Symptom+Relief+and+Side+Effects+Experienced+by+Women+Using+Compounded+Bioidentical+Hormone+Replacement+Therapy+and+Synthetic+Conjugated+Equine+Estrogen+and%2For+Progestin+Hormone+Replacement+Therapy%2C+Part+3.&amp;rft.volume=21&amp;rft.issue=1&amp;rft.pages=6-16&amp;rft.date=2017&amp;rft_id=info%3Apmid%2F28346192&amp;rft.aulast=Deleruyelle&amp;rft.aufirst=LJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-85"><span class="mw-cite-backlink"><b><a href="#cite_ref-85">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSuchowerskyMuthipeedika2005" class="citation journal cs1">Suchowersky O, Muthipeedika J (December 2005). <a rel="nofollow" class="external text" href="http://www.nature.com/ncpneuro/journal/v1/n2/full/ncpneuro0052.html">"A case of late-onset chorea"</a>. <i>Nat Clin Pract Neurol</i>. <b>1</b> (2): 113–6. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fncpneuro0052">10.1038/ncpneuro0052</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/16932507">16932507</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:11410333">11410333</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nat+Clin+Pract+Neurol&amp;rft.atitle=A+case+of+late-onset+chorea&amp;rft.volume=1&amp;rft.issue=2&amp;rft.pages=113-6&amp;rft.date=2005-12&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A11410333%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F16932507&amp;rft_id=info%3Adoi%2F10.1038%2Fncpneuro0052&amp;rft.aulast=Suchowersky&amp;rft.aufirst=O&amp;rft.au=Muthipeedika%2C+J&amp;rft_id=http%3A%2F%2Fwww.nature.com%2Fncpneuro%2Fjournal%2Fv1%2Fn2%2Ffull%2Fncpneuro0052.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-86"><span class="mw-cite-backlink"><b><a href="#cite_ref-86">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMacLennan2011" class="citation journal cs1">MacLennan, AH (August 2011). "HRT in difficult circumstances: are there any absolute contraindications?". <i>Climacteric</i>. <b>14</b> (4): 409–17. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3109%2F13697137.2010.543496">10.3109/13697137.2010.543496</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21355685">21355685</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:25426141">25426141</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Climacteric&amp;rft.atitle=HRT+in+difficult+circumstances%3A+are+there+any+absolute+contraindications%3F&amp;rft.volume=14&amp;rft.issue=4&amp;rft.pages=409-17&amp;rft.date=2011-08&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A25426141%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F21355685&amp;rft_id=info%3Adoi%2F10.3109%2F13697137.2010.543496&amp;rft.aulast=MacLennan&amp;rft.aufirst=AH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-Fugh-Berman2015-87"><span class="mw-cite-backlink">^ <a href="#cite_ref-Fugh-Berman2015_87-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Fugh-Berman2015_87-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Fugh-Berman2015_87-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Fugh-Berman2015_87-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Fugh-Berman2015_87-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Fugh-Berman2015_87-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Fugh-Berman2015_87-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Fugh-Berman2015_87-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Fugh-Berman2015_87-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Fugh-Berman2015_87-9"><sup><i><b>j</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFFugh-Berman2015" class="citation journal cs1">Fugh-Berman, Adriane (2015). "The Science of Marketing: How Pharmaceutical Companies Manipulated Medical Discourse on Menopause". <i>Women's Reproductive Health</i>. <b>2</b> (1): 18–23. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F23293691.2015.1039448">10.1080/23293691.2015.1039448</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/2329-3691">2329-3691</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Women%27s+Reproductive+Health&amp;rft.atitle=The+Science+of+Marketing%3A+How+Pharmaceutical+Companies+Manipulated+Medical+Discourse+on+Menopause&amp;rft.volume=2&amp;rft.issue=1&amp;rft.pages=18-23&amp;rft.date=2015&amp;rft_id=info%3Adoi%2F10.1080%2F23293691.2015.1039448&amp;rft.issn=2329-3691&amp;rft.aulast=Fugh-Berman&amp;rft.aufirst=Adriane&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-HumansOrganization2007-88"><span class="mw-cite-backlink"><b><a href="#cite_ref-HumansOrganization2007_88-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFIARC_Working_Group_on_the_Evaluation_of_Carcinogenic_Risks_to_HumansWorld_Health_OrganizationInternational_Agency_for_Research_on_Cancer2007" class="citation book cs1">IARC Working Group on the Evaluation of Carcinogenic Risks to Humans; World Health Organization; International Agency for Research on Cancer (2007). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=aGDU5xibtNgC&amp;pg=PA205"><i>Combined Estrogen-progestogen Contraceptives and Combined Estrogen-progestogen Menopausal Therapy</i></a>. World Health Organization. pp.&#160;205–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-92-832-1291-1" title="Special:BookSources/978-92-832-1291-1"><bdi>978-92-832-1291-1</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Combined+Estrogen-progestogen+Contraceptives+and+Combined+Estrogen-progestogen+Menopausal+Therapy&amp;rft.pages=205-&amp;rft.pub=World+Health+Organization&amp;rft.date=2007&amp;rft.isbn=978-92-832-1291-1&amp;rft.au=IARC+Working+Group+on+the+Evaluation+of+Carcinogenic+Risks+to+Humans&amp;rft.au=World+Health+Organization&amp;rft.au=International+Agency+for+Research+on+Cancer&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DaGDU5xibtNgC%26pg%3DPA205&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-JAMA-89"><span class="mw-cite-backlink">^ <a href="#cite_ref-JAMA_89-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-JAMA_89-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-JAMA_89-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFWriting_Group_for_the_Women&#39;s_Health_Initiative_Investigators2002" class="citation journal cs1">Writing Group for the Women's Health Initiative Investigators (2002). <a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjama.288.3.321">"Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial"</a>. <i><a href="/wiki/Journal_of_the_American_Medical_Association" class="mw-redirect" title="Journal of the American Medical Association">JAMA</a></i>. <b>288</b> (3): 321–333. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjama.288.3.321">10.1001/jama.288.3.321</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/12117397">12117397</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Risks+and+Benefits+of+Estrogen+Plus+Progestin+in+Healthy+Postmenopausal+Women%3A+Principal+Results+From+the+Women%27s+Health+Initiative+Randomized+Controlled+Trial&amp;rft.volume=288&amp;rft.issue=3&amp;rft.pages=321-333&amp;rft.date=2002&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.288.3.321&amp;rft_id=info%3Apmid%2F12117397&amp;rft.au=Writing+Group+for+the+Women%27s+Health+Initiative+Investigators&amp;rft_id=%2F%2Fdoi.org%2F10.1001%252Fjama.288.3.321&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid19196674-90"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19196674_90-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFChlebowskiKullerPrenticeStefanick2009" class="citation journal cs1">Chlebowski RT, Kuller LH, <a href="/wiki/Ross_Prentice" title="Ross Prentice">Prentice RL</a>, Stefanick ML, Manson JE, Gass M,  et&#160;al. (February 2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3963492">"Breast cancer after use of estrogen plus progestin in postmenopausal women"</a>. <i>The New England Journal of Medicine</i>. <b>360</b> (6): 573–87. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1056%2FNEJMoa0807684">10.1056/NEJMoa0807684</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3963492">3963492</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19196674">19196674</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=Breast+cancer+after+use+of+estrogen+plus+progestin+in+postmenopausal+women&amp;rft.volume=360&amp;rft.issue=6&amp;rft.pages=573-87&amp;rft.date=2009-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3963492%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F19196674&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa0807684&amp;rft.aulast=Chlebowski&amp;rft.aufirst=RT&amp;rft.au=Kuller%2C+LH&amp;rft.au=Prentice%2C+RL&amp;rft.au=Stefanick%2C+ML&amp;rft.au=Manson%2C+JE&amp;rft.au=Gass%2C+M&amp;rft.au=Aragaki%2C+AK&amp;rft.au=Ockene%2C+JK&amp;rft.au=Lane%2C+DS&amp;rft.au=Sarto%2C+GE&amp;rft.au=Rajkovic%2C+A&amp;rft.au=Schenken%2C+R&amp;rft.au=Hendrix%2C+SL&amp;rft.au=Ravdin%2C+PM&amp;rft.au=Rohan%2C+TE&amp;rft.au=Yasmeen%2C+S&amp;rft.au=Anderson%2C+G&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3963492&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-Krea2013-91"><span class="mw-cite-backlink"><b><a href="#cite_ref-Krea2013_91-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFKreatsoulasAnand2013" class="citation journal cs1">Kreatsoulas, C.; Anand, S. S. (2013). <a rel="nofollow" class="external text" href="http://pamw.pl/sites/default/files/PAMW_2013-3_Anand.pdf">"Menopausal hormone therapy for the primary prevention of chronic conditions. U.S. Preventive Services Task Force Recommendation Statement"</a> <span class="cs1-format">(PDF)</span>. <i>Polskie Archiwum Medycyny Wewnetrznej</i>. <b>123</b> (3): 112–117. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/23396275">23396275</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Polskie+Archiwum+Medycyny+Wewnetrznej&amp;rft.atitle=Menopausal+hormone+therapy+for+the+primary+prevention+of+chronic+conditions.+U.S.+Preventive+Services+Task+Force+Recommendation+Statement&amp;rft.volume=123&amp;rft.issue=3&amp;rft.pages=112-117&amp;rft.date=2013&amp;rft_id=info%3Apmid%2F23396275&amp;rft.aulast=Kreatsoulas&amp;rft.aufirst=C.&amp;rft.au=Anand%2C+S.+S.&amp;rft_id=http%3A%2F%2Fpamw.pl%2Fsites%2Fdefault%2Ffiles%2FPAMW_2013-3_Anand.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-ReferenceA-92"><span class="mw-cite-backlink"><b><a href="#cite_ref-ReferenceA_92-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFNelsonWalkerZakherMitchell2012" class="citation journal cs1">Nelson, H. D.; Walker, M.; Zakher, B.; Mitchell, J. (2012). <a rel="nofollow" class="external text" href="https://doi.org/10.7326%2F0003-4819-157-2-201207170-00466">"Menopausal hormone therapy for the primary prevention of chronic conditions: A systematic review to update the U.S. Preventive Services Task Force recommendations"</a>. <i>Annals of Internal Medicine</i>. <b>157</b> (2): 104–113. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.7326%2F0003-4819-157-2-201207170-00466">10.7326/0003-4819-157-2-201207170-00466</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/22786830">22786830</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Internal+Medicine&amp;rft.atitle=Menopausal+hormone+therapy+for+the+primary+prevention+of+chronic+conditions%3A+A+systematic+review+to+update+the+U.S.+Preventive+Services+Task+Force+recommendations&amp;rft.volume=157&amp;rft.issue=2&amp;rft.pages=104-113&amp;rft.date=2012&amp;rft_id=info%3Adoi%2F10.7326%2F0003-4819-157-2-201207170-00466&amp;rft_id=info%3Apmid%2F22786830&amp;rft.aulast=Nelson&amp;rft.aufirst=H.+D.&amp;rft.au=Walker%2C+M.&amp;rft.au=Zakher%2C+B.&amp;rft.au=Mitchell%2C+J.&amp;rft_id=%2F%2Fdoi.org%2F10.7326%252F0003-4819-157-2-201207170-00466&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-93"><span class="mw-cite-backlink"><b><a href="#cite_ref-93">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGeorge,_James_L.Colman,_Robert_W.Goldhaber,_Samuel_Z.Victor_J._Marder2006" class="citation book cs1">George, James L.; Colman, Robert W.; Goldhaber, Samuel Z.; Victor J. Marder (2006). <i>Hemostasis and thrombosis: basic principles and clinical practice</i>. Hagerstown, MD: Lippincott Williams &amp; Wilkins. pp.&#160;<a rel="nofollow" class="external text" href="https://books.google.com/books?id=Tz1V8BS5f–YC&amp;pg=PA1239">1239</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-7817-4996-1" title="Special:BookSources/978-0-7817-4996-1"><bdi>978-0-7817-4996-1</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Hemostasis+and+thrombosis%3A+basic+principles+and+clinical+practice&amp;rft.place=Hagerstown%2C+MD&amp;rft.pages=1239&amp;rft.pub=Lippincott+Williams+%26+Wilkins&amp;rft.date=2006&amp;rft.isbn=978-0-7817-4996-1&amp;rft.au=George%2C+James+L.&amp;rft.au=Colman%2C+Robert+W.&amp;rft.au=Goldhaber%2C+Samuel+Z.&amp;rft.au=Victor+J.+Marder&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid21117950-94"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid21117950_94-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDarabiAniPanjehpourRabbani2011" class="citation journal cs1">Darabi M, Ani M, Panjehpour M, Rabbani M, Movahedian A, Zarean E (2011). "Effect of estrogen receptor β A1730G polymorphism on ABCA1 gene expression response to postmenopausal hormone replacement therapy". <i>Genetic Testing and Molecular Biomarkers</i>. <b>15</b> (1–2): 11–5. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1089%2Fgtmb.2010.0106">10.1089/gtmb.2010.0106</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21117950">21117950</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Genetic+Testing+and+Molecular+Biomarkers&amp;rft.atitle=Effect+of+estrogen+receptor+%CE%B2+A1730G+polymorphism+on+ABCA1+gene+expression+response+to+postmenopausal+hormone+replacement+therapy&amp;rft.volume=15&amp;rft.issue=1%E2%80%932&amp;rft.pages=11-5&amp;rft.date=2011&amp;rft_id=info%3Adoi%2F10.1089%2Fgtmb.2010.0106&amp;rft_id=info%3Apmid%2F21117950&amp;rft.aulast=Darabi&amp;rft.aufirst=M&amp;rft.au=Ani%2C+M&amp;rft.au=Panjehpour%2C+M&amp;rft.au=Rabbani%2C+M&amp;rft.au=Movahedian%2C+A&amp;rft.au=Zarean%2C+E&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-ChlebowskiAnderson2015-95"><span class="mw-cite-backlink"><b><a href="#cite_ref-ChlebowskiAnderson2015_95-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFChlebowskiAnderson2015" class="citation journal cs1">Chlebowski, R. T.; Anderson, G. L. (2015). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4406918">"Menopausal hormone therapy and breast cancer mortality: clinical implications"</a>. <i>Therapeutic Advances in Drug Safety</i>. <b>6</b> (2): 45–56. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F2042098614568300">10.1177/2042098614568300</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/2042-0986">2042-0986</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4406918">4406918</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25922653">25922653</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Therapeutic+Advances+in+Drug+Safety&amp;rft.atitle=Menopausal+hormone+therapy+and+breast+cancer+mortality%3A+clinical+implications&amp;rft.volume=6&amp;rft.issue=2&amp;rft.pages=45-56&amp;rft.date=2015&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4406918%23id-name%3DPMC&amp;rft.issn=2042-0986&amp;rft_id=info%3Apmid%2F25922653&amp;rft_id=info%3Adoi%2F10.1177%2F2042098614568300&amp;rft.aulast=Chlebowski&amp;rft.aufirst=R.+T.&amp;rft.au=Anderson%2C+G.+L.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4406918&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-96"><span class="mw-cite-backlink"><b><a href="#cite_ref-96">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMazzuccoSantoroDeSotoLee2010" class="citation web cs1">Mazzucco AE, Santoro E, DeSoto M, Lee JH (December 2010). <a rel="nofollow" class="external text" href="http://www.center4research.org/hormone-therapy-menopause/">"Hormone Therapy and Menopause"</a>. <i>National Research Center for Women and Families</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=National+Research+Center+for+Women+and+Families&amp;rft.atitle=Hormone+Therapy+and+Menopause&amp;rft.date=2010-12&amp;rft.aulast=Mazzucco&amp;rft.aufirst=AE&amp;rft.au=Santoro%2C+E&amp;rft.au=DeSoto%2C+M&amp;rft.au=Lee%2C+JH&amp;rft_id=http%3A%2F%2Fwww.center4research.org%2Fhormone-therapy-menopause%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-97"><span class="mw-cite-backlink"><b><a href="#cite_ref-97">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGina_Kolata2007" class="citation news cs1">Gina Kolata (2007-04-19). <a rel="nofollow" class="external text" href="https://query.nytimes.com/gst/fullpage.html?res=9A03E6D91E3FF93AA25757C0A9619C8B63">"Sharp Drop in Rates of Breast Cancer Holds"</a>. <i>New York Times</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+York+Times&amp;rft.atitle=Sharp+Drop+in+Rates+of+Breast+Cancer+Holds&amp;rft.date=2007-04-19&amp;rft.au=Gina+Kolata&amp;rft_id=https%3A%2F%2Fquery.nytimes.com%2Fgst%2Ffullpage.html%3Fres%3D9A03E6D91E3FF93AA25757C0A9619C8B63&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-98"><span class="mw-cite-backlink"><b><a href="#cite_ref-98">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFRoni_Caryn_Rabin2007" class="citation news cs1">Roni Caryn Rabin (2007-08-28). <a rel="nofollow" class="external text" href="https://query.nytimes.com/gst/fullpage.html?res=9D03E6D91539F93BA1575BC0A9619C8B63&amp;sec=&amp;spon=&amp;pagewanted=1">"For a Low-Dose Hormone, Take Your Pick"</a>. <i>New York Times</i>. <q>Many women seeking natural remedies have turned to compounding pharmacies, which use bioidentical hormones that are chemically synthesized but with the same molecular structure as hormones produced by a woman's body.</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+York+Times&amp;rft.atitle=For+a+Low-Dose+Hormone%2C+Take+Your+Pick&amp;rft.date=2007-08-28&amp;rft.au=Roni+Caryn+Rabin&amp;rft_id=https%3A%2F%2Fquery.nytimes.com%2Fgst%2Ffullpage.html%3Fres%3D9D03E6D91539F93BA1575BC0A9619C8B63%26sec%3D%26spon%3D%26pagewanted%3D1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-99"><span class="mw-cite-backlink"><b><a href="#cite_ref-99">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFJohn_Gever2011" class="citation news cs1">John Gever (2011-04-05). <a rel="nofollow" class="external text" href="http://www.medpagetoday.com/OBGYN/HRT/25734">"New WHI Estrogen Analysis Shows Lower Breast Ca Risk"</a>. MedPageToday.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=New+WHI+Estrogen+Analysis+Shows+Lower+Breast+Ca+Risk&amp;rft.date=2011-04-05&amp;rft.au=John+Gever&amp;rft_id=http%3A%2F%2Fwww.medpagetoday.com%2FOBGYN%2FHRT%2F25734&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-100"><span class="mw-cite-backlink"><b><a href="#cite_ref-100">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSalpeterChengThabaneBuckley2009" class="citation journal cs1">Salpeter, S. R.; Cheng, J.; Thabane, L.; Buckley, N. S.; Salpeter, E. E. (2009). "Bayesian Meta-analysis of Hormone Therapy and Mortality in Younger Postmenopausal Women". <i>The American Journal of Medicine</i>. <b>122</b> (11): 1016–1022.e1. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.amjmed.2009.05.021">10.1016/j.amjmed.2009.05.021</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19854329">19854329</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+American+Journal+of+Medicine&amp;rft.atitle=Bayesian+Meta-analysis+of+Hormone+Therapy+and+Mortality+in+Younger+Postmenopausal+Women&amp;rft.volume=122&amp;rft.issue=11&amp;rft.pages=1016-1022.e1&amp;rft.date=2009&amp;rft_id=info%3Adoi%2F10.1016%2Fj.amjmed.2009.05.021&amp;rft_id=info%3Apmid%2F19854329&amp;rft.aulast=Salpeter&amp;rft.aufirst=S.+R.&amp;rft.au=Cheng%2C+J.&amp;rft.au=Thabane%2C+L.&amp;rft.au=Buckley%2C+N.+S.&amp;rft.au=Salpeter%2C+E.+E.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-101"><span class="mw-cite-backlink"><b><a href="#cite_ref-101">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFAndersonChlebowskiRossouwRodabough2006" class="citation journal cs1">Anderson, G. L.; Chlebowski, R. T.; Rossouw, J. E.; Rodabough, R. J.; McTiernan, A.; Margolis, K. L.; Aggerwal, A.; David Curb, J. D.; Hendrix, S. L.; Allan Hubbell, F. A.; Khandekar, J.; Lane, D. S.; Lasser, N.; Lopez, A. M.; Potter, J.; Ritenbaugh, C. (2006). "Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin". <i>Maturitas</i>. <b>55</b> (2): 103–115. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.maturitas.2006.05.004">10.1016/j.maturitas.2006.05.004</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/16815651">16815651</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Maturitas&amp;rft.atitle=Prior+hormone+therapy+and+breast+cancer+risk+in+the+Women%27s+Health+Initiative+randomized+trial+of+estrogen+plus+progestin&amp;rft.volume=55&amp;rft.issue=2&amp;rft.pages=103-115&amp;rft.date=2006&amp;rft_id=info%3Adoi%2F10.1016%2Fj.maturitas.2006.05.004&amp;rft_id=info%3Apmid%2F16815651&amp;rft.aulast=Anderson&amp;rft.aufirst=G.+L.&amp;rft.au=Chlebowski%2C+R.+T.&amp;rft.au=Rossouw%2C+J.+E.&amp;rft.au=Rodabough%2C+R.+J.&amp;rft.au=McTiernan%2C+A.&amp;rft.au=Margolis%2C+K.+L.&amp;rft.au=Aggerwal%2C+A.&amp;rft.au=David+Curb%2C+J.+D.&amp;rft.au=Hendrix%2C+S.+L.&amp;rft.au=Allan+Hubbell%2C+F.+A.&amp;rft.au=Khandekar%2C+J.&amp;rft.au=Lane%2C+D.+S.&amp;rft.au=Lasser%2C+N.&amp;rft.au=Lopez%2C+A.+M.&amp;rft.au=Potter%2C+J.&amp;rft.au=Ritenbaugh%2C+C.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-102"><span class="mw-cite-backlink"><b><a href="#cite_ref-102">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFHulleyGradyBushFurberg1998" class="citation journal cs1">Hulley, S.; Grady, D.; Bush, T.; Furberg, C.; Herrington, D.; Riggs, B.; Vittinghoff, E. (1998). <a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjama.280.7.605">"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group"</a>. <i>JAMA: The Journal of the American Medical Association</i>. <b>280</b> (7): 605–613. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjama.280.7.605">10.1001/jama.280.7.605</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/9718051">9718051</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA%3A+The+Journal+of+the+American+Medical+Association&amp;rft.atitle=Randomized+trial+of+estrogen+plus+progestin+for+secondary+prevention+of+coronary+heart+disease+in+postmenopausal+women.+Heart+and+Estrogen%2Fprogestin+Replacement+Study+%28HERS%29+Research+Group&amp;rft.volume=280&amp;rft.issue=7&amp;rft.pages=605-613&amp;rft.date=1998&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.280.7.605&amp;rft_id=info%3Apmid%2F9718051&amp;rft.aulast=Hulley&amp;rft.aufirst=S.&amp;rft.au=Grady%2C+D.&amp;rft.au=Bush%2C+T.&amp;rft.au=Furberg%2C+C.&amp;rft.au=Herrington%2C+D.&amp;rft.au=Riggs%2C+B.&amp;rft.au=Vittinghoff%2C+E.&amp;rft_id=%2F%2Fdoi.org%2F10.1001%252Fjama.280.7.605&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-103"><span class="mw-cite-backlink"><b><a href="#cite_ref-103">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSalpeterWalshGreyberOrmiston2004" class="citation journal cs1">Salpeter, S. R.; Walsh, J. M. E.; Greyber, E.; Ormiston, T. M.; Salpeter, E. E. (2004). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1492478">"Mortality associated with hormone replacement therapy in younger and older women"</a>. <i>Journal of General Internal Medicine</i>. <b>19</b> (7): 791–804. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1525-1497.2004.30281.x">10.1111/j.1525-1497.2004.30281.x</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1492478">1492478</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/15209595">15209595</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+General+Internal+Medicine&amp;rft.atitle=Mortality+associated+with+hormone+replacement+therapy+in+younger+and+older+women&amp;rft.volume=19&amp;rft.issue=7&amp;rft.pages=791-804&amp;rft.date=2004&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1492478%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F15209595&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1525-1497.2004.30281.x&amp;rft.aulast=Salpeter&amp;rft.aufirst=S.+R.&amp;rft.au=Walsh%2C+J.+M.+E.&amp;rft.au=Greyber%2C+E.&amp;rft.au=Ormiston%2C+T.+M.&amp;rft.au=Salpeter%2C+E.+E.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1492478&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-104"><span class="mw-cite-backlink"><b><a href="#cite_ref-104">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGrodsteinStampferColditzWillett1997" class="citation journal cs1">Grodstein, F.; Stampfer, M. J.; Colditz, G. A.; Willett, W. C.; Manson, J. E.; Joffe, M.; Rosner, B.; Fuchs, C.; Hankinson, S. E.; Hunter, D. J.; Hennekens, C. H.; Speizer, F. E. (1997). "Postmenopausal Hormone Therapy and Mortality". <i>New England Journal of Medicine</i>. <b>336</b> (25): 1769–1775. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1056%2FNEJM199706193362501">10.1056/NEJM199706193362501</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/9187066">9187066</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+England+Journal+of+Medicine&amp;rft.atitle=Postmenopausal+Hormone+Therapy+and+Mortality&amp;rft.volume=336&amp;rft.issue=25&amp;rft.pages=1769-1775&amp;rft.date=1997&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM199706193362501&amp;rft_id=info%3Apmid%2F9187066&amp;rft.aulast=Grodstein&amp;rft.aufirst=F.&amp;rft.au=Stampfer%2C+M.+J.&amp;rft.au=Colditz%2C+G.+A.&amp;rft.au=Willett%2C+W.+C.&amp;rft.au=Manson%2C+J.+E.&amp;rft.au=Joffe%2C+M.&amp;rft.au=Rosner%2C+B.&amp;rft.au=Fuchs%2C+C.&amp;rft.au=Hankinson%2C+S.+E.&amp;rft.au=Hunter%2C+D.+J.&amp;rft.au=Hennekens%2C+C.+H.&amp;rft.au=Speizer%2C+F.+E.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-105"><span class="mw-cite-backlink"><b><a href="#cite_ref-105">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBethea_CL2011" class="citation journal cs1">Bethea CL (Feb 2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3037166">"MPA: Medroxy-Progesterone Acetate Contributes to Much Poor Advice for Women"</a>. <i>Endocrinology</i>. <b>152</b> (2): 343–345. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fen.2010-1376">10.1210/en.2010-1376</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3037166">3037166</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21252179">21252179</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Endocrinology&amp;rft.atitle=MPA%3A+Medroxy-Progesterone+Acetate+Contributes+to+Much+Poor+Advice+for+Women&amp;rft.volume=152&amp;rft.issue=2&amp;rft.pages=343-345&amp;rft.date=2011-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3037166%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21252179&amp;rft_id=info%3Adoi%2F10.1210%2Fen.2010-1376&amp;rft.au=Bethea+CL&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3037166&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-106"><span class="mw-cite-backlink"><b><a href="#cite_ref-106">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFHarmanBrintonCedarsLobo2005" class="citation journal cs1">Harman SM, Brinton EA, Cedars M, Lobo R, Manson JE, Merriam GR, Miller VM, Naftolin F, Santoro N (March 2005). "KEEPS: The Kronos Early Estrogen Prevention Study". <i>Climacteric</i>. <b>8</b> (1): 3–12. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F13697130500042417">10.1080/13697130500042417</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/15804727">15804727</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:37219662">37219662</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Climacteric&amp;rft.atitle=KEEPS%3A+The+Kronos+Early+Estrogen+Prevention+Study&amp;rft.volume=8&amp;rft.issue=1&amp;rft.pages=3-12&amp;rft.date=2005-03&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A37219662%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15804727&amp;rft_id=info%3Adoi%2F10.1080%2F13697130500042417&amp;rft.aulast=Harman&amp;rft.aufirst=SM&amp;rft.au=Brinton%2C+EA&amp;rft.au=Cedars%2C+M&amp;rft.au=Lobo%2C+R&amp;rft.au=Manson%2C+JE&amp;rft.au=Merriam%2C+GR&amp;rft.au=Miller%2C+VM&amp;rft.au=Naftolin%2C+F&amp;rft.au=Santoro%2C+N&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid12730248-107"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid12730248_107-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMorleyPerry2003" class="citation journal cs1">Morley JE, Perry HM (May 2003). <a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fgerona%2F58.5.M409">"Androgens and women at the menopause and beyond"</a>. <i>J. Gerontol. A Biol. Sci. Med. Sci</i>. <b>58</b> (5): M409–16. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fgerona%2F58.5.M409">10.1093/gerona/58.5.M409</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/12730248">12730248</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Gerontol.+A+Biol.+Sci.+Med.+Sci.&amp;rft.atitle=Androgens+and+women+at+the+menopause+and+beyond&amp;rft.volume=58&amp;rft.issue=5&amp;rft.pages=M409-16&amp;rft.date=2003-05&amp;rft_id=info%3Adoi%2F10.1093%2Fgerona%2F58.5.M409&amp;rft_id=info%3Apmid%2F12730248&amp;rft.aulast=Morley&amp;rft.aufirst=JE&amp;rft.au=Perry%2C+HM&amp;rft_id=%2F%2Fdoi.org%2F10.1093%252Fgerona%252F58.5.M409&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid18488873-108"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18488873_108-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGarefalakisHickey2008" class="citation journal cs1">Garefalakis M, Hickey M (2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2544356">"Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidence"</a>. <i>Clin Interv Aging</i>. <b>3</b> (1): 1–8. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2147%2FCIA.S1043">10.2147/CIA.S1043</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2544356">2544356</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18488873">18488873</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin+Interv+Aging&amp;rft.atitle=Role+of+androgens%2C+progestins+and+tibolone+in+the+treatment+of+menopausal+symptoms%3A+a+review+of+the+clinical+evidence&amp;rft.volume=3&amp;rft.issue=1&amp;rft.pages=1-8&amp;rft.date=2008&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2544356%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F18488873&amp;rft_id=info%3Adoi%2F10.2147%2FCIA.S1043&amp;rft.aulast=Garefalakis&amp;rft.aufirst=M&amp;rft.au=Hickey%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2544356&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-Formoso-109"><span class="mw-cite-backlink"><b><a href="#cite_ref-Formoso_109-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFFormosoPerroneMaltoniBalduzzi2016" class="citation journal cs1">Formoso, G; Perrone, E; Maltoni, S; Balduzzi, S; Wilkinson, J; Basevi, V; Marata, AM; Magrini, N; D'Amico, R; Bassi, C; Maestri, E (12 October 2016). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6458045">"Short-term and long-term effects of tibolone in postmenopausal women"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>10</b>: CD008536. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD008536.pub3">10.1002/14651858.CD008536.pub3</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1469-493X">1469-493X</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6458045">6458045</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/27733017">27733017</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Short-term+and+long-term+effects+of+tibolone+in+postmenopausal+women.&amp;rft.volume=10&amp;rft.pages=CD008536&amp;rft.date=2016-10-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6458045%23id-name%3DPMC&amp;rft.issn=1469-493X&amp;rft_id=info%3Apmid%2F27733017&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD008536.pub3&amp;rft.aulast=Formoso&amp;rft.aufirst=G&amp;rft.au=Perrone%2C+E&amp;rft.au=Maltoni%2C+S&amp;rft.au=Balduzzi%2C+S&amp;rft.au=Wilkinson%2C+J&amp;rft.au=Basevi%2C+V&amp;rft.au=Marata%2C+AM&amp;rft.au=Magrini%2C+N&amp;rft.au=D%27Amico%2C+R&amp;rft.au=Bassi%2C+C&amp;rft.au=Maestri%2C+E&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6458045&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-110"><span class="mw-cite-backlink"><b><a href="#cite_ref-110">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFCummingsEttingerDelmasKenemans2008" class="citation journal cs1">Cummings, SR; Ettinger, B; Delmas, PD; Kenemans, P; Stathopoulos, V; Verweij, P; Mol-Arts, M; Kloosterboer, L; Mosca, L; Christiansen, C; Bilezikian, J; Kerzberg, EM; Johnson, S; Zanchetta, J; Grobbee, DE; Seifert, W; Eastell, R; LIFT Trial, Investigators. (14 August 2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3684062">"The effects of tibolone in older postmenopausal women"</a>. <i>The New England Journal of Medicine</i>. <b>359</b> (7): 697–708. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1056%2FNEJMoa0800743">10.1056/NEJMoa0800743</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3684062">3684062</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18703472">18703472</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=The+effects+of+tibolone+in+older+postmenopausal+women.&amp;rft.volume=359&amp;rft.issue=7&amp;rft.pages=697-708&amp;rft.date=2008-08-14&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3684062%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F18703472&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa0800743&amp;rft.aulast=Cummings&amp;rft.aufirst=SR&amp;rft.au=Ettinger%2C+B&amp;rft.au=Delmas%2C+PD&amp;rft.au=Kenemans%2C+P&amp;rft.au=Stathopoulos%2C+V&amp;rft.au=Verweij%2C+P&amp;rft.au=Mol-Arts%2C+M&amp;rft.au=Kloosterboer%2C+L&amp;rft.au=Mosca%2C+L&amp;rft.au=Christiansen%2C+C&amp;rft.au=Bilezikian%2C+J&amp;rft.au=Kerzberg%2C+EM&amp;rft.au=Johnson%2C+S&amp;rft.au=Zanchetta%2C+J&amp;rft.au=Grobbee%2C+DE&amp;rft.au=Seifert%2C+W&amp;rft.au=Eastell%2C+R&amp;rft.au=LIFT+Trial%2C+Investigators.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3684062&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-mayo2011-111"><span class="mw-cite-backlink"><b><a href="#cite_ref-mayo2011_111-0">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.mayoclinic.com/health/drug-information/DR602127">Estrogen (Vaginal Route)</a> from Mayo Clinic / Thomson Healthcare Inc. Portions of this document last updated: Nov. 1, 2011</span>
</li>
<li id="cite_note-112"><span class="mw-cite-backlink"><b><a href="#cite_ref-112">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSomboonpornDavisSeifBell2005" class="citation journal cs1">Somboonporn, W; Davis, S; Seif, MW; Bell, R (19 October 2005). <a rel="nofollow" class="external text" href="https://semanticscholar.org/paper/61d86a4f71f51c54e66a8621da7a5c3aed31bc9f">"Testosterone for peri- and postmenopausal women"</a>. <i>The Cochrane Database of Systematic Reviews</i> (4): CD004509. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD004509.pub2">10.1002/14651858.CD004509.pub2</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/16235365">16235365</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:21619940">21619940</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Testosterone+for+peri-+and+postmenopausal+women.&amp;rft.issue=4&amp;rft.pages=CD004509&amp;rft.date=2005-10-19&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A21619940%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F16235365&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD004509.pub2&amp;rft.aulast=Somboonporn&amp;rft.aufirst=W&amp;rft.au=Davis%2C+S&amp;rft.au=Seif%2C+MW&amp;rft.au=Bell%2C+R&amp;rft_id=https%3A%2F%2Fsemanticscholar.org%2Fpaper%2F61d86a4f71f51c54e66a8621da7a5c3aed31bc9f&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-113"><span class="mw-cite-backlink"><b><a href="#cite_ref-113">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFNorth_American_Menopause2005" class="citation journal cs1">North American Menopause, Society. (2005). <a rel="nofollow" class="external text" href="https://semanticscholar.org/paper/5a4d908cac38d7b4c3fe66023314c1e0ee913d8e">"The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society"</a>. <i>Menopause</i>. <b>12</b> (5): 496–511, quiz 649. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2F01.gme.0000177709.65944.b0">10.1097/01.gme.0000177709.65944.b0</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/16145303">16145303</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:5122078">5122078</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Menopause&amp;rft.atitle=The+role+of+testosterone+therapy+in+postmenopausal+women%3A+position+statement+of+The+North+American+Menopause+Society.&amp;rft.volume=12&amp;rft.issue=5&amp;rft.pages=496-511%2C+quiz+649&amp;rft.date=2005&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A5122078%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F16145303&amp;rft_id=info%3Adoi%2F10.1097%2F01.gme.0000177709.65944.b0&amp;rft.aulast=North+American+Menopause&amp;rft.aufirst=Society.&amp;rft_id=https%3A%2F%2Fsemanticscholar.org%2Fpaper%2F5a4d908cac38d7b4c3fe66023314c1e0ee913d8e&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-114"><span class="mw-cite-backlink"><b><a href="#cite_ref-114">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDrapier-FaureAzoulayAbramovici2005" class="citation journal cs1">Drapier-Faure, E; Azoulay, C; Abramovici, Y (July 2005). "[Acceptability of continuous combined versus cyclical HRT: a French multicentric randomized clinical study]". <i>Gynécologie, obstétrique &amp; fertilité</i>. <b>33</b> (7–8): 498–504. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.gyobfe.2005.04.024">10.1016/j.gyobfe.2005.04.024</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/16005674">16005674</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Gyn%C3%A9cologie%2C+obst%C3%A9trique+%26+fertilit%C3%A9&amp;rft.atitle=%5BAcceptability+of+continuous+combined+versus+cyclical+HRT%3A+a+French+multicentric+randomized+clinical+study%5D.&amp;rft.volume=33&amp;rft.issue=7%E2%80%938&amp;rft.pages=498-504&amp;rft.date=2005-07&amp;rft_id=info%3Adoi%2F10.1016%2Fj.gyobfe.2005.04.024&amp;rft_id=info%3Apmid%2F16005674&amp;rft.aulast=Drapier-Faure&amp;rft.aufirst=E&amp;rft.au=Azoulay%2C+C&amp;rft.au=Abramovici%2C+Y&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-115"><span class="mw-cite-backlink"><b><a href="#cite_ref-115">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFFeeleyWells2001" class="citation journal cs1">Feeley, KM; Wells, M (June 2001). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1731456">"Hormone replacement therapy and the endometrium"</a>. <i>Journal of Clinical Pathology</i>. <b>54</b> (6): 435–40. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjcp.54.6.435">10.1136/jcp.54.6.435</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1731456">1731456</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/11376015">11376015</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Clinical+Pathology&amp;rft.atitle=Hormone+replacement+therapy+and+the+endometrium.&amp;rft.volume=54&amp;rft.issue=6&amp;rft.pages=435-40&amp;rft.date=2001-06&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1731456%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F11376015&amp;rft_id=info%3Adoi%2F10.1136%2Fjcp.54.6.435&amp;rft.aulast=Feeley&amp;rft.aufirst=KM&amp;rft.au=Wells%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1731456&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-116"><span class="mw-cite-backlink"><b><a href="#cite_ref-116">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFJunkermannvon_HolstLangRakov2005" class="citation journal cs1">Junkermann, H; von Holst, T; Lang, E; Rakov, V (14 February 2005). "Influence of different HRT regimens on mammographic density". <i>Maturitas</i>. <b>50</b> (2): 105–10. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.maturitas.2004.04.008">10.1016/j.maturitas.2004.04.008</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/15653007">15653007</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Maturitas&amp;rft.atitle=Influence+of+different+HRT+regimens+on+mammographic+density.&amp;rft.volume=50&amp;rft.issue=2&amp;rft.pages=105-10&amp;rft.date=2005-02-14&amp;rft_id=info%3Adoi%2F10.1016%2Fj.maturitas.2004.04.008&amp;rft_id=info%3Apmid%2F15653007&amp;rft.aulast=Junkermann&amp;rft.aufirst=H&amp;rft.au=von+Holst%2C+T&amp;rft.au=Lang%2C+E&amp;rft.au=Rakov%2C+V&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-ReferenceB-117"><span class="mw-cite-backlink">^ <a href="#cite_ref-ReferenceB_117-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ReferenceB_117-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBeckAndersonKirk2017" class="citation journal cs1">Beck, KL; Anderson, MC; Kirk, JK (August 2017). "Transdermal estrogens in the changing landscape of hormone replacement therapy". <i>Postgraduate Medicine</i>. <b>129</b> (6): 632–636. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F00325481.2017.1334507">10.1080/00325481.2017.1334507</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28540770">28540770</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:205452835">205452835</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Postgraduate+Medicine&amp;rft.atitle=Transdermal+estrogens+in+the+changing+landscape+of+hormone+replacement+therapy.&amp;rft.volume=129&amp;rft.issue=6&amp;rft.pages=632-636&amp;rft.date=2017-08&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A205452835%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F28540770&amp;rft_id=info%3Adoi%2F10.1080%2F00325481.2017.1334507&amp;rft.aulast=Beck&amp;rft.aufirst=KL&amp;rft.au=Anderson%2C+MC&amp;rft.au=Kirk%2C+JK&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-MartinBarbieri2021-118"><span class="mw-cite-backlink"><b><a href="#cite_ref-MartinBarbieri2021_118-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMartinBarbieriCrowley_Jr.2021" class="citation web cs1">Martin, K. A.; Barbieri, R. L.; Crowley Jr., W. F. (September 24, 2021). <a rel="nofollow" class="external text" href="https://www.uptodate.com/contents/preparations-for-menopausal-hormone-therapy">"Preparations for menopausal hormone therapy"</a>. <i>UpToDate</i>. UpToDate<span class="reference-accessdate">. Retrieved <span class="nowrap">February 2,</span> 2022</span>. <q>Not recommended. Depot estrogen — Estrogen is also available in some, but not all, countries as long-acting (three to four weeks) injections of either estradiol cypionate or estradiol valerate. Given the other effective estrogen options, we do not use this approach (table 1).</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=UpToDate&amp;rft.atitle=Preparations+for+menopausal+hormone+therapy&amp;rft.date=2021-09-24&amp;rft.aulast=Martin&amp;rft.aufirst=K.+A.&amp;rft.au=Barbieri%2C+R.+L.&amp;rft.au=Crowley+Jr.%2C+W.+F.&amp;rft_id=https%3A%2F%2Fwww.uptodate.com%2Fcontents%2Fpreparations-for-menopausal-hormone-therapy&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-FDA2008-119"><span class="mw-cite-backlink">^ <a href="#cite_ref-FDA2008_119-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FDA2008_119-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116832.htm">"FDA Takes Action Against Compounded Menopause Hormone Therapy Drugs"</a>. <a href="/wiki/Food_and_Drug_Administration_(United_States)" class="mw-redirect" title="Food and Drug Administration (United States)">FDA</a>. 2008-01-09<span class="reference-accessdate">. Retrieved <span class="nowrap">2009-02-17</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA+Takes+Action+Against+Compounded+Menopause+Hormone+Therapy+Drugs&amp;rft.pub=FDA&amp;rft.date=2008-01-09&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2FNewsEvents%2FNewsroom%2FPressAnnouncements%2F2008%2Fucm116832.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-120"><span class="mw-cite-backlink"><b><a href="#cite_ref-120">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFCirigliano2007" class="citation journal cs1">Cirigliano, M (June 2007). "Bioidentical hormone therapy: a review of the evidence". <i>Journal of Women's Health</i>. <b>16</b> (5): 600–31. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1089%2Fjwh.2006.0311">10.1089/jwh.2006.0311</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/17627398">17627398</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Women%27s+Health&amp;rft.atitle=Bioidentical+hormone+therapy%3A+a+review+of+the+evidence.&amp;rft.volume=16&amp;rft.issue=5&amp;rft.pages=600-31&amp;rft.date=2007-06&amp;rft_id=info%3Adoi%2F10.1089%2Fjwh.2006.0311&amp;rft_id=info%3Apmid%2F17627398&amp;rft.aulast=Cirigliano&amp;rft.aufirst=M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid24398406-121"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid24398406_121-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSimon2014" class="citation journal cs1">Simon JA (July 2014). "What if the Women's Health Initiative had used transdermal estradiol and oral progesterone instead?". <i>Menopause</i>. <b>21</b> (7): 769–83. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FGME.0000000000000169">10.1097/GME.0000000000000169</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24398406">24398406</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:30292136">30292136</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Menopause&amp;rft.atitle=What+if+the+Women%27s+Health+Initiative+had+used+transdermal+estradiol+and+oral+progesterone+instead%3F&amp;rft.volume=21&amp;rft.issue=7&amp;rft.pages=769-83&amp;rft.date=2014-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A30292136%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F24398406&amp;rft_id=info%3Adoi%2F10.1097%2FGME.0000000000000169&amp;rft.aulast=Simon&amp;rft.aufirst=JA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-122"><span class="mw-cite-backlink"><b><a href="#cite_ref-122">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFPinkertonPickar2016" class="citation journal cs1">Pinkerton, JV; Pickar, JH (February 2016). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4927324">"Update on medical and regulatory issues pertaining to compounded and FDA-approved drugs, including hormone therapy"</a>. <i>Menopause</i>. <b>23</b> (2): 215–23. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FGME.0000000000000523">10.1097/GME.0000000000000523</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4927324">4927324</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26418479">26418479</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Menopause&amp;rft.atitle=Update+on+medical+and+regulatory+issues+pertaining+to+compounded+and+FDA-approved+drugs%2C+including+hormone+therapy.&amp;rft.volume=23&amp;rft.issue=2&amp;rft.pages=215-23&amp;rft.date=2016-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4927324%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26418479&amp;rft_id=info%3Adoi%2F10.1097%2FGME.0000000000000523&amp;rft.aulast=Pinkerton&amp;rft.aufirst=JV&amp;rft.au=Pickar%2C+JH&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4927324&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-123"><span class="mw-cite-backlink"><b><a href="#cite_ref-123">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFPinkertonPickar2016" class="citation journal cs1">Pinkerton, JV; Pickar, JH (February 2016). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4927324">"Update on medical and regulatory issues pertaining to compounded and FDA-approved drugs, including hormone therapy"</a>. <i>Menopause</i>. <b>23</b> (2): 215–23. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FGME.0000000000000523">10.1097/GME.0000000000000523</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4927324">4927324</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26418479">26418479</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Menopause&amp;rft.atitle=Update+on+medical+and+regulatory+issues+pertaining+to+compounded+and+FDA-approved+drugs%2C+including+hormone+therapy.&amp;rft.volume=23&amp;rft.issue=2&amp;rft.pages=215-23&amp;rft.date=2016-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4927324%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26418479&amp;rft_id=info%3Adoi%2F10.1097%2FGME.0000000000000523&amp;rft.aulast=Pinkerton&amp;rft.aufirst=JV&amp;rft.au=Pickar%2C+JH&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4927324&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-Singer2009-124"><span class="mw-cite-backlink">^ <a href="#cite_ref-Singer2009_124-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Singer2009_124-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Singer2009_124-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Singer2009_124-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSinger2009" class="citation news cs1">Singer, Natasha (4 August 2009). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2009/08/05/health/research/05ghost.html">"Medical Papers by Ghostwriters Pushed Therapy"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">13 July</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Medical+Papers+by+Ghostwriters+Pushed+Therapy&amp;rft.date=2009-08-04&amp;rft.aulast=Singer&amp;rft.aufirst=Natasha&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2009%2F08%2F05%2Fhealth%2Fresearch%2F05ghost.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid20838656-125"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid20838656_125-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid20838656_125-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid20838656_125-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid20838656_125-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid20838656_125-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid20838656_125-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFFugh-Berman2010" class="citation journal cs1">Fugh-Berman AJ (September 2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2935455">"The haunting of medical journals: how ghostwriting sold "HRT"<span class="cs1-kern-right"></span>"</a>. <i>PLOS Med</i>. <b>7</b> (9): e1000335. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1371%2Fjournal.pmed.1000335">10.1371/journal.pmed.1000335</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2935455">2935455</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20838656">20838656</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLOS+Med.&amp;rft.atitle=The+haunting+of+medical+journals%3A+how+ghostwriting+sold+%22HRT%22&amp;rft.volume=7&amp;rft.issue=9&amp;rft.pages=e1000335&amp;rft.date=2010-09&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2935455%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F20838656&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pmed.1000335&amp;rft.aulast=Fugh-Berman&amp;rft.aufirst=AJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2935455&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-MayMay2012-126"><span class="mw-cite-backlink">^ <a href="#cite_ref-MayMay2012_126-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MayMay2012_126-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-MayMay2012_126-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-MayMay2012_126-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-MayMay2012_126-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-MayMay2012_126-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-MayMay2012_126-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSteve_Kent_MaySteve_May2012" class="citation book cs1">Steve Kent May; Steve May (20 January 2012). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=g7hduew1u1IC&amp;pg=PA197"><i>Case Studies in Organizational Communication: Ethical Perspectives and Practices: Ethical Perspectives and Practices</i></a>. SAGE. pp.&#160;197–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-4129-8309-9" title="Special:BookSources/978-1-4129-8309-9"><bdi>978-1-4129-8309-9</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Case+Studies+in+Organizational+Communication%3A+Ethical+Perspectives+and+Practices%3A+Ethical+Perspectives+and+Practices&amp;rft.pages=197-&amp;rft.pub=SAGE&amp;rft.date=2012-01-20&amp;rft.isbn=978-1-4129-8309-9&amp;rft.au=Steve+Kent+May&amp;rft.au=Steve+May&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3Dg7hduew1u1IC%26pg%3DPA197&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid28801526-127"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid28801526_127-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid28801526_127-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMillerHarman2017" class="citation journal cs1">Miller VM, Harman SM (November 2017). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5792205">"An update on hormone therapy in postmenopausal women: mini-review for the basic scientist"</a>. <i>Am. J. Physiol. Heart Circ. Physiol</i>. <b>313</b> (5): H1013–H1021. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1152%2Fajpheart.00383.2017">10.1152/ajpheart.00383.2017</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5792205">5792205</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28801526">28801526</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Am.+J.+Physiol.+Heart+Circ.+Physiol.&amp;rft.atitle=An+update+on+hormone+therapy+in+postmenopausal+women%3A+mini-review+for+the+basic+scientist&amp;rft.volume=313&amp;rft.issue=5&amp;rft.pages=H1013-H1021&amp;rft.date=2017-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5792205%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28801526&amp;rft_id=info%3Adoi%2F10.1152%2Fajpheart.00383.2017&amp;rft.aulast=Miller&amp;rft.aufirst=VM&amp;rft.au=Harman%2C+SM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5792205&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-SorkinWilson2009-128"><span class="mw-cite-backlink"><b><a href="#cite_ref-SorkinWilson2009_128-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSorkinWilson2009" class="citation news cs1">Sorkin, Andrew Ross; Wilson, Duff (2009-01-25). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2009/01/26/business/26drug.html">"Pfizer Agrees to Pay $68 Billion for Rival Drug Maker Wyeth"</a>. <i>The New York Times</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer+Agrees+to+Pay+%2468+Billion+for+Rival+Drug+Maker+Wyeth&amp;rft.date=2009-01-25&amp;rft.aulast=Sorkin&amp;rft.aufirst=Andrew+Ross&amp;rft.au=Wilson%2C+Duff&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2009%2F01%2F26%2Fbusiness%2F26drug.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-Chiang2009-129"><span class="mw-cite-backlink"><b><a href="#cite_ref-Chiang2009_129-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.cnbc.com/id/33384753">"Pfizer Sizes Up: Closes $68B Wyeth Deal"</a>. 2009-10-19.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Sizes+Up%3A+Closes+%2468B+Wyeth+Deal&amp;rft.date=2009-10-19&amp;rft_id=https%3A%2F%2Fwww.cnbc.com%2Fid%2F33384753&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid21949743-130"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid21949743_130-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFTaoTengShaoWu2011" class="citation journal cs1">Tao M, Teng Y, Shao H, Wu P, Mills EJ (2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3174976">"Knowledge, perceptions and information about hormone therapy (HT) among menopausal women: a systematic review and meta-synthesis"</a>. <i>PLOS ONE</i>. <b>6</b> (9): e24661. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2011PLoSO...624661T">2011PLoSO...624661T</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1371%2Fjournal.pone.0024661">10.1371/journal.pone.0024661</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3174976">3174976</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21949743">21949743</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLOS+ONE&amp;rft.atitle=Knowledge%2C+perceptions+and+information+about+hormone+therapy+%28HT%29+among+menopausal+women%3A+a+systematic+review+and+meta-synthesis&amp;rft.volume=6&amp;rft.issue=9&amp;rft.pages=e24661&amp;rft.date=2011&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3174976%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21949743&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0024661&amp;rft_id=info%3Abibcode%2F2011PLoSO...624661T&amp;rft.aulast=Tao&amp;rft.aufirst=M&amp;rft.au=Teng%2C+Y&amp;rft.au=Shao%2C+H&amp;rft.au=Wu%2C+P&amp;rft.au=Mills%2C+EJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3174976&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-131"><span class="mw-cite-backlink"><b><a href="#cite_ref-131">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.sciencedaily.com/releases/2016/07/160720215141.htm">"Hormone therapy for brain performance: No effect, whether started early or late"</a>. <i>www.sciencedaily.com</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.sciencedaily.com&amp;rft.atitle=Hormone+therapy+for+brain+performance%3A+No+effect%2C+whether+started+early+or+late&amp;rft_id=https%3A%2F%2Fwww.sciencedaily.com%2Freleases%2F2016%2F07%2F160720215141.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
<li id="cite_note-132"><span class="mw-cite-backlink"><b><a href="#cite_ref-132">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDaviesHamodaBritish_Menopause_Society_Medical_Advisory2019" class="citation journal cs1">Davies, M; Hamoda, H; British Menopause Society Medical Advisory, Council. (11 February 2019). "Hormone replacement therapy: changes in prescribing practice". <i>BMJ (Clinical Research Ed.)</i>. <b>364</b>: l633. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fbmj.l633">10.1136/bmj.l633</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/30745316">30745316</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:73435897">73435897</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMJ+%28Clinical+Research+Ed.%29&amp;rft.atitle=Hormone+replacement+therapy%3A+changes+in+prescribing+practice.&amp;rft.volume=364&amp;rft.pages=l633&amp;rft.date=2019-02-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A73435897%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F30745316&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.l633&amp;rft.aulast=Davies&amp;rft.aufirst=M&amp;rft.au=Hamoda%2C+H&amp;rft.au=British+Menopause+Society+Medical+Advisory%2C+Council.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHormone+replacement+therapy" class="Z3988"></span></span>
</li>
</ol></div></div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hormone_replacement_therapy&amp;action=edit&amp;section=33" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul><li><a rel="nofollow" class="external text" href="https://www.hormone.org/diseases-and-conditions/womens-health/menopause/menopause-treatment">Menopause treatment</a>, Hormone Health Network, The Endocrine Society</li>
<li><a rel="nofollow" class="external text" href="http://www.menopause.org/">Sexual Health and Menopause Online</a>, The North American Menopause Society</li>
<li><a rel="nofollow" class="external text" href="https://www.fda.gov/ForConsumers/ByAudience/ForWomen/WomensHealthTopics/ucm117978.htm">Menopause</a>, US Food and Drug Administration</li></ul>
<div class="navbox-styles nomobile"><style data-mw-deduplicate="TemplateStyles:r1061467846">.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}</style></div><div role="navigation" class="navbox" aria-labelledby="Estradiol" style="padding:3px"><table class="nowraplinks mw-collapsible expanded navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1063604349"/><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Estradiol" title="Template:Estradiol"><abbr title="View this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Estradiol" title="Template talk:Estradiol"><abbr title="Discuss this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">t</abbr></a></li><li class="nv-edit"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Template:Estradiol&amp;action=edit"><abbr title="Edit this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">e</abbr></a></li></ul></div><div id="Estradiol" style="font-size:114%;margin:0 4em"><a href="/wiki/Estradiol" title="Estradiol">Estradiol</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Topics</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Estradiol" title="Estradiol">Estradiol (as a hormone)</a></li>
<li><a href="/wiki/Estradiol_(medication)" title="Estradiol (medication)">Estradiol (as a medication)</a></li>
<li><a href="/wiki/Pharmacodynamics_of_estradiol" title="Pharmacodynamics of estradiol">Pharmacodynamics of estradiol</a></li>
<li><a href="/wiki/Pharmacokinetics_of_estradiol" title="Pharmacokinetics of estradiol">Pharmacokinetics of estradiol</a></li>
<li><a href="/wiki/Estrogen" title="Estrogen">Estrogen (as a hormone)</a></li>
<li><a href="/wiki/Estrogen_(medication)" title="Estrogen (medication)">Estrogen (as a medication)</a></li>
<li><a class="mw-selflink selflink">Menopausal hormone therapy</a></li>
<li><a href="/wiki/Feminizing_hormone_therapy" title="Feminizing hormone therapy">Feminizing hormone therapy</a></li>
<li><a href="/wiki/Estradiol-containing_birth_control_pill" title="Estradiol-containing birth control pill">Estradiol-containing birth control pill</a></li>
<li><a href="/wiki/Combined_injectable_birth_control" title="Combined injectable birth control">Combined injectable birth control</a></li>
<li><a href="/wiki/High-dose_estrogen" title="High-dose estrogen">High-dose estrogen</a></li>
<li><a href="/wiki/Hydroxylation_of_estradiol" title="Hydroxylation of estradiol">Hydroxylation of estradiol</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Estrogen_ester" title="Estrogen ester">Esters</a></th><td class="navbox-list-with-group navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Estradiol_acetate" title="Estradiol acetate">Estradiol acetate</a></li>
<li><a href="/wiki/Estradiol_acetylsalicylate" title="Estradiol acetylsalicylate">Estradiol acetylsalicylate</a></li>
<li><a href="/wiki/Estradiol_anthranilate" title="Estradiol anthranilate">Estradiol anthranilate</a></li>
<li><a href="/wiki/Estradiol_benzoate_butyrate" title="Estradiol benzoate butyrate">Estradiol benzoate butyrate</a></li>
<li><a href="/wiki/Estradiol_benzoate_cyclooctenyl_ether" title="Estradiol benzoate cyclooctenyl ether">Estradiol benzoate cyclooctenyl ether</a></li>
<li><a href="/wiki/Estradiol_benzoate" title="Estradiol benzoate">Estradiol benzoate</a></li>
<li><a href="/wiki/Estradiol_butyrylacetate" title="Estradiol butyrylacetate">Estradiol butyrylacetate</a></li>
<li><a href="/wiki/Estradiol_cyclooctyl_acetate" title="Estradiol cyclooctyl acetate">Estradiol cyclooctyl acetate</a></li>
<li><a href="/wiki/Estradiol_cypionate" title="Estradiol cypionate">Estradiol cypionate</a></li>
<li><a href="/wiki/Estradiol_decanoate" title="Estradiol decanoate">Estradiol decanoate</a></li>
<li><a href="/wiki/Estradiol_diacetate" title="Estradiol diacetate">Estradiol diacetate</a></li>
<li><a href="/wiki/Estradiol_dibutyrate" title="Estradiol dibutyrate">Estradiol dibutyrate</a></li>
<li><a href="/wiki/Estradiol_dienantate" title="Estradiol dienantate">Estradiol dienantate</a></li>
<li><a href="/wiki/Estradiol_dipropionate" title="Estradiol dipropionate">Estradiol dipropionate</a></li>
<li><a href="/wiki/Estradiol_distearate" title="Estradiol distearate">Estradiol distearate</a></li>
<li><a href="/wiki/Estradiol_disulfate" title="Estradiol disulfate">Estradiol disulfate</a></li>
<li><a href="/wiki/Estradiol_diundecylate" title="Estradiol diundecylate">Estradiol diundecylate</a></li>
<li><a href="/wiki/Estradiol_diundecylenate" title="Estradiol diundecylenate">Estradiol diundecylenate</a></li>
<li><a href="/wiki/Estradiol_enantate" title="Estradiol enantate">Estradiol enantate</a></li>
<li><a href="/wiki/Estradiol_furoate" title="Estradiol furoate">Estradiol furoate</a></li>
<li><a href="/wiki/Estradiol_glucuronide" title="Estradiol glucuronide">Estradiol glucuronide</a></li>
<li><a href="/wiki/Estradiol_hemisuccinate" title="Estradiol hemisuccinate">Estradiol hemisuccinate</a></li>
<li><a href="/wiki/Estradiol_hexahydrobenzoate" title="Estradiol hexahydrobenzoate">Estradiol hexahydrobenzoate</a></li>
<li><a href="/wiki/Estradiol_monopropionate" title="Estradiol monopropionate">Estradiol monopropionate</a></li>
<li><a href="/wiki/Estradiol_mustard" title="Estradiol mustard">Estradiol mustard</a></li>
<li><a href="/wiki/Estradiol_palmitate" title="Estradiol palmitate">Estradiol palmitate</a></li>
<li><a href="/wiki/Estradiol_phenylpropionate" title="Estradiol phenylpropionate">Estradiol phenylpropionate</a></li>
<li><a href="/wiki/Estradiol_phosphate" title="Estradiol phosphate">Estradiol phosphate</a></li>
<li><a href="/wiki/Estradiol_pivalate" title="Estradiol pivalate">Estradiol pivalate</a></li>
<li><a href="/wiki/Estradiol_propoxyphenylpropionate" title="Estradiol propoxyphenylpropionate">Estradiol propoxyphenylpropionate</a></li>
<li><a href="/wiki/Estradiol_salicylate" title="Estradiol salicylate">Estradiol salicylate</a></li>
<li><a href="/wiki/Estradiol_stearate" title="Estradiol stearate">Estradiol stearate</a></li>
<li><a href="/wiki/Estradiol_sulfamate" title="Estradiol sulfamate">Estradiol sulfamate</a></li>
<li><a href="/wiki/Estradiol_sulfate" title="Estradiol sulfate">Estradiol sulfate</a></li>
<li><a href="/wiki/Estradiol_undecylate" title="Estradiol undecylate">Estradiol undecylate</a></li>
<li><a href="/wiki/Estradiol_undecylenate" title="Estradiol undecylenate">Estradiol undecylenate</a></li>
<li><a href="/wiki/Estradiol_valerate" title="Estradiol valerate">Estradiol valerate</a></li>
<li><a href="/wiki/Estramustine_phosphate" title="Estramustine phosphate">Estramustine phosphate (estradiol normustine phosphate)</a></li>
<li><a href="/wiki/Estrogen_ester" title="Estrogen ester">Estrogen ester</a></li>
<li><a href="/wiki/Polyestradiol_phosphate" title="Polyestradiol phosphate">Polyestradiol phosphate</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Related</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Estrone_(medication)" title="Estrone (medication)">Estrone</a></li>
<li><a href="/wiki/Estriol_(medication)" title="Estriol (medication)">Estriol</a></li>
<li><a href="/wiki/Estetrol_(medication)" title="Estetrol (medication)">Estetrol</a></li>
<li><a href="/wiki/Ethinylestradiol" title="Ethinylestradiol">Ethinylestradiol</a></li>
<li><a href="/wiki/Conjugated_estrogens" title="Conjugated estrogens">Conjugated estrogens</a></li>
<li><a href="/wiki/Esterified_estrogens" title="Esterified estrogens">Esterified estrogens</a></li>
<li><a href="/wiki/Estrone_sulfate_(medication)" title="Estrone sulfate (medication)">Estrone sulfate</a></li>
<li><a href="/wiki/Estropipate" title="Estropipate">Estropipate (piperazine estrone sulfate)</a></li></ul>
</div></td></tr></tbody></table></div>
<div class="navbox-styles nomobile"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1061467846"/></div><div role="navigation" class="navbox" aria-labelledby="Estrogens_and_antiestrogens" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1063604349"/><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Estrogens_and_antiestrogens" title="Template:Estrogens and antiestrogens"><abbr title="View this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Estrogens_and_antiestrogens" title="Template talk:Estrogens and antiestrogens"><abbr title="Discuss this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">t</abbr></a></li><li class="nv-edit"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Template:Estrogens_and_antiestrogens&amp;action=edit"><abbr title="Edit this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">e</abbr></a></li></ul></div><div id="Estrogens_and_antiestrogens" style="font-size:114%;margin:0 4em"><a href="/wiki/Estrogen_(medication)" title="Estrogen (medication)">Estrogens</a> and <a href="/wiki/Antiestrogen" title="Antiestrogen">antiestrogens</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Estrogen_(medication)" title="Estrogen (medication)">Estrogens</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0;background:#DDDDFF;"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:10em;;text-align:center;"><a href="/wiki/Estrogen_receptor" title="Estrogen receptor"><abbr title="Estrogen receptor">ER</abbr></a> agonists</th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em">
<ul><li><i>Steroidal:</i> <a href="/wiki/Alfatradiol" title="Alfatradiol">Alfatradiol</a></li>
<li>Certain <a href="/wiki/Androgen" title="Androgen">androgens</a>/<a href="/wiki/Anabolic_steroid" title="Anabolic steroid">anabolic steroids</a> (e.g., <a href="/wiki/Testosterone_(medication)" title="Testosterone (medication)">testosterone</a>, <a href="/wiki/List_of_androgen_esters#Testosterone_esters" title="List of androgen esters">testosterone esters</a>, <a href="/wiki/Methyltestosterone" title="Methyltestosterone">methyltestosterone</a>, <a href="/wiki/Metandienone" title="Metandienone">metandienone</a>, <a href="/wiki/List_of_androgen_esters#Nandrolone_esters" title="List of androgen esters">nandrolone esters</a>) (via estrogenic metabolites)</li>
<li>Certain <a href="/wiki/Progestin" class="mw-redirect" title="Progestin">progestins</a> (e.g., <a href="/wiki/Norethisterone" title="Norethisterone">norethisterone</a>, <a href="/wiki/Noretynodrel" title="Noretynodrel">noretynodrel</a>, <a href="/wiki/Etynodiol_diacetate" title="Etynodiol diacetate">etynodiol diacetate</a>, <a href="/wiki/Tibolone" title="Tibolone">tibolone</a>)</li>
<li><a href="/wiki/Clomestrone" title="Clomestrone">Clomestrone</a></li>
<li><a href="/wiki/Cloxestradiol_acetate" title="Cloxestradiol acetate">Cloxestradiol acetate</a></li>
<li><a href="/wiki/Conjugated_estriol" title="Conjugated estriol">Conjugated estriol</a></li>
<li><a href="/wiki/Conjugated_estrogens" title="Conjugated estrogens">Conjugated estrogens</a></li>
<li><a href="/wiki/Epiestriol" title="Epiestriol">Epiestriol</a></li>
<li><a href="/wiki/Epimestrol" title="Epimestrol">Epimestrol</a></li>
<li><a href="/wiki/Esterified_estrogens" title="Esterified estrogens">Esterified estrogens</a></li>
<li><a href="/wiki/Estetrol_(medication)" title="Estetrol (medication)">Estetrol</a><sup>†</sup></li>
<li><a href="/wiki/Estradiol_(medication)" title="Estradiol (medication)">Estradiol</a></li>
<li><a href="/wiki/List_of_estrogen_esters#Estradiol_esters" title="List of estrogen esters">Estradiol esters</a> (e.g., <a href="/wiki/Estradiol_acetate" title="Estradiol acetate">estradiol acetate</a>, <a href="/wiki/Estradiol_benzoate" title="Estradiol benzoate">estradiol benzoate</a>, <a href="/wiki/Estradiol_cypionate" title="Estradiol cypionate">estradiol cypionate</a>, <a href="/wiki/Estradiol_enanthate" class="mw-redirect" title="Estradiol enanthate">estradiol enanthate</a>, <a href="/wiki/Estradiol_undecylate" title="Estradiol undecylate">estradiol undecylate</a>, <a href="/wiki/Estradiol_valerate" title="Estradiol valerate">estradiol valerate</a>, <a href="/wiki/Polyestradiol_phosphate" title="Polyestradiol phosphate">polyestradiol phosphate</a>, <a href="/wiki/Estradiol_ester_mixture" class="mw-redirect" title="Estradiol ester mixture">estradiol ester mixtures</a> (<a href="/wiki/Climacteron" class="mw-redirect" title="Climacteron">Climacteron</a>))</li>
<li><a href="/wiki/Estramustine_phosphate" title="Estramustine phosphate">Estramustine phosphate</a></li>
<li><a href="/wiki/Estriol_(medication)" title="Estriol (medication)">Estriol</a></li>
<li><a href="/wiki/List_of_estrogen_esters#Estriol_esters" title="List of estrogen esters">Estriol esters</a> (e.g., <a href="/wiki/Estriol_succinate" title="Estriol succinate">estriol succinate</a>, <a href="/wiki/Polyestriol_phosphate" title="Polyestriol phosphate">polyestriol phosphate</a>)</li>
<li><a href="/wiki/Estrogenic_substances" title="Estrogenic substances">Estrogenic substances</a></li>
<li><a href="/wiki/Estrone_(medication)" title="Estrone (medication)">Estrone</a></li>
<li><a href="/wiki/List_of_estrogen_esters#Estrone_esters" title="List of estrogen esters">Estrone esters</a>
<ul><li><a href="/wiki/Estrone_sulfate_(medication)" title="Estrone sulfate (medication)">Estrone sulfate</a></li>
<li><a href="/wiki/Estropipate" title="Estropipate">Estropipate (piperazine estrone sulfate)</a></li></ul></li>
<li><a href="/wiki/Ethinylestradiol" title="Ethinylestradiol">Ethinylestradiol</a><sup>#</sup>
<ul><li><a href="/wiki/Ethinylestradiol_sulfonate" title="Ethinylestradiol sulfonate">Ethinylestradiol sulfonate</a></li></ul></li>
<li><a href="/wiki/Hydroxyestrone_diacetate" title="Hydroxyestrone diacetate">Hydroxyestrone diacetate</a></li>
<li><a href="/wiki/Mestranol" title="Mestranol">Mestranol</a></li>
<li><a href="/wiki/Methylestradiol" title="Methylestradiol">Methylestradiol</a></li>
<li><a href="/wiki/Moxestrol" title="Moxestrol">Moxestrol</a></li>
<li><a href="/wiki/Nilestriol" title="Nilestriol">Nilestriol</a></li>
<li><a href="/wiki/Prasterone" title="Prasterone">Prasterone (dehydroepiandrosterone; DHEA)</a>
<ul><li><a href="/wiki/Prasterone_enanthate" title="Prasterone enanthate">Prasterone enanthate</a></li>
<li><a href="/wiki/Prasterone_sulfate" title="Prasterone sulfate">Prasterone sulfate</a></li></ul></li>
<li><a href="/wiki/Promestriene" title="Promestriene">Promestriene</a></li>
<li><a href="/wiki/Quinestradol" title="Quinestradol">Quinestradol</a></li>
<li><a href="/wiki/Quinestrol" title="Quinestrol">Quinestrol</a></li></ul>
<ul><li><i>Nonsteroidal:</i> <a href="/wiki/Benzestrol" title="Benzestrol">Benzestrol</a></li>
<li><a href="/wiki/Bifluranol" title="Bifluranol">Bifluranol</a></li>
<li><a href="/wiki/Chlorotrianisene" title="Chlorotrianisene">Chlorotrianisene</a></li>
<li><a href="/wiki/Dienestrol" title="Dienestrol">Dienestrol</a>
<ul><li><a href="/wiki/Dienestrol_diacetate" title="Dienestrol diacetate">Dienestrol diacetate</a></li></ul></li>
<li><a href="/wiki/Diethylstilbestrol" title="Diethylstilbestrol">Diethylstilbestrol (stilbestrol)</a></li>
<li><a href="/wiki/List_of_estrogen_esters#Diethylstilbestrol_esters" title="List of estrogen esters">Diethylstilbestrol esters/ethers</a>
<ul><li><a href="/wiki/Dimestrol" title="Dimestrol">Dimestrol (diethylstilbestrol dimethyl ether)</a></li>
<li><a href="/wiki/Fosfestrol" title="Fosfestrol">Fosfestrol (diethylstilbestrol diphosphate)</a></li>
<li><a href="/wiki/Mestilbol" title="Mestilbol">Mestilbol (diethylstilbestrol monomethyl ether)</a></li></ul></li>
<li><a href="/wiki/Doisynoestrol" title="Doisynoestrol">Doisynoestrol (fenocycline)</a></li>
<li><a href="/wiki/Hexestrol" title="Hexestrol">Hexestrol</a>
<ul><li><a href="/wiki/List_of_estrogen_esters#Hexestrol_esters" title="List of estrogen esters">Hexestrol esters</a></li></ul></li>
<li><a href="/wiki/Methallenestril" title="Methallenestril">Methallenestril</a></li>
<li><a href="/wiki/Methestrol" title="Methestrol">Methestrol (promethestrol)</a>
<ul><li><a href="/wiki/Methestrol_dipropionate" title="Methestrol dipropionate">Methestrol dipropionate (promethestrol dipropionate)</a></li></ul></li>
<li><a href="/wiki/Paroxypropione" title="Paroxypropione">Paroxypropione</a></li>
<li><a href="/wiki/Quadrosilan" title="Quadrosilan">Quadrosilan</a></li>
<li><a href="/wiki/Triphenylbromoethylene" title="Triphenylbromoethylene">Triphenylbromoethylene</a></li>
<li><a href="/wiki/Triphenylchloroethylene" title="Triphenylchloroethylene">Triphenylchloroethylene</a></li>
<li><a href="/wiki/Zeranol" title="Zeranol">Zeranol</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:10em;;text-align:center;"><a href="/wiki/Progonadotropin" title="Progonadotropin">Progonadotropins</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Antiandrogen" title="Antiandrogen">Antiandrogens</a> (e.g., <a href="/wiki/Bicalutamide" title="Bicalutamide">bicalutamide</a>)</li>
<li><a href="/wiki/GnRH_agonist" class="mw-redirect" title="GnRH agonist"><abbr title="gonadotropin-releasing hormone">GnRH</abbr> agonists</a> (e.g., <a href="/wiki/Gonadotropin-releasing_hormone" title="Gonadotropin-releasing hormone"><abbr title="gonadotropin-releasing hormone">GnRH</abbr> (gonadorelin)</a>, <a href="/wiki/Leuprorelin" title="Leuprorelin">leuprorelin</a>)</li>
<li><a href="/wiki/Gonadotropin" title="Gonadotropin">Gonadotropins</a> (e.g., <a href="/wiki/Follicle-stimulating_hormone" title="Follicle-stimulating hormone"><abbr title="follicle-stimulating hormone">FSH</abbr></a>, <a href="/wiki/Luteinizing_hormone" title="Luteinizing hormone"><abbr title="luteinizing hormone">LH</abbr></a>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Antiestrogen" title="Antiestrogen">Antiestrogens</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0;background:#DDDDFF;"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:10em;;text-align:center;"><a href="/wiki/Estrogen_receptor" title="Estrogen receptor"><abbr title="Estrogen receptor">ER</abbr></a> antagonists<br />(incl. <a href="/wiki/Selective_estrogen_receptor_modulators" class="mw-redirect" title="Selective estrogen receptor modulators"><abbr title="selective estrogen receptor modulators">SERMs</abbr></a>/<a href="/wiki/Selective_estrogen_receptor_downregulators" class="mw-redirect" title="Selective estrogen receptor downregulators"><abbr title="selective estrogen receptor downregulators">SERDs</abbr></a>)</th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Acolbifene" title="Acolbifene">Acolbifene</a><sup>†</sup></li>
<li><a href="/wiki/Anordrin" title="Anordrin">Anordrin</a></li>
<li><a href="/wiki/Bazedoxifene" title="Bazedoxifene">Bazedoxifene</a></li>
<li><a href="/wiki/Broparestrol" title="Broparestrol">Broparestrol</a></li>
<li><a href="/wiki/Clomifene" title="Clomifene">Clomifene</a><sup>#</sup></li>
<li><a href="/wiki/Cyclofenil" title="Cyclofenil">Cyclofenil</a></li>
<li><a href="/wiki/Enclomifene" title="Enclomifene">Enclomifene</a><sup>†</sup></li>
<li><a href="/wiki/Epitiostanol" title="Epitiostanol">Epitiostanol</a></li>
<li><a href="/wiki/Lasofoxifene" title="Lasofoxifene">Lasofoxifene</a></li>
<li><a href="/wiki/Mepitiostane" title="Mepitiostane">Mepitiostane</a></li>
<li><a href="/wiki/Ormeloxifene" title="Ormeloxifene">Ormeloxifene</a></li>
<li><a href="/wiki/Ospemifene" title="Ospemifene">Ospemifene</a></li>
<li><a href="/wiki/Raloxifene" title="Raloxifene">Raloxifene</a></li>
<li><a href="/wiki/Tamoxifen" title="Tamoxifen">Tamoxifen</a><sup>#</sup></li>
<li><a href="/wiki/Toremifene" title="Toremifene">Toremifene</a></li></ul>
<ul><li><i>Exclusively antagonistic:</i> <a href="/wiki/Fulvestrant" title="Fulvestrant">Fulvestrant</a></li></ul>
<ul><li><i>Noncompetitive inhibitors:</i> <a href="/wiki/Trilostane" title="Trilostane">Trilostane</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:10em;;text-align:center;"><a href="/wiki/Aromatase_inhibitor" title="Aromatase inhibitor">Aromatase inhibitors</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="padding:0"><div style="padding:0 0.25em">
<ul><li><i>First-generation:</i> <a href="/wiki/Aminoglutethimide" title="Aminoglutethimide">Aminoglutethimide</a></li>
<li><a href="/wiki/Testolactone" title="Testolactone">Testolactone</a></li></ul>
<ul><li><i>Second-generation:</i> <a href="/wiki/Fadrozole" title="Fadrozole">Fadrozole</a></li>
<li><a href="/wiki/Formestane" title="Formestane">Formestane</a></li></ul>
<ul><li><i>Third-generation:</i> <a href="/wiki/Anastrozole" title="Anastrozole">Anastrozole</a></li>
<li><a href="/wiki/Exemestane" title="Exemestane">Exemestane</a></li>
<li><a href="/wiki/Letrozole" title="Letrozole">Letrozole</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:10em;;text-align:center;"><a href="/wiki/Antigonadotropin" title="Antigonadotropin">Antigonadotropins</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Androgen" title="Androgen">Androgens</a>/<a href="/wiki/Anabolic_steroid" title="Anabolic steroid">anabolic steroids</a> (e.g., <a href="/wiki/Testosterone" title="Testosterone">testosterone</a>, <a href="/wiki/List_of_androgen_esters#Testosterone_esters" title="List of androgen esters">testosterone esters</a>, <a href="/wiki/List_of_androgen_esters#Nandrolone_esters" title="List of androgen esters">nandrolone esters</a>, <a href="/wiki/Oxandrolone" title="Oxandrolone">oxandrolone</a>, <a href="/wiki/Fluoxymesterone" title="Fluoxymesterone">fluoxymesterone</a>)</li>
<li><a href="/wiki/D2_receptor" class="mw-redirect" title="D2 receptor">D<sub>2</sub> receptor</a> <a href="/wiki/Dopamine_antagonist" title="Dopamine antagonist">antagonists</a> (<a href="/wiki/Prolactin" title="Prolactin">prolactin</a> releasers) (e.g., <a href="/wiki/Domperidone" title="Domperidone">domperidone</a>, <a href="/wiki/Metoclopramide" title="Metoclopramide">metoclopramide</a>, <a href="/wiki/Risperidone" title="Risperidone">risperidone</a>, <a href="/wiki/Haloperidol" title="Haloperidol">haloperidol</a>, <a href="/wiki/Chlorpromazine" title="Chlorpromazine">chlorpromazine</a>, <a href="/wiki/Sulpiride" title="Sulpiride">sulpiride</a>)</li>
<li><a href="/wiki/GnRH_agonist" class="mw-redirect" title="GnRH agonist"><abbr title="gonadotropin-releasing hormone">GnRH</abbr> agonists</a> (e.g., <a href="/wiki/Leuprorelin" title="Leuprorelin">leuprorelin</a>, <a href="/wiki/Goserelin" title="Goserelin">goserelin</a>)</li>
<li><a href="/wiki/GnRH_antagonist" class="mw-redirect" title="GnRH antagonist"><abbr title="gonadotropin-releasing hormone">GnRH</abbr> antagonists</a> (e.g., <a href="/wiki/Cetrorelix" title="Cetrorelix">cetrorelix</a>, <a href="/wiki/Elagolix" title="Elagolix">elagolix</a>)</li>
<li><a href="/wiki/Progestogen" title="Progestogen">Progestogens</a> (e.g., <a href="/wiki/Chlormadinone_acetate" title="Chlormadinone acetate">chlormadinone acetate</a>, <a href="/wiki/Cyproterone_acetate" title="Cyproterone acetate">cyproterone acetate</a>, <a href="/wiki/Gestonorone_caproate" title="Gestonorone caproate">gestonorone caproate</a>, <a href="/wiki/Hydroxyprogesterone_caproate" title="Hydroxyprogesterone caproate">hydroxyprogesterone caproate</a>, <a href="/wiki/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">medroxyprogesterone acetate</a>, <a href="/wiki/Megestrol_acetate" title="Megestrol acetate">megestrol acetate</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:10em;;text-align:center;">Others</th><td class="navbox-list-with-group navbox-list navbox-even" style="padding:0"><div style="padding:0 0.25em">
<ul><li><i>Mixed mechanism of action:</i> <a href="/wiki/Danazol" title="Danazol">Danazol</a></li>
<li><a href="/wiki/Gestrinone" title="Gestrinone">Gestrinone</a></li></ul>
<ul><li><i>Androstenedione immunogens:</i> <a href="/wiki/Androvax" title="Androvax">Androvax (androstenedione albumin)</a></li>
<li><a href="/wiki/Ovandrotone_albumin" title="Ovandrotone albumin">Ovandrotone albumin (Fecundin)</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0;background:#DDDDFF;"><div style="padding:0 0.25em"><div class="hlist">
<ul><li><sup>#</sup><a href="/wiki/WHO_Model_List_of_Essential_Medicines" title="WHO Model List of Essential Medicines">WHO-EM</a></li>
<li><sup>‡</sup><a href="/wiki/List_of_withdrawn_drugs" title="List of withdrawn drugs">Withdrawn</a> from market</li>
<li><a href="/wiki/Clinical_trial" title="Clinical trial">Clinical trials</a>:
<ul><li><sup>†</sup><a href="/wiki/Phases_of_clinical_research#Phase_III" title="Phases of clinical research">Phase III</a></li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div>
<dl><dt>See also</dt>
<dd><a href="/wiki/Template:Estrogen_receptor_modulators" title="Template:Estrogen receptor modulators">Estrogen receptor modulators</a></dd>
<dd><a href="/wiki/Template:Androgens_and_antiandrogens" title="Template:Androgens and antiandrogens">Androgens and antiandrogens</a></dd>
<dd><a href="/wiki/Template:Progestogens_and_antiprogestogens" title="Template:Progestogens and antiprogestogens">Progestogens and antiprogestogens</a></dd>
<dd><a href="/wiki/List_of_steroidal_estrogens" class="mw-redirect" title="List of steroidal estrogens">List of estrogens</a></dd></dl></div></td></tr></tbody></table></div>
<div class="navbox-styles nomobile"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1061467846"/></div><div role="navigation" class="navbox" aria-labelledby="Progestogens_and_antiprogestogens" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1063604349"/><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Progestogens_and_antiprogestogens" title="Template:Progestogens and antiprogestogens"><abbr title="View this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Progestogens_and_antiprogestogens" title="Template talk:Progestogens and antiprogestogens"><abbr title="Discuss this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">t</abbr></a></li><li class="nv-edit"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Template:Progestogens_and_antiprogestogens&amp;action=edit"><abbr title="Edit this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">e</abbr></a></li></ul></div><div id="Progestogens_and_antiprogestogens" style="font-size:114%;margin:0 4em"><a href="/wiki/Progestogen_(medication)" title="Progestogen (medication)">Progestogens</a> and <a href="/wiki/Antiprogestogen" title="Antiprogestogen">antiprogestogens</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Progestogen_(medication)" title="Progestogen (medication)">Progestogens</a><br />(and <a href="/wiki/Progestin" class="mw-redirect" title="Progestin">progestins</a>)</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0;background:#DDDDFF;"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="PR_agonists" scope="row" class="navbox-group" style="width:8em;;text-align:center;"><a href="/wiki/Progesterone_receptor" title="Progesterone receptor"><abbr title="Progesterone receptor">PR</abbr></a> <a href="/wiki/Agonist" title="Agonist">agonists</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em">
<ul><li><i>Progesterone derivatives:</i> <a href="/wiki/Progesterone_(medication)" title="Progesterone (medication)">Progesterone</a></li>
<li><a href="/wiki/Quingestrone" title="Quingestrone">Quingestrone</a></li></ul>
<ul><li><i>Retroprogesterone derivatives:</i> <a href="/wiki/Dydrogesterone" title="Dydrogesterone">Dydrogesterone</a></li>
<li><a href="/wiki/Trengestone" title="Trengestone">Trengestone</a></li></ul>
<ul><li><i>17α-Hydroxyprogesterone (and closely related) derivatives:</i> <i>17α-Hydroxylated:</i> <a href="/wiki/Acetomepregenol" title="Acetomepregenol">Acetomepregenol (mepregenol diacetate)</a></li>
<li><a href="/wiki/Algestone_acetophenide" title="Algestone acetophenide">Algestone acetophenide (dihydroxyprogesterone acetophenide)</a></li>
<li><a href="/wiki/Anagestone_acetate" title="Anagestone acetate">Anagestone acetate</a></li>
<li><a href="/wiki/Chlormadinone_acetate" title="Chlormadinone acetate">Chlormadinone acetate</a></li>
<li><a href="/wiki/Chlormethenmadinone_acetate" title="Chlormethenmadinone acetate">Chlormethenmadinone acetate</a></li>
<li><a href="/wiki/Cyproterone_acetate" title="Cyproterone acetate">Cyproterone acetate</a></li>
<li><a href="/wiki/Delmadinone_acetate" title="Delmadinone acetate">Delmadinone acetate</a></li>
<li><a href="/wiki/Flugestone_acetate" title="Flugestone acetate">Flugestone acetate (flurogestone acetate)</a></li>
<li><a href="/wiki/Flumedroxone_acetate" title="Flumedroxone acetate">Flumedroxone acetate</a></li>
<li><a href="/wiki/Hydroxyprogesterone_acetate" title="Hydroxyprogesterone acetate">Hydroxyprogesterone acetate</a></li>
<li><a href="/wiki/Hydroxyprogesterone_caproate" title="Hydroxyprogesterone caproate">Hydroxyprogesterone caproate</a></li>
<li><a href="/wiki/Hydroxyprogesterone_heptanoate" title="Hydroxyprogesterone heptanoate">Hydroxyprogesterone heptanoate</a></li>
<li><a href="/wiki/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">Medroxyprogesterone acetate</a><sup>#</sup></li>
<li><a href="/wiki/Megestrol_acetate" title="Megestrol acetate">Megestrol acetate</a></li>
<li><a href="/wiki/Melengestrol_acetate" title="Melengestrol acetate">Melengestrol acetate</a></li>
<li><a href="/wiki/Methenmadinone_acetate" title="Methenmadinone acetate">Methenmadinone acetate</a></li>
<li><a href="/wiki/Osaterone_acetate" title="Osaterone acetate">Osaterone acetate</a></li>
<li><a href="/wiki/Pentagestrone_acetate" title="Pentagestrone acetate">Pentagestrone acetate</a></li>
<li><a href="/wiki/Proligestone" title="Proligestone">Proligestone</a>; <i>17α-Methylated:</i> <a href="/wiki/Medrogestone" title="Medrogestone">Medrogestone</a>; <i>Others:</i> <a href="/wiki/Haloprogesterone" title="Haloprogesterone">Haloprogesterone</a></li></ul>
<ul><li><i>19-Norprogesterone derivatives:</i> <i>17α-Hydroxylated:</i> <a href="/wiki/Gestonorone_caproate" title="Gestonorone caproate">Gestonorone caproate (gestronol hexanoate)</a></li>
<li><a href="/wiki/Nomegestrol_acetate" title="Nomegestrol acetate">Nomegestrol acetate</a></li>
<li><a href="/wiki/Norgestomet" title="Norgestomet">Norgestomet</a></li>
<li><a href="/wiki/Segesterone_acetate" title="Segesterone acetate">Segesterone acetate (nestorone, elcometrine)</a>; <i>17α-Methylated:</i> <a href="/wiki/Demegestone" title="Demegestone">Demegestone</a></li>
<li><a href="/wiki/Promegestone" title="Promegestone">Promegestone</a></li>
<li><a href="/wiki/Trimegestone" title="Trimegestone">Trimegestone</a></li></ul>
<ul><li><i>Testosterone derivatives:</i> <i>Estranes:</i> <a href="/wiki/Danazol" title="Danazol">Danazol</a></li>
<li><a href="/wiki/Dimethisterone" title="Dimethisterone">Dimethisterone</a></li>
<li><a href="/wiki/Ethisterone" title="Ethisterone">Ethisterone</a></li></ul>
<ul><li><i>19-Nortestosterone derivatives:</i> <i>Estranes:</i> <a href="/wiki/Allylestrenol" title="Allylestrenol">Allylestrenol</a></li>
<li><a href="/wiki/Altrenogest" title="Altrenogest">Altrenogest</a></li>
<li><a href="/wiki/Dienogest" title="Dienogest">Dienogest</a></li>
<li><a href="/wiki/Etynodiol_diacetate" title="Etynodiol diacetate">Etynodiol diacetate</a></li>
<li><a href="/wiki/Lynestrenol" title="Lynestrenol">Lynestrenol</a></li>
<li><a href="/wiki/Norethisterone" title="Norethisterone">Norethisterone (norethindrone)</a><sup>#</sup></li>
<li><a href="/wiki/Norethisterone_acetate" title="Norethisterone acetate">Norethisterone acetate</a></li>
<li><a href="/wiki/Norethisterone_enanthate" title="Norethisterone enanthate">Norethisterone enanthate</a></li>
<li><a href="/wiki/Noretynodrel" title="Noretynodrel">Noretynodrel</a></li>
<li><a href="/wiki/Norgesterone" title="Norgesterone">Norgesterone</a></li>
<li><a href="/wiki/Norgestrienone" title="Norgestrienone">Norgestrienone</a></li>
<li><a href="/wiki/Normethandrone" title="Normethandrone">Normethandrone (methylestrenolone)</a></li>
<li><a href="/wiki/Norvinisterone" title="Norvinisterone">Norvinisterone</a></li>
<li><a href="/wiki/Oxendolone" title="Oxendolone">Oxendolone</a></li>
<li><a href="/wiki/Quingestanol_acetate" title="Quingestanol acetate">Quingestanol acetate</a></li>
<li><a href="/wiki/Tibolone" title="Tibolone">Tibolone</a>; <i>Gonanes:</i> <a href="/wiki/Desogestrel" title="Desogestrel">Desogestrel</a></li>
<li><a href="/wiki/Etonogestrel" title="Etonogestrel">Etonogestrel</a></li>
<li><a href="/wiki/Gestodene" title="Gestodene">Gestodene</a></li>
<li><a href="/wiki/Gestrinone" title="Gestrinone">Gestrinone</a></li>
<li><a href="/wiki/Levonorgestrel" title="Levonorgestrel">Levonorgestrel</a><sup>#</sup></li>
<li><a href="/wiki/Norelgestromin" title="Norelgestromin">Norelgestromin</a></li>
<li><a href="/wiki/Norgestimate" title="Norgestimate">Norgestimate</a></li>
<li><a href="/wiki/Norgestrel" title="Norgestrel">Norgestrel</a></li></ul>
<ul><li><i>Spirolactone derivatives:</i> <a href="/wiki/Drospirenone" title="Drospirenone">Drospirenone</a></li></ul>
<ul><li><i>Others:</i> <a href="/wiki/Anabolic%E2%80%93androgenic_steroid" class="mw-redirect" title="Anabolic–androgenic steroid">Anabolic–androgenic steroids</a> (e.g., <a href="/wiki/Nandrolone" title="Nandrolone">nandrolone</a> and <a href="/wiki/Nandrolone_ester" class="mw-redirect" title="Nandrolone ester">esters</a>, <a href="/wiki/Trenbolone" title="Trenbolone">trenbolone</a> and <a href="/wiki/Trenbolone_ester" class="mw-redirect" title="Trenbolone ester">esters</a>, <a href="/wiki/Ethylestrenol" title="Ethylestrenol">ethylestrenol</a>, <a href="/wiki/Norethandrolone" title="Norethandrolone">norethandrolone</a>, others)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Antiprogestogen" title="Antiprogestogen">Antiprogestogens</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0;background:#DDDDFF;"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:8em;;text-align:center;"><a href="/wiki/Selective_progesterone_receptor_modulators" class="mw-redirect" title="Selective progesterone receptor modulators"><abbr title="Selective progesterone receptor modulators">SPRMs</abbr></a></th><td class="navbox-list-with-group navbox-list navbox-even" style="padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Telapristone" title="Telapristone">Telapristone</a><sup>§</sup></li>
<li><a href="/wiki/Ulipristal_acetate" title="Ulipristal acetate">Ulipristal acetate</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:8em;;text-align:center;"><a href="/wiki/Progesterone_receptor" title="Progesterone receptor"><abbr title="Progesterone receptor">PR</abbr></a> <a href="/wiki/Receptor_antagonist" title="Receptor antagonist">antagonists</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Aglepristone" title="Aglepristone">Aglepristone</a></li>
<li><a href="/wiki/Mifepristone" title="Mifepristone">Mifepristone</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-even hlist" style="width:100%;padding:0;background:#DDDDFF;"><div style="padding:0 0.25em"><div class="hlist">
<ul><li><sup>#</sup><a href="/wiki/WHO_Model_List_of_Essential_Medicines" title="WHO Model List of Essential Medicines">WHO-EM</a></li>
<li><sup>‡</sup><a href="/wiki/List_of_withdrawn_drugs" title="List of withdrawn drugs">Withdrawn</a> from market</li>
<li><a href="/wiki/Clinical_trial" title="Clinical trial">Clinical trials</a>:
<ul><li><sup>†</sup><a href="/wiki/Phases_of_clinical_research#Phase_III" title="Phases of clinical research">Phase III</a></li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div>
<dl><dt>See also</dt>
<dd><a href="/wiki/Template:Progesterone_receptor_modulators" title="Template:Progesterone receptor modulators">Progesterone receptor modulators</a></dd>
<dd><a href="/wiki/Template:Androgens_and_antiandrogens" title="Template:Androgens and antiandrogens">Androgens and antiandrogens</a></dd>
<dd><a href="/wiki/Template:Estrogens_and_antiestrogens" title="Template:Estrogens and antiestrogens">Estrogens and antiestrogens</a></dd>
<dd><a href="/wiki/List_of_steroidal_progestogens" class="mw-redirect" title="List of steroidal progestogens">List of progestogens</a></dd></dl></div></td></tr></tbody></table></div>
<div class="navbox-styles nomobile"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1061467846"/></div><div role="navigation" class="navbox" aria-labelledby="Androgens_and_antiandrogens" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1063604349"/><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Androgens_and_antiandrogens" title="Template:Androgens and antiandrogens"><abbr title="View this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Androgens_and_antiandrogens" title="Template talk:Androgens and antiandrogens"><abbr title="Discuss this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">t</abbr></a></li><li class="nv-edit"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Template:Androgens_and_antiandrogens&amp;action=edit"><abbr title="Edit this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">e</abbr></a></li></ul></div><div id="Androgens_and_antiandrogens" style="font-size:114%;margin:0 4em"><a href="/wiki/Androgen" title="Androgen">Androgens</a> and <a href="/wiki/Antiandrogen" title="Antiandrogen">antiandrogens</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Androgen" title="Androgen">Androgens</a><br />(incl. <a href="/wiki/Anabolic%E2%80%93androgenic_steroid" class="mw-redirect" title="Anabolic–androgenic steroid"><abbr title="anabolic–androgenic steroid">AAS</abbr></a>)</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0;background:#DDDDFF;"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;"><a href="/wiki/Androgen_receptor" title="Androgen receptor"><abbr title="Androgen receptor">AR</abbr></a> <a href="/wiki/Agonist" title="Agonist">agonists</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em">
<ul><li><i>Testosterone derivatives:</i> <a href="/wiki/Androstenediol_dipropionate" title="Androstenediol dipropionate">Androstenediol dipropionate</a></li>
<li><a href="/wiki/Boldenone_undecylenate" title="Boldenone undecylenate">Boldenone undecylenate</a></li>
<li><a href="/wiki/Clostebol" title="Clostebol">Clostebol</a></li>
<li><a href="/wiki/Clostebol_acetate" title="Clostebol acetate">Clostebol acetate</a></li>
<li><a href="/wiki/Clostebol_caproate" title="Clostebol caproate">Clostebol caproate</a></li>
<li><a href="/wiki/Clostebol_propionate" title="Clostebol propionate">Clostebol propionate</a></li>
<li><a href="/wiki/Cloxotestosterone_acetate" title="Cloxotestosterone acetate">Cloxotestosterone acetate</a></li>
<li><a href="/wiki/Prasterone" title="Prasterone">Prasterone (dehydroepiandrosterone, DHEA)</a></li>
<li><a href="/wiki/Prasterone_enanthate" title="Prasterone enanthate">Prasterone enanthate (DHEA enanthate)</a></li>
<li><a href="/wiki/Prasterone_sulfate" title="Prasterone sulfate">Prasterone sulfate (DHEA sulfate)</a></li>
<li><a href="/wiki/Quinbolone" title="Quinbolone">Quinbolone</a></li>
<li><a href="/wiki/Testosterone_(medication)" title="Testosterone (medication)">Testosterone</a><sup>#</sup></li>
<li><a href="/wiki/List_of_androgen_esters#Testosterone_esters" title="List of androgen esters">Testosterone esters</a> (e.g., <a href="/wiki/Testosterone_cypionate" title="Testosterone cypionate">testosterone cypionate</a>, <a href="/wiki/Testosterone_enanthate" title="Testosterone enanthate">testosterone enanthate</a>, <a href="/wiki/Testosterone_propionate" title="Testosterone propionate">testosterone propionate</a>, <a href="/wiki/Testosterone_undecanoate" title="Testosterone undecanoate">testosterone undecanoate</a>, <a href="/wiki/Testosterone_ester_mixture" class="mw-redirect" title="Testosterone ester mixture">testosterone ester mixtures</a> (<a href="/wiki/Deposterona" class="mw-redirect" title="Deposterona">Deposterona</a>, <a href="/wiki/Omnadren" class="mw-redirect" title="Omnadren">Omnadren</a>, <a href="/wiki/Testosterone_propionate/testosterone_phenylpropionate/testosterone_isocaproate/testosterone_decanoate" title="Testosterone propionate/testosterone phenylpropionate/testosterone isocaproate/testosterone decanoate">Sustanon</a>, <a href="/wiki/Testoviron_depot" class="mw-redirect" title="Testoviron depot">Testoviron Depot</a>))</li></ul>
<ul><li><i>Dihydrotestosterone derivatives:</i> <a href="/wiki/Androstanolone" title="Androstanolone">Androstanolone (stanolone, dihydrotestosterone, DHT)</a></li>
<li><a href="/wiki/List_of_androgen_esters#Dihydrotestosterone_esters" title="List of androgen esters">Androstanolone esters</a></li>
<li><a href="/wiki/Bolazine_capronate" title="Bolazine capronate">Bolazine capronate</a></li>
<li><a href="/wiki/Drostanolone_propionate" title="Drostanolone propionate">Drostanolone propionate (dromostanolone propionate)</a></li>
<li><a href="/wiki/Epitiostanol" title="Epitiostanol">Epitiostanol</a></li>
<li><a href="/wiki/Mepitiostane" title="Mepitiostane">Mepitiostane</a></li>
<li><a href="/wiki/Mesterolone" title="Mesterolone">Mesterolone</a></li>
<li><a href="/wiki/Metenolone_acetate" title="Metenolone acetate">Metenolone acetate (methenolone acetate)</a></li>
<li><a href="/wiki/Metenolone_enanthate" title="Metenolone enanthate">Metenolone enanthate (methenolone enanthate)</a></li>
<li><a href="/wiki/Stenbolone_acetate" title="Stenbolone acetate">Stenbolone acetate</a></li></ul>
<ul><li><i>19-Nortestosterone derivatives:</i> <a href="/wiki/Bolandiol_dipropionate" title="Bolandiol dipropionate">Bolandiol dipropionate</a></li>
<li><a href="/wiki/List_of_androgen_esters#Nandrolone_esters" title="List of androgen esters">Nandrolone esters</a> (e.g., <a href="/wiki/Nandrolone_decanoate" title="Nandrolone decanoate">nandrolone decanoate</a>, <a href="/wiki/Nandrolone_phenylpropionate" title="Nandrolone phenylpropionate">nandrolone phenylpropionate</a>)</li>
<li><a href="/wiki/Norclostebol" title="Norclostebol">Norclostebol</a></li>
<li><a href="/wiki/Norclostebol_acetate" title="Norclostebol acetate">Norclostebol acetate</a></li>
<li><a href="/wiki/Oxabolone_cipionate" title="Oxabolone cipionate">Oxabolone cipionate (oxabolone cypionate)</a></li>
<li><a href="/wiki/Trenbolone_acetate" title="Trenbolone acetate">Trenbolone acetate</a></li>
<li><a href="/wiki/Trenbolone_hexahydrobenzylcarbonate" title="Trenbolone hexahydrobenzylcarbonate">Trenbolone hexahydrobenzylcarbonate (trenbolone cyclohexylmethylcarbonate)</a></li></ul>
<ul><li><i>17α-Alkylated testosterone derivatives:</i> <a href="/wiki/Bolasterone" title="Bolasterone">Bolasterone</a></li>
<li><a href="/wiki/Calusterone" title="Calusterone">Calusterone</a></li>
<li><a href="/wiki/Chlorodehydromethyltestosterone" title="Chlorodehydromethyltestosterone">Chlorodehydromethyltestosterone (CDMT)</a></li>
<li><a href="/wiki/Fluoxymesterone" title="Fluoxymesterone">Fluoxymesterone</a></li>
<li><a href="/wiki/Formebolone" title="Formebolone">Formebolone</a></li>
<li><a href="/wiki/Metandienone" title="Metandienone">Metandienone (methandienone, methandrostenolone)</a></li>
<li><a href="/wiki/Methandriol" title="Methandriol">Methandriol (methylandrostenediol)</a></li>
<li><a href="/wiki/Methandriol_bisenanthoyl_acetate" title="Methandriol bisenanthoyl acetate">Methandriol bisenanthoyl acetate</a></li>
<li><a href="/wiki/Methandriol_dipropionate" title="Methandriol dipropionate">Methandriol dipropionate</a></li>
<li><a href="/wiki/Methandriol_propionate" title="Methandriol propionate">Methandriol propionate</a></li>
<li><a href="/wiki/Methyltestosterone" title="Methyltestosterone">Methyltestosterone</a></li>
<li><a href="/wiki/Methyltestosterone_3-hexyl_ether" title="Methyltestosterone 3-hexyl ether">Methyltestosterone 3-hexyl ether</a></li>
<li><a href="/wiki/Oxymesterone" title="Oxymesterone">Oxymesterone</a></li>
<li><a href="/wiki/Penmesterol" title="Penmesterol">Penmesterol</a></li>
<li><a href="/wiki/Tiomesterone" title="Tiomesterone">Tiomesterone (thiomesterone)</a></li></ul>
<ul><li><i>17α-Alkylated dihydrotestosterone derivatives:</i> <a href="/wiki/Androisoxazole" title="Androisoxazole">Androisoxazole</a></li>
<li><a href="/wiki/Furazabol" title="Furazabol">Furazabol</a></li>
<li><a href="/wiki/Mebolazine" title="Mebolazine">Mebolazine (dimethazine)</a></li>
<li><a href="/wiki/Mestanolone" title="Mestanolone">Mestanolone</a></li>
<li><a href="/wiki/Oxandrolone" title="Oxandrolone">Oxandrolone</a></li>
<li><a href="/wiki/Oxymetholone" title="Oxymetholone">Oxymetholone</a></li>
<li><a href="/wiki/Stanozolol" title="Stanozolol">Stanozolol</a></li></ul>
<ul><li><i>17α-Alkylated 19-nortestosterone derivatives:</i> <a href="/wiki/Ethylestrenol" title="Ethylestrenol">Ethylestrenol</a></li>
<li><a href="/wiki/Mibolerone" title="Mibolerone">Mibolerone</a></li>
<li><a href="/wiki/Norethandrolone" title="Norethandrolone">Norethandrolone</a></li>
<li><a href="/wiki/Normethandrone" title="Normethandrone">Normethandrone (methylestrenolone, normethisterone)</a></li>
<li><a href="/wiki/Propetandrol" title="Propetandrol">Propetandrol (propethandrol)</a></li></ul>
<ul><li><i>17α-Vinyltestosterone derivatives:</i> <a href="/wiki/Norvinisterone" title="Norvinisterone">Norvinisterone (vinylnortestosterone)</a></li></ul>
<ul><li><i>17α-Ethynyltestosterone derivatives:</i> <a href="/wiki/Danazol" title="Danazol">Danazol</a></li>
<li><a href="/wiki/Gestrinone" title="Gestrinone">Gestrinone</a></li>
<li><a href="/wiki/Progestin" class="mw-redirect" title="Progestin">Progestins</a> (e.g., <a href="/wiki/Ethisterone" title="Ethisterone">ethisterone (ethynyltestosterone)</a>, <a href="/wiki/Levonorgestrel" title="Levonorgestrel">levonorgestrel</a>, <a href="/wiki/Norgestrel" title="Norgestrel">norgestrel</a>, <a href="/wiki/Norethisterone" title="Norethisterone">norethisterone (norethindrone)</a>, <a href="/wiki/Lynestrenol" title="Lynestrenol">lynestrenol</a>, <a href="/wiki/Norgestrienone" title="Norgestrienone">norgestrienone</a>)</li>
<li><a href="/wiki/Tibolone" title="Tibolone">Tibolone</a></li></ul>
<ul><li><i>Progesterone derivatives:</i> <a href="/wiki/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">Medroxyprogesterone acetate</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;"><a href="/wiki/Progonadotropin" title="Progonadotropin">Progonadotropins</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Antiestrogen" title="Antiestrogen">Antiestrogens</a> (e.g., <a href="/wiki/Tamoxifen" title="Tamoxifen">tamoxifen</a>, <a href="/wiki/Clomifene" title="Clomifene">clomifene</a>)</li>
<li><a href="/wiki/GnRH_agonist" class="mw-redirect" title="GnRH agonist">GnRH agonists</a> (e.g., <a href="/wiki/Gonadotropin-releasing_hormone" title="Gonadotropin-releasing hormone">GnRH (gonadorelin)</a>, <a href="/wiki/Leuprorelin" title="Leuprorelin">leuprorelin</a>)</li>
<li><a href="/wiki/Gonadotropin" title="Gonadotropin">Gonadotropins</a> (e.g., <a href="/wiki/Luteinizing_hormone" title="Luteinizing hormone"><abbr title="luteinizing hormone">LH</abbr></a>, <a href="/wiki/Human_chorionic_gonadotropin" title="Human chorionic gonadotropin"><abbr title="human chorionic gonadotropin">hCG</abbr></a>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Antiandrogen" title="Antiandrogen">Antiandrogens</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0;background:#DDDDFF;"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;"><a href="/wiki/Androgen_receptor" title="Androgen receptor"><abbr title="Androgen receptor">AR</abbr></a> <a href="/wiki/Receptor_antagonist" title="Receptor antagonist">antagonists</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em">
<ul><li><i>Steroidal:</i> <a href="/wiki/Abiraterone_acetate" title="Abiraterone acetate">Abiraterone acetate</a></li>
<li><a href="/wiki/Canrenone" title="Canrenone">Canrenone</a></li>
<li><a href="/wiki/Chlormadinone_acetate" title="Chlormadinone acetate">Chlormadinone acetate</a></li>
<li><a href="/wiki/Cyproterone_acetate" title="Cyproterone acetate">Cyproterone acetate</a></li>
<li><a href="/wiki/Delmadinone_acetate" title="Delmadinone acetate">Delmadinone acetate</a></li>
<li><a href="/wiki/Dienogest" title="Dienogest">Dienogest</a></li>
<li><a href="/wiki/Drospirenone" title="Drospirenone">Drospirenone</a></li>
<li><a href="/wiki/Medrogestone" title="Medrogestone">Medrogestone</a></li>
<li><a href="/wiki/Megestrol_acetate" title="Megestrol acetate">Megestrol acetate</a></li>
<li><a href="/wiki/Nomegestrol_acetate" title="Nomegestrol acetate">Nomegestrol acetate</a></li>
<li><a href="/wiki/Osaterone_acetate" title="Osaterone acetate">Osaterone acetate</a></li>
<li><a href="/wiki/Oxendolone" title="Oxendolone">Oxendolone</a></li>
<li><a href="/wiki/Potassium_canrenoate" title="Potassium canrenoate">Potassium canrenoate</a></li>
<li><a href="/wiki/Spironolactone" title="Spironolactone">Spironolactone</a></li></ul>
<ul><li><i>Nonsteroidal:</i> <a href="/wiki/Apalutamide" title="Apalutamide">Apalutamide</a></li>
<li><a href="/wiki/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li>
<li><a href="/wiki/Cimetidine" title="Cimetidine">Cimetidine</a></li>
<li><a href="/wiki/Darolutamide" title="Darolutamide">Darolutamide</a></li>
<li><a href="/wiki/Enzalutamide" title="Enzalutamide">Enzalutamide</a></li>
<li><a href="/wiki/Flutamide" title="Flutamide">Flutamide</a></li>
<li><a href="/wiki/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li>
<li><a href="/wiki/Nilutamide" title="Nilutamide">Nilutamide</a></li>
<li><a href="/wiki/Seviteronel" title="Seviteronel">Seviteronel</a><sup>†</sup></li>
<li><a href="/wiki/Topilutamide" title="Topilutamide">Topilutamide (fluridil)</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;"><a href="/wiki/Steroidogenesis_inhibitor" title="Steroidogenesis inhibitor">Steroidogenesis<br />inhibitors</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/5%CE%B1-Reductase_inhibitor" title="5α-Reductase inhibitor">5α-Reductase</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Alfatradiol" title="Alfatradiol">Alfatradiol</a></li>
<li><a href="/wiki/Dutasteride" title="Dutasteride">Dutasteride</a></li>
<li><a href="/wiki/Epristeride" title="Epristeride">Epristeride</a></li>
<li><a href="/wiki/Finasteride" title="Finasteride">Finasteride</a></li>
<li><a href="/wiki/Saw_palmetto_extract" title="Saw palmetto extract">Saw palmetto extract</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Others</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Abiraterone_acetate" title="Abiraterone acetate">Abiraterone acetate</a></li>
<li><a href="/wiki/Aminoglutethimide" title="Aminoglutethimide">Aminoglutethimide</a></li>
<li><a href="/wiki/Bifluranol" title="Bifluranol">Bifluranol</a></li>
<li><a href="/wiki/Cyproterone_acetate" title="Cyproterone acetate">Cyproterone acetate</a></li>
<li><a href="/wiki/Flutamide" title="Flutamide">Flutamide</a></li>
<li><a href="/wiki/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li>
<li><a href="/wiki/Nilutamide" title="Nilutamide">Nilutamide</a></li>
<li><a href="/wiki/Seviteronel" title="Seviteronel">Seviteronel</a><sup>†</sup></li>
<li><a href="/wiki/Spironolactone" title="Spironolactone">Spironolactone</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;"><a href="/wiki/Antigonadotropin" title="Antigonadotropin">Antigonadotropins</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/D2_receptor" class="mw-redirect" title="D2 receptor">D<sub>2</sub> receptor</a> <a href="/wiki/Dopamine_antagonist" title="Dopamine antagonist">antagonists</a> (<a href="/wiki/Prolactin_releaser" class="mw-redirect" title="Prolactin releaser">prolactin releasers</a>) (e.g., <a href="/wiki/Domperidone" title="Domperidone">domperidone</a>, <a href="/wiki/Metoclopramide" title="Metoclopramide">metoclopramide</a>, <a href="/wiki/Risperidone" title="Risperidone">risperidone</a>, <a href="/wiki/Haloperidol" title="Haloperidol">haloperidol</a>, <a href="/wiki/Chlorpromazine" title="Chlorpromazine">chlorpromazine</a>, <a href="/wiki/Sulpiride" title="Sulpiride">sulpiride</a>)</li>
<li><a href="/wiki/Estrogen" title="Estrogen">Estrogens</a> (e.g., <a href="/wiki/Bifluranol" title="Bifluranol">bifluranol</a>, <a href="/wiki/Diethylstilbestrol" title="Diethylstilbestrol">diethylstilbestrol</a>, <a href="/wiki/Estradiol" title="Estradiol">estradiol</a>, <a href="/wiki/List_of_estrogen_esters#Estradiol_esters" title="List of estrogen esters">estradiol esters</a>, <a href="/wiki/Ethinylestradiol" title="Ethinylestradiol">ethinylestradiol</a>, <a href="/wiki/Ethinylestradiol_sulfonate" title="Ethinylestradiol sulfonate">ethinylestradiol sulfonate</a>, <a href="/wiki/Paroxypropione" title="Paroxypropione">paroxypropione</a>)</li>
<li><a href="/wiki/GnRH_agonist" class="mw-redirect" title="GnRH agonist">GnRH agonists</a> (e.g., <a href="/wiki/Leuprorelin" title="Leuprorelin">leuprorelin</a>)</li>
<li><a href="/wiki/GnRH_antagonist" class="mw-redirect" title="GnRH antagonist">GnRH antagonists</a> (e.g., <a href="/wiki/Cetrorelix" title="Cetrorelix">cetrorelix</a>)</li>
<li><a href="/wiki/Progestogen" title="Progestogen">Progestogens</a> (incl., <a href="/wiki/Chlormadinone_acetate" title="Chlormadinone acetate">chlormadinone acetate</a>, <a href="/wiki/Cyproterone_acetate" title="Cyproterone acetate">cyproterone acetate</a>, <a href="/wiki/Hydroxyprogesterone_caproate" title="Hydroxyprogesterone caproate">hydroxyprogesterone caproate</a>, <a href="/wiki/Gestonorone_caproate" title="Gestonorone caproate">gestonorone caproate</a>, <a href="/wiki/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">medroxyprogesterone acetate</a>, <a href="/wiki/Megestrol_acetate" title="Megestrol acetate">megestrol acetate</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;">Others</th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em">
<ul><li><i>Androstenedione immunogens:</i> <a href="/wiki/Androvax" title="Androvax">Androvax (androstenedione albumin)</a></li>
<li><a href="/wiki/Ovandrotone_albumin" title="Ovandrotone albumin">Ovandrotone albumin (Fecundin)</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-even hlist" style="width:100%;padding:0;background:#DDDDFF;"><div style="padding:0 0.25em"><div class="hlist">
<ul><li><sup>#</sup><a href="/wiki/WHO_Model_List_of_Essential_Medicines" title="WHO Model List of Essential Medicines">WHO-EM</a></li>
<li><sup>‡</sup><a href="/wiki/List_of_withdrawn_drugs" title="List of withdrawn drugs">Withdrawn</a> from market</li>
<li><a href="/wiki/Clinical_trial" title="Clinical trial">Clinical trials</a>:
<ul><li><sup>†</sup><a href="/wiki/Phases_of_clinical_research#Phase_III" title="Phases of clinical research">Phase III</a></li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div>
<dl><dt>See also</dt>
<dd><a href="/wiki/Template:Androgen_receptor_modulators" title="Template:Androgen receptor modulators">Androgen receptor modulators</a></dd>
<dd><a href="/wiki/Template:Estrogens_and_antiestrogens" title="Template:Estrogens and antiestrogens">Estrogens and antiestrogens</a></dd>
<dd><a href="/wiki/Template:Progestogens_and_antiprogestogens" title="Template:Progestogens and antiprogestogens">Progestogens and antiprogestogens</a></dd>
<dd><a href="/wiki/List_of_androgens/anabolic_steroids" title="List of androgens/anabolic steroids">List of androgens/anabolic steroids</a></dd></dl></div></td></tr></tbody></table></div></div>